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INVESTIGATIONS INTO THE FIBRINOLYTIC SYSTEM OF HUMAN
MIXED NATIVE SALIVA
Fibrinolysis is defined and a review of modern and historical concepts
of the fibrinolytic system is presented.
The nature of human mixed native saliva (MNS) and the problems of
its investigation are discussed. The literature concerning the fibrin¬
olytic activity of MNS, parotid and submandibular/sublingual saliva
is reviewed and the lack of agreement noted.
Preliminary investigations are described which establish the sensi¬
tivity of the fibrin plate technique and the consistent presence of
specific plasminogen activator activity in MNS. Considerable inter
and intra-personal variation in this activity is observed, but no vari¬
ation due to sex is recorded. The stability of plasminogen activator
is assessed at various temperatures over varying lengths of time.
Examination of supernatants and filtrates of MNS are described as
well as of the isolated parotid and submandibular/sublingual salivas.
Evidence is presented suggesting the absence of a soluble activator
and this is later substantiated in density gradient and gel chroma¬
tography experiments.
The elimination of a soluble activator establishes the activator activity
as residing in the salivary pellet which, consists of salivary mucus,
bacteria, leukocytes and desquamated epithelial cells. Systematic
investigations using fibrin plates and fibrinolytic autographs to test
both fresh and freeze-thawed suspensions of cells in tris buffer and
MNS supernatant establish the desquamated epithelial cells and cell
fragme nts/
fragments as providing by far the greatest amount of plasminogen
activator activity. More specific investigations of the salivary flora
are described.
The streptokinase-activated proactivator activity of MNS is investi¬
gated and two components are separated, a soluble proactivator and
a cell-associated proactivator.
Using the techniques of two dimensional immunodiffusion, tanned red
cell haemagglutination inhibition immunoassay, and by observing the
molecular weight and action of fractions of MNS supernatant obtained
by gel chromatography (Sephadex G200) when combined with strepto¬
kinase and incubated upon bovine fibrin plates, it is established that
all the streptokinase-activated soluble proactivator can be accounted
for by the presence of plasminogen.
Systematic examination of components of the salivary pellet using
bovine fibrin plates and bovine fibrin autographs in the presence of
streptokinase both with and without epsilon-aminocaproic acid is
described and although all cell types examined display proactivator
activity, the most prominent are epithelial cells. The possibility
that some of this proactivator activity might also be due to plasmin¬
ogen is discussed.
It is concluded that no soluble plasminogen activator exists in human
saliva and that the activator activity of MNS is brought about by the
incubation of epithelial cells possessing weak activator activity with
plasminogen secreted in the saliva of the major salivary glands. An
experiment demonstrating this is described. A diagramatic repre¬
sentation of the fibrinolytic system (activator and proactivator) in
human MNS is presented.
A /
iii
A short discussion as to the possible function of the fibrinolytic
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"Fibrinolysis can be defined as the enzymatic breakdown
of fibrin to fragments which are no longer able to form a
coherent net" (von Kaulla, 1963 ). Although the enzym¬
atic breakdown can be brought about by a variety of proteo¬
lytic enzymes, fibrinolysis in the 'clinical sense' is pro¬
duced by the enzyme plasmin, the proteolytic action of
which is non-specific but in the presence of inhibitors in
the blood, attacks only fibrin to which it is adsorbed (Rat-
noff, 1953). Dissolution by the fibrinolytic system is
determined not only by the presence of plasmin, but also
and primarily, by its content of substances capable of
converting plasminogen to plasmin, plasminogen activators
(Alkjaersig et al, 1958a).
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(ii) HISTORICAL AND MODERN CONCEPTS OF FIBRINOLYSIS: A
REVIEW
In his work 'De Sedibus et Causis Morborum' (The Seats and Causes
of Diseases), Morgagni (17 69) observed that blood remains fluid in
cases of sudden death. John Hunter (1794) made the same observ¬
ation while hunting, but it was not for many years that properly con¬
trolled scientific investigations into the relationship that exists bet¬
ween exercise and this phenomenon were made (Fearnley and Lackner,
1955: Billimoria et al, 1959: Ogston and Fullerton, 1961: Menon
et al, 1967 and Cash, 1968 and 1969).
Denis (1838) recorded that fibrin can dissolve spontaneously in an
alkaline solution of 16% nitrate. Liebig (cited by von Kaulla, 1963 )
was at first unable to confirm this but he did so later when, like Denis,
he used human fibrin in place of bovine fibrin he had used previously.
Thus, from the earliest days, a species difference was recorded which
has since been largely ignored.
Plosz (1873) noted that fibrin left in salt solution dissolved, but that
the ability to dissolve was eliminated by repeated salt extraction.
From this, he concluded that the extraction must elute a material
essential for the dissolution of the fibrin. Green (1887) noted that
the rate of dissolution is much less rapid in serum than in salt solu¬
tion and Denys and Marbaix (1889) found that a thermolabile proteo¬
lytic agent appears in serum after mixture with chloroform and ether.
Delezenne and Pozerski (1903) showed that this proteolytic agent in the
serum has the ability to digest gelatine and casein: an activity that is
inhibited by the addition of untreated serum.
The word 'fibrinolysis' was first used by Dastre in 1893. He studied
the influence of repeated haemorrhage upon the fibrinolytic activity of
the/
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the blood of dogs and noted that fibrin dissolves when left in contact
with the blood from which it is derived. This dissolution he called
'fibrinolysis'.
Nolf (1904 and 1905) published his work on the physio-pathology of
fibrinolysis, based on the principle that peptone injections produce
incoagulability of the blood in hepatectomized dogs (Gley & Le Bas,
1897). Nolf reported that this phenomenon is associated with a
marked increase in fibrinolytic activity that is due to irritation by
peptone of the vascular wall and the consequent release into the
circulatory system of a substance that enhances normal fibrinolysis.
He found it much easier to induce a fibrinolytic reaction by peptone
in dogs which are overfed on meat than in dogs not fed meat, thus
observing a possible association between diet and the fibrinolytic
activity of blood. In 1906, Morawitz offered a partial explanation
for Hunter's observations upon chased animals by noting that the
blood from victims of sudden death contains no fibrinogen and
speculated that this results from its digestion by an enzyme.
Furthermore, the victim's blood can destroy the fibrinogen and
fibrin of normal blood. Hedin (1903) found spontaneous fibrino¬
lytic activity in the globulin fraction of ox blood and Opie & Barker
(1907) were able to repeat this work and, in addition, show that
fibrinolytic activity induced by chloroform and ether treatment of
serum, resides in the globulin fraction of plasma obtained by salt
precipitation. Apart from some work by Nolf (1921) which showed
that proteolytic activity accompanied by fibrinolysis can be gener¬
ated in mammalian and avian plasma by chloroform, little other
work of significance took place until 1933.
Streptococcal fibrinolysis was discovered at the Rockefeller Institute
in 1933 by Tillett and Garner. It is from this very important con¬
tribution to the knowledge of fibrinolytic mechanisms that most
subsequent work on fibrinolysis stems, and thus it forms the natural
watershed between the largely fragmentary studies and the systematic
and/
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and interrelated work that has continued ever since.
Tillett and Garner (1933) found that the filtrates and broths of beta-
haemolytic streptococci cause rapid liquifaction of human blood clots.
Milstone (1941) showed that fibrin obtained from highly purified fib¬
rinogen is resistant to the lytic action of streptococcal filtrates, but
that lysis occurs when a small quantity of euglobulin fraction is added
to the test system. He called this accessory component the 'lytic
factor'. Christensen and MacLeod (1945) demonstrated that beta-
haemolytic streptococci produce an activator or kinase which they
termed 'streptokinase'. Streptokinase converts an inactive pre¬
cursor which they called 'plasminogen' to 'plasmin', the active pro¬
teolytic enzyme. Milstone's lytic factor is thus seen to be plasmin¬
ogen, and its active form plasmin can also develop autocatalytically
from plasminogen when serum is treated with chloroform. It was
now apparent why highly purified fibrin is not lysed by streptococcal
filtrates since purification diminishes the contaminating plasminogen
and there is consequently little enzyme precursor for streptokinase
to convert to plasmin.
The more important relevant aspects of the fibrinolytic system will




Plasminogen, a beta globulin (Robbins and Summaria, 1963) is the
inactive precursor of the enzyme plasmin and is present in the blood
and most body fluids (Sherry, 1966). The presence of plasminogen
in various human tissues was suggested by Kowalski et al (1958) and
Wille (1957) demonstrated appreciable amounts of plasminogen and
antiplasmin in the human placenta. In various exudates and trans¬
udates, a correlation exists between plasminogen and fibrinogen
levels: where fibrinogen is low or absent, plasminogen is reduced
or absent and where fibrinogen is abundant, plasminogen is present
in high concentrations (Sherry, 1966). Nitta et al, (1967) suggest
plasminogen might be present in saliva. No quantitative estimation
has, however, been made nor has its presence been determined by
direct methods. The site of production of plasminogen is uncertain.
Barnhart and Riddle (1963) using a fluorescent antibody-antigen tech¬
nique have shown that plasminogen is present in, and therefore could
be produced by, eosinophils. This work does not seem to have been
repeated.
Sgouris et al (1960) estimated the plasminogen levels in fresh human
plasma with a caseinolytic method and a mean value of 2. 58 (1. 72 -
3. 20) caseinolytic units per millilitre was determined. Plasmin
activity has also been assessed by its action upon modified fibrin
plates, its esterase activity with synthetic esters and by clot lysis
(Troll et al, 1954; Alkjaersig et al, 1959 and Wolf, 1968). An
elegant and more sensitive method for the estimation of plasminogen
was devised by Ludlam and Das (1971) who adapted the tanned red cell
haemagglutination inhibition immunoassay (TRCHII) for plasminogen.
Characterization:
Milstone first precipitated plasminogen out in the euglobulin fraction
of/
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of plasma in 1941. Plasminogen extraction from Cohn Fraction III
with a strong mineral acid (Christensen and Smith, 1950) was modified
by Kline (1953) and Kline and Fishman (1961) to obtain a higher degree
of purity. Concern about the technique however was expressed by
Slotta and Michl (1962) who suggested acid treatment procedures pro¬
bably produce several changes in the plasminogen molecule including
changes in molecular weight and substrate specificity. This object¬
ion was overcome when Wallen and Bergstrom (1959) and Alkjaersig
(1964) prepared plasminogen completely soluble at neutral pH by
chromatographic techniques. Wallen and Wiman (1972) have demon¬
strated ten different forms of plasminogen using zymographic analysis
after starch gel electrophoresis. However, of these, only six have
electrophoretic properties identical to those in human plasma. The
other four forms they suggest are probably altered forms of plasmin¬
ogen brought into being by proteolytic degradation during the extraction
processes.
Wallen and Wiman (1970, 1972) have identified two groups of plasmin¬
ogen from Cohn Fraction III, namely Glutamic acid NH^-terminal
plasminogen (Glu-plasminogen) and Lysine (or valine) amino terminal
residue plasminogen (Lys-plasminogen).
The chief characteristics of these two forms have been summarised by
Collen and Maeyer (1975).
Glu-plasminogen 1. NH -terminal glutamic acid.
2. Isoelectric points pH 6. 0 and 6. 6.
3. Electrophoretic mobility on starch
gel very similar to that of plasmin¬
ogen in unfractioned plasma.
Lys-plasminogen 1. NH -terminal lysine (or valine).
2. Isoelectric points pH 7. 3 and 8. 8.
3. Different electrophoretic mobility
from/
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from that of plasminogen in
unfractioned plasma.
Summaria et al (1973)have suggested that both forms are present in
circulating human plasma but the work of Collen and Maeyer (1975)
and Collen et al (1975) supports the view of Wallen and Wiman (1972)
that the Glu-plasminogen is the native form and that Lys-plasminogen
represents proteolytic degradation products of the native form.
Collen et al (1975) obtained Glu-plasminogen from fresh frozen human
plasma with over 90% recovery by affinity chromatography with lysine-
coupled agarose in the presence of the plasmin inhibitor aprotinin.
They also showed that the highly purified material had 20 - 24 CTA
units/mg. protein; an apparent molecular weight of 90, 000 * 2800
and that its six main molecular forms had isoelectric points ranging
from pH 6. 1 - 7.1. Plasminogen similarly prepared from Cohn
Fraction III paste pre-treated with aprotinin had the same molecular
forms and, in addition, other isoenzymes with isoelectric points
ranging from pH 6. 5 - 8.4 with an amino-terminal lysine residue
and an apparent molecular weight of 84, 300 - 3, 100 were present.
Using radioiodine - labelled plasminogen preparation, Collen and
Maeyer (1975) showed that when these preparations were injected
into men, the half life of Glu-plasminogen was 2 - 2. 5 days while
that of Lys-plasminogen was only 0. 8 days.
These data indicate that plasminogen isoenzymes with high molecular
weight, low isoelectric points, glutamic acid amino-terminal resid¬
ues and a long half life represent the native circulating plasminogen.
PLASMIN
The conversion of plasminogen to its activated form plasmin is a
proteolytic process and according to Alkjaersig et al (1958b) can
be considered analogous to the formation of other proteolytic enzymes
from/
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from their inactive precursors.
Robbins et al (1967) using Lys-plasminogen found that the polypeptide
chain of plasminogen is cleaved by urokinase at a single arginyl-
valine bond with apparently no molecular weight loss, and that the
active plasmin molecule produced is composed of two polypeptide
chains of different sizes linked by at least one disulphide bridge.
The molecular weight of the smaller chain (light chain) is about
25, 700 (Summaria et al, 1967) and that of the larger fragment (heavy
chain) 48, 000 (Summaria and Robbins, 1971).
However, during activation, there is a weight loss of plasminogen
from 81,000 - 75,400 (Barlow et al, 1969). The difference in mole¬
cular weights would be explainable by the liberation of a peptide frag¬
ment but the search for such a material has been unsuccessful. Recent
work by Wiman and Wallen (1975) suggests a two stage mechanism.
In the first stage, an 8, 000 molecular weight peptide is released from
the NH -terminal part of Glu-plasminogen. The remaining protein
z
represents one intermediate which in the second stage is cleaved to
give the plasmin molecule consisting of a light and heavy chain which
are connected by at least one disulphide bridge. The appearance of
enzymatic activity is related to the formation of the two chain plasmin
molecule. The intermediate product seems to be enzymatically in¬
active. Wiman (1973) reported that the material released in the first
step of the activation consisted of two peptides designated peptide I and
peptide II. The work of Rickli and Otavsky (1973) points in the same
direction and recently Rickli (1975) has prepared a model of the acti¬
vation mechanism. ( Diag. 1. ).
Step 1.
Proteolytic attack of urokinase in the NH^ terminal region of Glu-plas¬
minogen which leads to the liberation of a protein moiety and the con¬
comitant formation of a protein component still consisting of a single
polypeptide/
10
polypeptide chain. This protein is enzymatically inactive and it
represents an intermediate activation product.
Step 2.
The intermediate protein is hydrolysed by urokinase at a single peptide
bond apparently without liberating peptide material, thus forming the
active plasmin molecule. The enzyme is consistently described as
containing two polypeptide chains of different size, a heavy and a light,
chain which are connected by at least one disulphide bond. The experi¬
mental evidence indicates that the bond cleaved in the second stage is
an arginyl-valine bond as originally observed by Robbins et al. (1967).
According to these authors, the active centre is located in the light
chain.
With catalytic amounts of streptokinase, the nature and sequence of
events are probably the same as with urokinase and it appears that
similar and even identical activation products are obtained. With
stoichiometric amounts of streptokinase, however, the order of cleav¬
age of peptide bonds is reversed. Nevertheless, it appears this path¬
way finally yields activation products consistent with those described
above. (Rickli, 1975).
Plasmin itself is non-specific and can digest many proteins including
fibrinogen and fibrin. It is in the presence of inhibitors, e.g. in
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Schematic representation of the two-step activation mechanism
of human plasminogen induced by urokinase (UK). The arrows indicate
the observed cleavage of peptide bonds. (Rickli, 1975).
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STREPTOKINASE AND PROACTIVATOR
The early work upon streptokinase culminated with Christensen and
MacLeod (1945) demonstrating that beta-haemolytic streptococci
produce an activator capable of converting plasminogen to plasmin.
Mullertz and Lassen (1953) reported that the activation of plasmin¬
ogen by streptokinase is indirect and requires a further factor which
they called proactivator.
When streptokinase is placed on a bovine fibrin plate no lysis develops.
When streptokinase is placed on a human fibrin plate , a zone of
lysis does develop. Both plates contain plasminogen , therefore ,
either a species difference manifest in a variant of the plasminogen
molecule exists which is not susceptible to activation by streptokinase,
or an additional 'factor' exists in the human plate upon which strepto¬
kinase first acts and which in turn , when activated , activates plasmin¬
ogen ( Mullertz & Lassen , 1953 : Mullertz , 1955 &. 1956 ).
If proactivator exists ( the 'factor' above) , it is probable that a two
stage reaction is involved. Streptokinase initially would react rapidly
and stoichiometrically with proactivator in plasma ( Troll & Sherry,
1955 ) to form activator which would convert plasminogen to plasmin
(Alkjaersig et al , 1958b ). The existence of proactivator as a specific
substance is questionable. An early alternative , quoted by Amerytand
Claeys (1970) but without citation , is termed the inhibitor theory.
This theory presupposes the presence of large amounts of streptokinase
inhibitor in the blood of most species, except man and monkey. This
is unlikely since only a small amount of activator is produced in any
resistant species, even when large amounts of streptokinase are used
and the addition of a small amount of human euglobulin is capable of
promoting fibrinolysis (Kline, 1960).
De Renzo(1960) observed that proactivator had never been isolated
and human plasminogen had never been prepared devoid of proacti¬
vator/
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vator activity and, consequently agreed with Ablondi and Hagan (1956)
that plasminogen and proactivator are probably one and the same
thing. Little definitive work seems to have been done at this time to
elucidate the chemical sequence of events in the interaction of strep¬
tokinase and plasminogen and virtually nothing was known about the
molecular nature of the products found in the interaction; probably
because the generation of activator, activation of plasminogen and
autodigestion of the enzymes are occurring simultaneously. How¬
ever, it was known that the relative concentrations of human plasmin
and bovine plasminogen activator demonstrable in a streptokinase -
human plasminogen reaction mixture depends primarily upon the ratio
of streptokinase and plasminogen. When streptokinase is present in
high concentrations relative to plasminogen, activator activity pre¬
dominates, whereas an excess of human plasminogen favours the
generation of plasmin activity (Kline and Fishman, 1961: Markus
and Ambrus, 1960: De Renzo, 1960 and Alkjaersig et al, 1958b).
The work of Kline and Fishman (1961)has confirmed the results of
Zylber et al (1959) that streptokinase reacts with plasmin to form
activator activity and that such a complex represented one molecular
form of activator. Davies et aL(1964) found the molecular weight of
the streptokinase-plasminogen reaction product very close to the sum
of the molecular weights of unmodified streptokinase and unmodified
plasminogen, but he conceded in his discussion upon this finding that
the reaction product could well be a streptokinase-plasmin product
as had been suggested by Zylber et al.(1959) and Alkjaersig et al
(1958b) as the molecular weight of this reaction product would be very
close to that of a streptokinase-plasminogen product if such a product
existed. Thus in respect of streptokinase, 'activator' was believed
to be a complex of human plasminogen or plasmin and streptokinase
(De Renzo et al, 1967: Summaria et al, 1969: Ling et al, 1965 and




In 1971, Kline and Ts'ao demonstrated that spontaneous plasmin
activity can be removed almost completely from human plasminogen
preparations by extraction with soybean trypsin inhibitor and treat¬
ment with diisopropyl fluorophosphate. The conversion of this plas¬
minogen to plasmin by catalytic amounts of streptokinase then pro¬
ceeds independently of the availability of preformed plasmin. Thus
there is the added possibility of streptokinase being capable of acti¬
vating plasminogen directly without the prior formation of a plasmin
complex or any other plasminogen activator.
Reddy and Markus (1972) agree that streptokinase can activate human
plasminogen directly in the absence of spontaneous plasmin, but pre¬
sent evidence which they claim shows that streptokinase does not
activate human plasminogen by a direct catalytic process, but that
the streptokinase-plasminogen complex is the predominant activator
species and that plasmin when present can act as proactivator.
Putting the problem in perspective, Reddy and Markus (197 2) feel
there is sufficient evidence to show that when streptokinase is added
to human plasminogen, it immediately forms stable stoichiometric
complexes with plasmin and plasminogen, both of which can function
as activators, leaving little, if any, streptokinase in the free state.
Thus there is no need to ascribe to streptokinase an independent en¬
zymatic role, albeit that in highly artificial circumstances, it may
be capable of activating bovine plasminogen. The question arises as
to how this happens. The data presented by Reddy and Markus (1972)
and independently by McClintock and Bell (1971) provides evidence that
an active centre is formed in the zymogen molecule upon interaction
with streptokinase. Further evidence for an active site was provided
by Reddy and Markus (1973). In addition, they were also able to show
that pancreatic trypsin inhibitor abolishes both the activator activity
and the ability to react with an active centre - specific reagent. This
is accomplished, not by displacement of streptokinase, but by the for¬
mation of a ternary complex with streptokinase-plasminogen.
Recently, /
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Recently, evidence has been presented by McClintock et al (1974) for
the existence of two distinct pathways of streptokinase - mediated
activation of human plasminogen. They have observed with cata¬
lytic amounts of streptokinase the cleavage of Glu-plasminogen
first into fragments with a molecular weight of 80, 000 and 5, 000 fol¬
lowed by a cleavage of the 80, 000 fragment into 60, 000 and 20, 000
fragments. According to NH terminal analyses the small peptide
z
occupies the NH terminal part of Glu-plasminogen. The fragments
z
with a molecular weight of 60, 000 and 20, 000 possess NH -terminal
lysine and valine respectively and may, therefore, correspond to the
heavy and light chains of plasmin generated by urokinase.
Interaction of Glu-plasminogen with stoichiometric amounts of strep¬
tokinase leads to the formation of a plasminogen-streptokinase comp¬
lex.
The peptide bond cleavage of plasminogen within this complex occurs
in the reverse order to that of the activation with catalytic amounts of
streptokinase. A first split produces fragments with molecular
weights of 65, 000 and 20, 000 and from the heavier component a 5, 000
molecular weight peptide is then cleaved to yield a remaining fragment
with a molecular weight of 60, 000.
NH -terminal analyses indicate however, that the nature of the pep-
Z
tide bond, cleaved in both pathways, is most likely the same. The
reason for the difference in sequence of events must apparently be
sought in conformational alterations in the plasminogen molecule.
It is assumed that such changes or rearrangements in the zymogen
occur when it combines with streptokinase to form the stoichiometric
complex. Thus the concept of proactivator as Mullertz understood
it, a separate substance in human plasma and in no way to be confused
with plasminogen and essential for streptokinase bovine plasminogen
activation might reasonably be thought to be unnecessary for an under¬
standing of the mode of action of streptokinase. However, evidence
is/
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is accumulating that, (1) some streptokinase activated plasminogen
proactivator does after all exist and (2) a plasminogen proactivator
which is not activatable by streptokinase also exists.
1. Takada et al (1965, 1968, 1969 and 1969) first repeated the work
of Mullertz and Lassen (1953), then after using the heated plate tech¬
nique, claimed that proactivator cannot be plasminogen or plasmin
because the plate is not lysed even after the proactivator is activated
by streptokinase. Accordingly, they claim proactivator cannot
simply be a complex of streptokinase and plasminogen.
A heated fibrin plate is not simply a plasminogen free plate as the
heating changes the reactivity of the fibrin (Shiba et al, 1973) and
therefore, on this evidence, plasminogen cannot be excluded from
the role of proactivator.
However, Takada et al.(1970) claim to have fractioned by gel filt¬
ration, a proactivator (called proactivator A) for both human and
bovine plasminogen and have shown that there is no cross reactivity
of this substance with highly purified preparations of plasminogen in
immunodiffusion tests. Furthermore, a mixture of streptokinase
and proactivator could not digest casein in the absence of plasmino¬
gen. Small amounts of streptokinase converted this isolated pro¬
activator into activator which in turn converted human plasminogen
to plasmin, but the same amount of streptokinase could scarcely
activate plasminogen in the absence of proactivator. Takada was
able to further show that this isolated proactivator is acid labile,
and loses its activity even at 56°C whereas plasminogen is only
denatured over 85°C. He quotes Lassen (1952) as his authority
for this claim of plasminogen stability, but Lassen in fact made no
such claim. If his graphs are studied, it will be seen that denatur-
ation is largely a function of time as well as temperature. Lassen
effectively destroyed all available plasminogen in a plate in fifteen
minutes at a temperature of 95°C and in fifty-five minutes at 70°C.
At/
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At 60°C, only about 20% of undenatured plasminogen remained after
sixty minutes. Lassen did not continue heating beyond this time
and clearly Takada's claim in reference to Lassen's work is suspect.
Takada concluded that his findings were in no way incompatible with
the finding that streptokinase forms a complex with human plasmin¬
ogen or plasmin (indeed he refers to human plasminogen as 'pro-
activator B') nor even that it attacks human plasminogen directly,
but simply that that was not the whole story. Further characterization
of 'proactivator A' (Takada et al, 1972) has led to an estimation of its
molecular weight, 275, 000 - 25, 000. Proactivator A migrates in the
alpha macroglobulin region in electrophoresis, is very homogeneous
and has a sedimentation rate of 11. 7S. This isolated substance was
once more shown to promote caseinolysis induced by human plasmin¬
ogen and streptokinase, but had no effect on the activation of human
plasminogen by urokinase.
The fact first established by Blatt et al (1964) and confirmed by Reddy
and Markus (1972)in their experiments that maximum activity towards
human plasminogen is obtained when streptokinase and plasminogen
are present in a 1:1 molar ratio limits, Reddy claims, the choice of
proactivator to either plasminogen or plasmin. Clearly, if any other
proactivator, such as proactivator A had been responsible for the
mechanism of activation, the streptokinase-plasminogen ratio at maxi¬
mum activator activity would have been less than 1.0. Not an easy
criticism to refute. Kinetic studies performed by Werkheiser and
Markus (1964) suggest that the streptokinase activation of human plas¬
minogen is catalysed by 'Activator 1', a complex formed between strep¬
tokinase and 'Proactivator 1', which is a substance postulated to be
present in variable amounts in solutions of human plasmin - strepto¬
kinase complex discussed above. Thus so far, the proactivator A




2. In addition to the streptokinase activated proactivators discussed
above, there is strong evidence to suggest the existence of a plasmin¬
ogen proactivator which is not activated by streptokinase. To ex¬
plain this, a short digression is necessary.
The activation of Hageman factor is required for the initiation of three
biologically active protein sequences in human plasma. The coagu¬
lation sequence proceeds by the activation of Hageman factor upon
precursor plasma thromboplastin antecedent (pre-PTA)(Ratnoff et al,
1961) and the kinin-generating pathway by the action of activated Hage¬
man factor upon prekallikrein (Kaplan and Austen, 1970 and 1971).
Thirdly, Niewiarowski and Prou-Wartelle (1959) demonstrated that
activation of factor XII induced formation of plasmin from plasmino¬
gen. Later Iatridis and Ferguson (1962) found that this activation
required participation of a second factor. Ogston et al (1969) worked
on the isolation and purification of this plasma plasminogen proactivator
and named it Hageman factor - co-factor. It has been shown that pre¬
kallikrein is also involved in plasminogen activation as the kaolin in¬
duced plasmin formation in prekallikrein deficient plasma is reduced
(Wuepper, 1972: Weiss et al, 1974 and Saito et al, 1974). The prob¬
lem then has arisen as to whether or not unactivated Hageman factor-
co-factor is identical to prekallikrein. Whereas Kaplan and Austen
(1972) and Cochrane et al (1973) deny that kallikrein can transform
plasminogen to plasmin both Colman (1969) and Wendel et al (1972)
have reported that it can. Studies by Laake and Vennerod (1974)
indicate that plasma prekallikrein and factor XH-dependent plasmin¬
ogen proactivator are identical.
The results, therefore, of current work are confusing and until further
evidence is forthcoming, it is probably reasonable to consider Hageman




To summarise the position to date is difficult, but it is probably
fair to say that : -
Firstly, streptokinase forms a complex with human plasminogen and
or plasmin which has an activator activity capable of lysing both human
and bovine fibrin, and that such a complex is not formed with bovine
plasminogen, the reason for which is not known but may presumably
be related to some unknown species difference. That streptokinase
can, under special circumstances, activate purified human plasmino¬
gen without first forming plasmin-streptokinase activator is estab¬
lished.
It has been recently reported that while native streptokinase cannot
activate bovine plasminogen, a derivative of streptokinase (SK"^)
prepared by interaction of streptokinase with human plasminogen is
capable of activating bovine plasminogen (Reddy and Kline, 1975).
They present evidence to show that the activator activity of SK"^ to¬
wards bovine plasminogen requires the presence of trace amounts
of human plasmin. When SK'*' preparations were completely freed
of plasmin by passage through a lysine-sepharose column, bovine
activator activity disappeared, but human activator activity remained.
Addition of human plasminogen to the column-treated SK^ preparation
reinstated the bovine plasminogen activator activity. This work is a
further demonstration of the proactivator nature of human plasminogen.
Secondly, evidence exists that a human plasminogen proactivator may
be present in human plasma as an alpha macroglobulin which, when
activated by streptokinase, is capable of converting both human and
bovine plasminogen to plasmin.
Thirdly, a proactivator exists which is not streptokinase activatable
but which is essential in the pathway for Hageman Factor (or Hageman
fragments) to convert plasminogen to plasmin.
TISSUE ACTIVATOR
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The earliest suggestion that tissues might produce a substance with
fibrinolytic properties came from those working upon tissue culture
who observed lysis of the plasma clots used as nutrient medium
(Lambert & Hanes, 1911: Fleisher & Loeb, 1915). Fleisher and
Loeb claimed that the genito-urinary tract was most active and the
liver almost inactive although species differences were found to exist.
Demuth and Van Riesen (1928) suggested that the cells released a
substance which activated a proteolytic enzyme in the medium, rather
than a substance that lysed fibrinogen directly, an opinion substanti¬
ated later by Fischer (1946) and Astrup and Permin (1947). In 1947,
Astrup and Permin devised the fibrin plate (see Part II). They were
able to prove that the fibrinolytic activity present in tissues is indeed
due primarily to a plasminogen activator rather than a fibrinolytic
enzyme. They further showed that the ability to activate plasminogen
was retained by a tissue even after several weeks immersion in a
toluene and chloroform solution. The ability then to activate plasmino¬
gen is not dependent, or at least not entirely, on the metabolism of the
living cell.
Astrup and Sterndorff (1952) showed that saline extracts prepared from
human lung and pig brain were active when estimated by the fibrin plate
method but no activity was demonstrable on the plasminogen-free heated
plate (Lassen, 1952). In addition to the readily saline extractable and
labile activator, a much less soluble activator, stable at pH 3 and cap¬
able of withstanding heating at 70°C for thirty minutes, is present in
greater proportions and can be extracted with 2M potassium thiocyanate
(Astrup & Stage, 1952). Albrechtsen (1957) employing this technique
demonstrated large amounts of tissue activator in the uterus, adrenal
and 1 ymph nodes, prostate, thyroid, lungs and ovary but found the
liver almost inactive. No correlation between the activator concen¬
tration and age or sex could be established although considerable in¬
dividual variation was observed.
A /
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A histochemical technique (fibrinolytic autography), based upon the
fibrin plate method, in which frozen sections of fresh tissue are placed
upon thin layers of fibrin made upon glass slides was developed by Todd
in 1958. Following incubation and staining, foci of fibrinolysis can be
seen in relation to those structures containing tissue plasminogen acti¬
vator.
EPITHELIAL CELLS
It has been shown that some epithelial cells contain activators of plas¬
minogen. Squamous epithelial cells from human vagina (Tympanidis
et al, 1968) and rat vagina (Henrichsen and Astrup, 1967) have been
found to be fibrinolytically active. Tympanidis et al (1968) observed
that vaginal epithelial cells at a stage of their hormonally regulated
evolutionary development acquire the capability to produce and release
plasminogen activator. They suggest the prior hormonal influence
could possibly explain why some cells are fibrinolytically active while
others apparently in the same stage of development are inactive. It
would appear that younger cells release activity during the period in
which they become mature and begin to undergo degeneration. This
was evident from the previous studies in the rat (Henrichsen and Astrup,
i
1967) where cornified cells were usually inactive while at stages where
cells apparently were losing their nuclei, active anuclear cells could be
observed among the bulk of inactive cornified cells. This finding is
similar to the observation that corneal epithelial cells, normally fib-
i r
rinolytically inactive, are able to release plasminogen activator after
injury or during degeneration (Pandolfi and Astrup, 1967). These
findings suggest the possibility of plasminogen activator activity being
related to degenerating epithelium. Kwaan et al (1969) consider that
this may be the reason for increased fibrinolytic activity in the inflamed
rectal mucosa in patients suffering from acute ulcerative colitis. Birn
and Fejerskov (1971) appear to have been the first workers to study
human oral epithelial cells. Using fibrinolytic autography and control¬
ling/
21
ling their work by examining endothelial cells under similar con¬
ditions, they found that squamous epithelial cells from the buccal
mucosa are fibrinolytically active although not to the same extent
as endothelial cells. The fibrinolytic activity was mainly associ¬
ated with the basal, parabasal and spinous cells but occasional foci
were related to anuclear cells. In each of their smears, only 10 -
30 pericellular areas of lysis were recorded and the majority of the
cells did not show any activity at all. Myhre-Jensen and Astrup
(1971) carried out experiments upon squamous epithelium derived
from the oral cavity and oesophagus of the rat, guinea pig and rabbit
and from this work provided additional evidence of the presence of
plasminogen activator in surface epithelial cells of some species
i r
and of the release of this activity during normal cellular degener¬
ation or after injury. The activity appeared to originate in the
intermediate cell layers of the stratified squamous epithelium,
whilst the basal layers and the most superficial cornified layers
were inactive. Fibrinolysis also seemed most marked in areas of
cellular detachment. Wunschmann-Henderson and Astrup (1972)
using a combination of Papanicolaou's staining technique and fib¬
rinolytic autography demonstrated the presence of fibrinolytic acti¬
vity in buccal smears to be correlated with specific states of cellular
maturation. The highest percentage of fibrinolytic cells was found
among the groups of younger desquamated epithelial cells.
/
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THE SEQUENTIAL ACTION OF PLASMIN UPON FIBRIN AND
FIBRINOGEN,
Human fibrinogen is composed of two pseudo-identical monomers
joined by a number of symmetrical disulphide bonds (Soderqvist
and Blomback, 1971). Each monomer consists of three poly¬
peptide chains the respective molecular weights of which are
63, 800, 56, 000 and 47, 000. These molecular weights are con¬
sistent with the estimated molecular weight of 340, 000 of the dimer
(McKee et al, 1966). The N-terminal segment of the fibrinogen
molecule contains eleven disulphide bridges which form a firm
"Disulphide Knot", the primary structure of which consists of
about 16% of the whole fibrinogen and has been completely eluci¬
dated.
Very little is known as yet about the remaining C-terminal part.
Plasmic hydrolysis of fibrinogen produces high molecular weight
Fragments. Nussenzweig and Seligman (1960) identified and partly
characterized five terminal digestion products called Fragments A,
B, C, D and E. The physiologically early degradation products
which are potent anticoagulants have been isolated from partial
plasmin digests and designated as Fragments X and Y. A scheme
for the asymmetrical fragmentation of fibrinogen by plasmin has







































(MARDER et al, 1972).
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DEGRADATION PATHWAY OF FIBRINOGEN
BY PLASMIN
Marder, 1972.
In the early phase of plasmic hydrolysis, the beta and gamma chains
of, fibrinogen lose small molecular weight peptides at the N- terminal
and C- terminal ends, respectively. Large polypeptides are prog¬
ressively being split from the C-terminal part of the alpha chain.
Fragment X was found to be a heterogeneous population of molecules
differing in the length of their alpha chains. On further digestion,
one pair of disulphide-bound beta and gamma chains is released from
the fragment X, giving rise to fragment Y, which in turn splits into
another beta-gamma dimer and fragment E. The beta-gamma dimer
corresponds to Fragment D and Fragment E may be identified at least
partially with the disulphide knot (Furlan and Beck, 197 2). Fragments
A, B, C, D and E are resistant to further digestion by plasmin. Each
fragment represents an intact portion of fibrinogen and it is not sur¬
prising, therefore, that they all have similar antigenic activity - the
two major determinants being the D and E antigens. Fibrinogen, Frag¬
ment X and Fragment Y each carry both determinants while Fragments
D and E carry only the one respectively. Thus an antiserum raised
to fibrinogen or a mixture of the products (i. e. with both anti-D and
anti-E activity) will react with all fragments. This common immuno¬
logical activity is the basis of many of the assay systems for FDP.
The degradation of fibrin by plasmin is believed to follow the same path¬
way as above and so far using routine immunological methods, no sig¬
nificant/
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nificant difference has been demonstrated between fibrin products
and fibrinogen products. However, a very recent radioimmunassay
technique does detect slight differences between these two groups
(Plow and Edgington , 197 2 ).
Fibrin/fibrinogen degradation products have been demonstrated in the
serum of 95% of normal healthy individuals to a level of five micro-
grammes/ml. , these circulating fragments being identical to those
prepared and described using in vitro techniques (Das et al, 1967).
An increase in this level is caused by one of two ways, either by
primary activation of the fibrinolytic system giving rise to FDP or
by secondary activation stimulated by increased coagulation and .re¬
sulting in the breakdown of fibrin to FDP.
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THE FIBRINOLYTIC MECHANISM IN VIVO
The basic components of the fibrinolytic system, plasminogen, plasmin,
activators and proactivators of plasminogen, but not plasminogen inhib¬
itors have been discussed. If is, therefore, appropriate now
to consider in a simplified manner how these parts may be integrated
to form the whole. Two main mechanisms of fibrinolysis in vivo
have been proposed: the Sherry hypothesis, and the plasmin-inhibitor
complex hypothesis advocated by Ambrus.
The Sherry Hypothesis
The hypothesis (Sherry et al, 1959) is widely accepted as a working
hypothesis to explain how the relatively non-specific proteolytic enzyme,
plasmin, is largely restricted in vivo to a single highly specific action,
digestion of fibrin.
In a system that includes both plasma and clot, plasminogen exists in
two phases. Plasminogen in the plasma represents the soluble phase
and plasminogen in the clot the gel phase. Plasminogen activation in
the soluble phase, produces no effects on susceptible substrates in the
plasma because plasma antiplasmin rapidly inhibits plasmin as it is
formed. However, rapid plasma plasminogen activation may, by a
temporary overwhelming of the antiplasmin mechanism, permit the
appearance of free plasmin in the circulation with digestion of a variety
of substrates including fibrinogen and other coagulation factors and
hence produce a haemorrhagic state.
Plasminogen activation in the clot or gel phase, where the effect of
inhibitors on adsorbed activator and plasminogen is weaker than in the
plasma, produces a different result. Under these conditions because
of the spatial relationship of plasminogen and fibrin, plasminogen
activation produces fibrinolysis. Lytic activity then is considered
as a function of clot plasminogen content. Sherry suggests that the
main function of plasma plasminogen is to endow any intravascular
fibrin that may form with the means to bring about its own lysis when
activator/
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activator is either adsorbed upon it during its formation or subse¬
quently diffuses into it from the plasma. Plasminogen is known to
have a strong affinity for fibrinogen and fibrin (e. g. Blomback and
Blomback, 1956) and activator is also adsorbed onto fibrin (Fearn-
ley et al, 1952).
The Plasminogen-Inhibitor Complex Mechanism (Ambrus)
A brus and Markus (1960) have suggested that plasmin may circu¬
late in the plasma as a dissociable complex with antiplasmin, and
that fibrin competes for the plasmin with antiplasmin: in this way,
there is dissociation of the plasmin-antiplasmin complex and speci¬
fic localization of plasmin on fibrin. Thus effective substrate specif¬
icity is conferred on plasmin.
Objections
The Sherry hypothesis is almost universally accepted but evidence
is accumulating to suggest plasminogen is not, in fact, adsorbed to
fibrin when it forms and that the only plasminogen present in a
thrombus is that contained in the trapped plasma (Hedner et al,
1966: Ogston et al, 1966). -De Witt (1964) and Fantl (1962) demon¬
strated that the plasminogen contect of plasma and serum is identi¬
cal. A further objection is raised by the observations of McNicol
et al (1965) and by Dalai et al (1969) that in artificial thrombi per¬
fused with plasminogen activator in saline, full thrombolysis may
not occur unless the perfusion medium is plasminogen-enriched.
Sharp et al (1972) had demonstrated that antiplasmin is also present
in trapped plasma within a thrombus.
The objections outlined above do themselves raise problems. One
of these is succinctly put by Sharp, "If it be accepted that plasmin¬
ogen is not bound to fibrin and that in the fibrin mass, plasminogen
and antiplasmin are contained only in the trapped plasma, how can
activator induce thrombolysis? "
A/
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A variation of the Ambrus hypothesis has been forwarded by Sharp
et al (1972). It is that activator can link with an alpha globulin in
the plasma or in the trapped plasma of a thrombus and generate from
the plasminogen, a plasmin that is protected from the action of anti-
plasmin, the receptor linkage for antiplasmin apparently being blocked
by the alpha globulin.
Confirmatory evidence for any of these hypotheses is lacking but there
are sufficient problems inherent in each to make the research worker
use them only as working models always ready to be modified as new
facts come to light.
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THE ROLE OF THE FIBRINOLYTIC SYSTEM IN VIVO
There is evidence to support the view that urokinase has a physio¬
logical role in maintaining the patency of the urinary tract (McNicol
et al, 1961) and a similar function may exist elsewhere as plasmin¬
ogen activator is found in milk (Astrup & Sterndorff, 1953), tears
(Storm, 1955), saliva (Albrechtsen & Thaysen, 1955), and seminal
fluid (Albrechtsen, 1958). Tissue fibrinolytic activity is localized
in sites at the angle of the anterior chamber of the eye and is re¬
lated to the canal of Schlemm (Kwaan & Astrup, 1963). In the foetus
and newborn infant, outflow of aqueous humour has not yet been
established and the fibrinolytic activity at this stage is also absent
(Pandolfi & Kwaan, 1967). The diffuse superficial fibrinolytic
activity of normal endometrium increases during the menstrual
cycle and is maximal at the time of menstruation in the shed endo¬
metrium (Todd, 1964). In women with menorrhagia, Rybo (1966)
reported that the levels of plasminogen activator in the endometrium
were higher than those in women with normal menstrual loss.
Plasma fibrinolytic activity may be reduced in patients suffering
from diseases associated with thrombosis (McNicol & Douglas, 1972).
Nestel (1959) found reduced plasma fibrinolytic activity in a group of
patients with intermittent claudication as compared with healthy
controls. Ellison and Brown (1965) observed that in patients with a
previous episode of pulmonary embolism systemic fibrinolytic acti¬
vity was low. In patients suffering from deep venous thrombosis,
Pandolfi et al (1969) found reduced systemic fibrinolytic activity,
and plasminogen activator in their vein walls was also reduced.
High levels of naturally occurring fibrinolytic inhibitor may be associ¬
ated with widespread thrombotic disease (Nilsson et al, 1966: Brak-
man et al, 1966).
In 1970, 63, 640 deaths were recorded in Scotland and of these 33, 958
(53.4%)/
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(53.4%) were attributed to the circulatory system. Heart disease
accounted for 21,497 and cerebrovascular disease for 9, 952 deaths.
To put these figures in perspective in terms of death rate per 100, 000
of the population the neoplasia figures are 271 male and 217 female
compared with 460 male and 370 female for heart disease (Annual
Report of the Registrar General for Scotland 1970: Part 1. 'Mor¬
tality Statistics' No. 116).
The formation of fibrin is a part of normal tissue repair but in order
to restore normal conditions, the fibrin has to be dissolved. In large
infected wounds where great numbers of leukocytes are present,
fibrin may be removed chiefly by a cellular mechanism (Astrup,
1968) but as the weak lytic effect of leukocytes is caused predomi¬
nantly by a protease (Astrup et al, 1967: Wunschmann-Henderson
et al, 1972) they probably play a secondary role, the principal role
being played by the capillary endothelial cells at the commencement
of and during organisation as these cells produce considerable
quantities of plasminogen activator (Astrup et al, 1967). The fib¬
rinolytic activity of human joint tissues, synovial membranes and
fibrous capsular tissues is low (Astrup and Sjolin, 1958: Nikitin
et al, 1968) as is the content of tissue thromboplastin. These
findings may explain why haemophilic patients bleed easily into
their joints and why extensive fibrosis is a common finding in these
joints.
Cliffton and Grossi (1955) were able to demonstrate that with carcin¬
omas of the breast which were activators of human plasminogen in
vitro, there was a higher incidence of positive axillary nodes in vivo
although anti-coagulants and fibrinolysins have been shown to reduce
the growth and spread of malignant tumours in experimental animals
(Wood et al, 1961: Cliffton and Agostino, 1965). Ogston et al (1971)
observed that the presence of hepatic metastases was associated with
the reduced plasminogen levels in association with low activator levels.
The significance of this is not yet known.
Thus/
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Thus the process of fibrinolysis and fibrinolytic activity is ubiquit¬
ous not only anatomically, but also by its participation in the clas¬
sical divisions of pathology, inflammation and neoplasia. If to this





The salivary glands of man consist of three paired, large glands
(parotid, submandibular and sublingual) and the smaller glands
(labial, lingual, palatal and buccal). In this work, the secretion
of any one of these glands is prefixed by the name of the gland, e. g.
'parotid saliva'.
Naturally pooled salivary secretions complete with cellular matter,
gingival fluid etc. are referred to as 'mixed native saliva' or MNS.
Cannulation or cupping enables the collection of a specific secretion
and if two such secretions are pooled, the resulting fluid is called
'artificially mixed saliva' or AMS.
The salivary secretions flow into a cavity which is open to the atmos¬
phere and is therefore heavily contaminated with bacteria. The
cavity is lined by oral mucous membrane which continually sheds
epithelial cells and in the dentate a variable amount of gingival
fluid containing leukocytes is added to the MNS. From time to time
during the day, a certain amount of food debris will also be in sus¬
pension. Thus the fluid that bathes the teeth and oral mucosa (MNS)




4. Leukocytes and gingival fluid.
5. Food debris.
With the exception of food debris, these were all considered in re¬




MNS is the fluid that actually bathes the teeth and mucosa and ulti¬
mately it must be the action of this fluid that has to be assessed when
consideration is given to the effect saliva has on, for example, blood
clotting in a tooth socket or digestive action within a food bolus.
Centrifuged MNS gives lower figures for some constituents than does
uncentrifuged (Jenkins, 1966) but on the other hand, if the suspended
matter is not removed analytical procedures are much more difficult.
For practical purposes, this separation must take place and two en¬
tities recognised, the supernatant and the pellet. The separation
itself is not without hazard for ultracentrifugation can break up cells
but such centrifugation is required as many of the suspended particles
in saliva are very small indeed.
Qualitative examination of supernatant saliva is generally straight
forward, and the absence or presence of an enzyme, electrolyte or
vitamin determined, but accurate quantitative analysis is extremely
difficult. The contributory secretions differ in composition and
relative contribution. The individual contributary secretions do
themselves vary in composition with conditions such as rate of flow,
type and intensity of stimulus, time of day or week, and the nature
and time of the last meal prior to collection. The presence of living
bacteria, if they have not all been removed by centrifugation, and the
spontaneous loss of carbon dioxide after collection causes changes in
the composition on standing and thus the accuracy of some analytical
techniques depends upon the length of time elapsing between collection
and analysis.
Collection of 'pure' saliva by cannulation and cupping is full of pit¬
falls. In this work, the writer has had recourse to collect parotid and
submandibular/sublingual saliva and has found many problems not
always mentioned by other workers. The impression given by some
workers/
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workers is'that cannulation or cupping will provide a 'pure' secretion.
Examination of the secretions collected in this work frequently reveal¬
ed the presence of desquamated epithelial cells and cell fragments which
necessitated removal by centrifugation. When a Curby cup was in situ
and apparently well attached, it was interesting to observe that when a
few drops of Cochineal food dye was placed by pipette into the subject's
mouth, there were occasions when it would not have been necessary to
resort to a colorimeter to determine the presence of the dye in the
'pure' parotid saliva.
The writer cannot claim ever to have collected unstimulated saliva.
With practiced people in the Laboratory who were used regularly for
pilot experiments, it became easier to collect saliva and a practice
effect, although never measured in this work, was certainly apparent.
At best, a distinction could be made between deliberately stimulated
saliva and very carefully collected relatively unstimulated saliva. To
extrapolate one's findings from a study population to the community is
not without danger. The writer found that although he took most of his
subjects at random from the student body, the criteria of "no clinical
evidence of gingivitis" removed several from the samples and when col¬
lection did begin approximately one third of the subjects proved quite
hopeless for obtaining an adequate sample of every saliva. Parotid
collection proved most difficult, mainly with the unstimulated flow,
and even MNS collection, naively assumed at the start of the work to
be straightforward frequently provided more froth than fluid.
Variables such as age, sex, time of collection and time of the last meal
are data that can be recorded objectively, but many of the above vari¬
ables cannot be assessed.
From the comments made in the literature and from what the writer
experienced during preliminary investigations,the following salivas
were chosen for this work.
1./
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1. MNS. This is the fluid that bathes the teeth and mucosa and is
ultimately the substance acting upon a blood clot in the mouth.
Every effort was made to collect it under two conditions; relative¬
ly unstimulated being as near as practically possible to representing
the fluid bathing the oral structures at rest, and stimulated when
'
large quantities of MNS or its supernatant were required for quali¬
tative analysis.
2. The supernatant of MNS. Generated from stimulated MNS first by
low speed centrifugation at 4154 g. and then a further centrifugation
of the supernatant at 3 6, 664 g. Qualitative analysis was carried out
upon the supernatant for soluble activator(s) and plasminogen.
3. Isolated secretions from parotid and submandibular/sublingual
salivary glands in order to obtain information concerning the source
of soluble activator or of plasminogen. Less than 8% of the sali¬
vary secretions arise from the minor salivary glands (Dawes and
Wood, 1973) and therefore it is reasonable always to examine the
paired glands first.
4. Salivary pellet. In the analytical sieve this may be taken as con¬
sisting of four main parts, viz. mucus, bacteria, epithelial cells
and leukocytes. These constituents were studied separately, and
following isolation were also recombined with the supernatant of
MNS to indicate a possible role in vivo.
Details of the collection of saliva are contained in the Methodology.
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(ii) THE FIBRINOLYTIC ACTIVITY OF SALIVA
Using the bovine fibrin plate much improved by Astrup and Mullertz
(1952), Albrechtsen and Thaysen (1955) first described the fibrino¬
lytic activity of saliva. They found that plating both parotid and
mixed native saliva (MNS) produced only "slight" activity, but that
the addition of streptokinase to the salivas enhanced activity con¬
siderably. Heated fibrin plates were considered as synonymous with
plasminogen-free plates and upon these they found no activity either
with or without the addition of streptokinase, and from this deduced
the absence of both plasminogen and a fibrinolytic enzyme. Human
fibrinogen used in the assessment of salivary fibrinolytic activity
appears to have been first used by Taylor et al (1964) when saliva was
substituted for euglobulin in a clot lysis time experiment. They found
lysis of the clot occurred rapidly in all samples tested being most
rapid in MNS and parotid. MNS supernatant while producing lysis, did
so less rapidly. No details of saliva collection, centrifugation or con¬
trol other than with saline are given. They concluded that a fibrino¬
lytic enzyme must be present together with a streptokinase-activated
proactivator, but not a plasminogen activator. They also found that
when the pellet was tested for lysis, in most instances lysis did not
go to completion in twenty-four hours. Dolci (1965) using thromb-
elastographic techniques deduced the presence of both activator and
pro-activator, and Tortelli (1967) returning to bovine fibrin plates con¬
cluded that MNS has a fibrinolytic activity that is enhanced by strepto¬
kinase but that MNS supernatant, parotid and submandibular saliva do
not cause fibrinolysis except with the addition of streptokinase. He
concludes that the fibrinolytic activity must be related to the pellet
(cf. Taylor et al, 1964). Schulte published eleven papers between
1964 and 1967 concerning saliva and fibrinolysis and in 1970 presented
a summary of his findings. His experimental methods were confined
to the bovine fibrin plate and thrombelastographic techniques. He
claims the presence of an activator in small quantities and pro-acti¬
vator/
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vator in much larger amounts. Pro-activator was always demon¬
strable but activator was not present on some days. Plasmin¬
ogen and plasmin are absent. Schulte and Gewalt (1964) found
that sex had no influence upon activator or pro-activator activity,
but Schulte and Goens (1967) found that pro-activator and activator
activity increase during menstruation.
Nitta et al (1967) produced the first physicochemical study of the
properties of the fibrinolytic substances in human saliva. They
undertook this study because they found (as the writer has discovered
also) that the results of previous workers were "not always coincident
except concerning the presence of pro-activator." Their basic
methodology is confined, however, to heated and unheated bovine
fibrin plates, the testing of salivas upon these plates with and
without streptokinase, and the examination of saliva following
fractioning on a Sephadex G7 5 column. From their work, they
conclude the absence of an activator and the presence of large
amounts of pro-activator and lesser amounts of plasminogen.
They found the fibrinolytic substances are inhibited by epsilon-
amino-caproic acid (eACA) and in very low concentration (whole
- 6
saliva fibrinolysis inhibited with 2 MeACA). Schulte (1970)
however claims, "The fibrinolytic actions of human saliva can
be inhibited by eACA, but very high local concentrations are re¬
quired". The pro-activator and plasminogen Nitta et al (1967)
believe are activated in vivo by bacterial contamination, but pre¬
sent no evidence for this, while Tortelli (1967) claims the bacteria
in the pellet are completely inactive. The results of Sephadex
fractionation on G75 (Nitta et al, 1967) are interesting since they
show the presence of a streptokinase-activated pro-activator
emerging with a molecular weight in excess of 50 - 70, 000.
More recent work of Wedgwood (1970) has failed to clarify the very
muddled picture that the literature provides. Adapting the euglob-
ulin lysis time method of Taylor et al (1964) he found the end point
very hard to read because of the turbid nature of saliva and he con¬
cludes/
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eludes that the activator must be "a part of, or adsorbed to the muco-
protein moiety of saliva".
It appears from the literature that only the most general conclusions
can be drawn.
1. MNS may contain a weak plasminogen activator(s). The
results on bovine fibrin plates are disputed and human
fibrin plates do not appear to have been used up to date
(1973).
2. There is complete agreement that a streptokinase-activated
proactivator is present in MNS.
3. The source of both activator and proactivator in MNS is
unknown and conflicting views exist concerning the im¬
portance or otherwise of the salivary pellet.
4. One attempt has been made to provide some physiocochemi -
cal information about the proactivator. It has been given
a molecular weight in excess of 70, 000 and is strepto¬
kinase activated which is strongly suggestive of being plas¬
minogen but it has never been demonstrated directly as such.
A neat summary of the position in 1967 is contained in the paper by
Nitta et al (1967) and this is reproduced below. At the commence¬
ment of this work, the position concerning knowledge about the fib¬
rinolytic activity of human mixed native saliva is adequately des¬
cribed in this table. No significant information has been published
since.
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(iii) OBJECTIVES
To provide answers to the following three questions
1. Does human mixed native saliva possess specific
plasminogen activator activity?
2. If activator activity is present, what is its source?




Chapter 1 The Fibrin Plate.
Chapter 2 Experiments :
Experiment 1. Optimum incubation time for
solutions applied to fibrin plates.
Experiment 2. Sensitivity of standard human and
standard bovine fibrin plates.
Experiment 3. Interplate variation in sensitivity
and its correction.
Experiment 4. MNS. Plasminogen activator activity
or non-specific proteolysis ?
Experiment 5. Normal range of plasminogen
activator activity in MNS.
Experiment 6. Stability of plasminogen activator
in MNS.
Experiment 7. Intra-personal variation in plas¬
minogen activator activity in MNS.




The fibrin plate was originally described by Permin (1947) and later
improved by Astrup and Mullertz (1952) who suggested optimal con¬
ditions for its use in the estimation of Plasmin. It has proved use¬
ful for the estimation of the plasminogen activator in urine, urokinase
(Smyrniotis, Fletcher, Alkjaersig and Sherry, 1959: Holemans, Mc-
Connell and Johnston, 1966) and also for the activity of various prote¬
olytic enzymes (Astrup and Alkjaersig, 1952: Haverkate and Traaf,
1974).
A solution of fibrinogen is clotted with thrombin in a Petri dish and
on the fibrin so prepared is placed a small amount of the substance
to be assayed. The plate is then incubated for a set period and lysis
is manifest as a clear circular zone, the area of lysis (being con¬
veniently defined as the product of two perpendicular diameters) giv¬
ing a measure of the fibrinolytic activity of the substance tested.
Three variants of the fibrin plate have been developed: namely,
plates prepared with bovine fibrinogen, with human fibrinogen, and
bovine or human fibrin plates heated to destroy the plasminogen con¬
tent in order that plasmin activity might be directly assayed (Lassen,
1952). These variants have all been used to investigate the fibrin¬
olytic activity of human saliva (Albrechtsen and Thaysen, 1955:
Taylor et al, 1963: Schulte and Gewalt, 1964: Dolci, 1965: Nitta
et al, 1967: Tortelli, 1967: Wedgwood, 1970).
The fibrin plate has some disadvantages. Salt and hydrogen ion
concentration have to lie within the limits for which thrombin can
form an adequately polymerised clot with fibrinogen. This fact
imposes a pH range of 6. 8 - 8. 2 and an ionic strength not higher
than that found in an 0.45 Molar solution of sodium chloride (Wolf,
1972). /
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1972). The test system is therefore rigid. When fibrin plates are
used for the estimation of plasminogen (measured by determining
optimum generation of plasmin from the areas of lysis after plas¬
minogen kinase interaction) the plasminogen originally present on
the fibrin plate must first be inactivated. This is normally achieved
by heating the plates (Lassen, 1952) but this decreases the sensitivity
of the fibrin substrate towards subsequent digestion by plasmin (Alk-
jaersig, Fletcher, and Sherry, 1959: Wolf, 1968: Shiba, Igarashi
and Takeuchi, 1973). In the light of this information, the heated
plate was not used in this investigation and a direct method for plas¬
minogen estimation was developed.
Unheated fibrin plates often show spontaneous lysis during storage
prior to use. The addition of calcium chloride at an end concent¬
ration of 0. 001M. enables fibrin plates to be stored for up to seven
days at 4°C. with no apparent alteration in sensitivity (Tsapogas
and Flute, 1964). For standardisation, all plates used in this work
were freshly prepared. It was found that in the attempt to be econo¬
mical, it was not possible to reuse disposable Petri dishes without
first treating them with a silicone solution, otherwise a high incid¬
ence of spontaneous lysis occurred. Conversely, by using this
silicone treatment in conjunction with calcium chloride spontaneous
lysis was eliminated. (For details of Silicone treatment, see
Methodology, p XXIII ).
Recent work (Noren, Ramstrom, & Wallen, 1975) has demonstrated
the elegance and economy of using fibrin agar plates for measuring
saliva fibrinolytic activity. This work is a development of the
original system described by Heimburger and Schwick (1962) and
improved by Wolf (1968), and Stuckey & Wolf (1969). However,
it was considered wise not to change to the agar system towards the
end of the investigation and thus the standard fibrin plate was used
throughout, modified only by the addition of calcium chloride. Very
recently/
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recently, Haverkate & Brakman (1975) have expressed concern
about adding agar to fibrin plates as they fear it might influence
the results. They do not say why they think this. (For details
of the preparation of fibrin plates, see Methodology, pi).
The application of solutions to fibrin plates
The application of non-viscous liquids such as urokinase is readily
accomplished using a glass blow out pipette and a neat circular
drop may be obtained on the plate. Mixed native saliva and sub¬
mandibular saliva are so viscous that the drop size is very ir¬
regular and because the drop hangs on the pipette, it has to be
tapped off achieving, at best, an irregular and inaccurately placed
blob. The method is totally unsatisfactory.
In order to achieve accurate reproducible drops, a micrometer
syringe was attached to a modified microscope base (Figure 1)
It was possible to deliver a drop of the desired volume, but not as
neatly as might be expected, as the drop tended to hang from the
needle point and required a tap to be released. The alternative
method was to lower the drop on to the plate and then lift the
needle, but this generally resulted in either damaging the plate
or lifting some of the viscous liquid back up with the needle. The
method was not as satisfactory as had been anticipated and it was also
very time consuming considering that frequently upwards of forty
plates were set up at any one time. To be used regularly, a large
supply of disposable needles and glass syringes would have been
necessary. The method was abandoned.
Joyce & Tyler (1973) carried out a systematic examination of
various dispensing pipettes and concluded that the most accurate
in the range required for fibrin plate experiments, 0 - 200 micro
litres, was the Gilson Pipetman P200. The disposable tips are







delivered are simple, and of considerable importance is the "second
pressure" which allows viscous fluids to be completely expelled from
the pipette. Initially, the drops delivered with this pipette were ir¬
regular, but with practice neat reproducible circles were achieved.
In this work, all drops were delivered using the Gilson Pipetman
P200.
Interpretation of lysis
After incubation, a blue dye (bromothymol blue) is added to the lysed
area and the now clearly demarcated area of lysis is measured by
calculating the product of two perpendicular diameters measured by
placing the transparent plate over centimetre graph paper. It is
possible to measure to half of one millimetre by this method. The
bromothymol blue is made up in ethyl alcohol (for details, see Meth¬
odology, p ii ) and if it is applied a.s a neat solution to a human
fibrin plate directly, and not into an area of lysis, it will itself lyse
the fibrin where it is applied within minutes. It is very important,
therefore, to apply the dye to one area of lysis at a time and read it
immediately. This is simple as the dye disperses rapidly within
the lysed fibrin. If the operator now applies a drop of the dye to the
other two or three lysed areas on the plate and remeasures the first
lysed area, it will be found that the initially clearly demarcated peri¬
meter is hazy and its external diameter is anywhere between "a half
and one millimetre increased in size. It was observed that this in¬
crease applied regardless of the size of the initial lysis and thus the
larger the initial size of lysis, the more important it became to read
the plate at once. The haziness of the border is due to the diffusion
of the dye into the fibrin, and if the plate is left overnight, the whole
plate will be pale blue by morning.
It is the experience of the writer that determining what actually is
lysis is not always easy. If a solution of 5 Ploug units/ml. of uro¬
kinase/
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kinase is doubly diluted and applied as 0. 03 ml. drops to fibrin plates,
then interpretation of lysis becomes difficult below a strength of 6. 25%
(Part II, Expt. 2 ). When a smaller concentration is applied to
human plates, an area of lysis is usually obtained but it is shallow and
only sometimes penetrates the three millimetre thickness of the fibrin
on which occasion the penetration is that of an inverted cone. (Upon
bovine plates, the area is more clearly demarcated and the walls of
the lysed area are nearly parallel). At still smaller concentrations,
there is a disturbance of the surface indicated by the dispersion of
the dye, but no actual penetration of the fibrin through to the base of
the Petri dish. This activity is not recordable, but it is different
to the behaviour of the negative control solutions. When dye is applied
to an area upon which tris buffer has been incubated, the dye moment¬
arily remains as a blob before spreading very slowly and with no
characteristic whirling action. Veiy weak solutions of known acti¬
vators upon bovine plates occasionally produced an area of opacity
on the plate and rarely odd phenomena occurred such as concentric areas
of lysed and unlysed fibrin and a "double well" effect in which clearly
definite lysis had taken place over quite a wide area with a much smaller
central area of lysis which penetrated through to the plate.
In view of these variables, it was necessary to establish criteria by
which lysis could be interpretated.
1. Lysis Lysis is present where there is penetration through the
fibrin to the base of the Petri dish and when in con¬
junction with this, the applied dye demarcates a clear
area that can be easily measured. Experience has
shown that on human fibrin plates, the minimal size
of lysis that can be measured with confidence is 64
sq. mm. (8x8 mm. ) Bovine fibrin plates allow read¬
ings down to 49 sq. mm. (7x7 mm. )
2./
47
2. Probable Lysis This term indicates that there has been a
disturbance of the fibrin immediately below
where the test solution has been applied and
that a liquid is present in which dye has dis¬
persed, but there is no penetration through
to the base of the plate, neither can the area
be accurately determined. This applies to
both human and bovine fibrin plates and is
indicated in result tables by an *.





Object: To establish the optimum incubation time for test
solutions applied to fibrin plates.
Materials:
1. Standard human fibrin plates, (SHFP). Methodology, p. I
2. Urokinase. 5 Ploug units/ml. in tris buffer pH 7.8, 0. 15M.
3. Negative control. Tris buffer pH 7.8, 0. 15M.
Method:
Three drops of 0. 03 ml. of urokinase and an 0. 03 ml. drop of tris
buffer were plated on each of seven SHFP. The plates were incub¬
ated at 37°C. After eighteen hours, plate number 1 was removed
and the areas of lysis recorded. The remaining plates were re¬
moved at hourly intervals and the areas of lysis recorded. The
experiment was repeated twenty times.
Results:
These are recorded in Table 1 (Appendix 1) and on Graph 1. The
negative control solution did not produce lysis.
Summary of Results:
Average areas of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. of
urokinase (5 Ploug units/ml. ) upon SHFP after incubation at 37°C
from 18 to 24 hours.
Incubation Time (hours)
18 19 20 21 22
Mean (20 tests) 299 327 343 376 407





Progress curve for urokinase activated human plas¬
minogen (contained within a standard human fibrin
plate) from 18 to 24 hours. Urokinase: 0.03 ml.
drop volume. Cone. 5 Ploug units/ml. pH 7. 8
Temperature +37 C.
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Mean values for 23 and 24 hours incubation are not given as several
plates showed total lysis.
Discussion:
Graph 1 shows the progress curve for urokinase activated human plas-
monogen (contained within a standard human fibrin plate) between 18
and 24 hours incubation. (The line of best fit has been placed in ac¬
cordance with the method of least squares (Croxton & Cowden, 1963)).
The curve clearly indicates increased lysis (plasminogen activation)
with increased incubation time.
With the appearance of totally lysed plates at 24 hours incubation, a
shorter incubation time is indicated.
A small range of readings was obtained at 19 hours with a standard
deviation of only thirty and this was also a convenient time for experi¬
ment planning. This experiment was conducted using only standard
human fibrin plates because these alone would be used to assess acti¬
vator activity. A similar time of incubation would be used with bo¬
vine plates in the assessment of proactivator activity in order to
standardise incubation times.
Conclusion:




Object: To assess the sensitivity of standard human and
bovine fibrin plates at 19 hours incubation.
Materials:
1. Standard human and bovine fibrin plates. Methodology, p. I & IV
2. Urokinase. 5 Ploug units/ml. in tris buffer, pH 7.8, 0. 15M.
3. Dilutant and negative control solution. Tris buffer, pH 7.8,
0. 15M.
Method:
Urokinase was serially diluted in tris buffer to provide solutions with
a range of concentration from 5 Ploug units/ml. (100%) - 0.08 Ploug
units/ml. (1.56%). For each test, seven bovine and seven human
plates were prepared. Upon plate 1 of each type were placed three
drops (each 0. 03 ml. ) of urokinase at a concentration of 100%. In
the centre of each plate was placed one similar drop of tris buffer as
a negative control. This procedure was repeated upon plates 2-7
but using a different dilution of urokinase on each plate. The plates
were incubated for 19 hours. The average of the three lysed areas
per plate was recorded as the area lysed in square millimetres. The
experiment was repeated twenty times.
Results:
These are recorded in tables 2 and 3 (Appendix 1) and on graphs 2
and 3,




Average areas lysed by urokinase upon SHFP and
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LOG. UROKINASE CONC. EXPRESSED AS A % OF 5 PLOUG UNITS/ML.
Log of the average areas lysed by urokinase upon SHFP
and SBFP after 19 hours incubation at 37°C.
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Average areas of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. drops
of urokinase doubly diluted to a concentration of 1. 56% upon (a) SBFP





Urokinase concentrations as a percentage
of 5 Ploug units/ml.
100 50 25 12.5 6.25 3.125 1.56
246 164 122 100 0









300 204 163 130 98





From these results, it is evident that measurable lysis occurred with
urokinase at dilutions greater than 12. 5% of the standard urokinase
solution upon SBFP, and at dilutions greater than 6. 25% upon SHFP
o
after 19 hours incubation at 37 C.
Probable lysis of the human fibrin plate frequently occurred at 3. 125%.
It is evident that for estimation of plasminogen activator activity of
human MNS the human plate is to be preferred as it is more sensitive
than the bovine and there is no species difference between the sub¬
strate and the test salivas.
Conclusions:
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SHFP would be used for the estimation of plasminogen activator
activity in human saliva.
SHFP could detect as little as 0.31 Ploug units/ml. urokinase
o
after 19 hours incubation at 37 C.
SBFP could detect as little as 0. 62-Ploug units/ml. urokinase
o
after 19 hours incubation at 37 C.
Experiment 3
S3
Object: To assess the inter-plate variation in sensitivity and
its correction.
Method:
Positive and negative controls were set up with every SHFP and
SBFP used. All fibrin plates were set up in one of three ways.
1. In which strong plasminogen activator activity was
anticipated, e.g. Mixed native saliva. Fig. 2.
2. In which weak plasminogen activator activity was anti¬
cipated, e.g. Parotid saliva. Fig. 3.
3. "Screening". When large numbers of solutions were
to be tested for activity and only a few were expected
to be positive (e.g. Sephadex G200 fractions of sali¬
vary supernatant), plates as in Fig. 4 were set up,
and a test solution showing evidence of lysis after
19 hours incubation was then set up again as in either
1 or 2 above, having been stored overnight at 4°C.
The areas lysed by urokinase in each part of every experiment were
averaged and the result recorded as the "Urokinase Value" for that
part of the experiment. Any experiment in which the tris buffer
negative controls came up positive was considered totally invalid
and the experiment was repeated. Many batches of bovine and
human fibrinogen were used during the experimental work, but the
urokinase control solutions were all derived from the one original
solution prepared in October 1972 and deep frozen in 1 ml. aliquots
at -40°C.
When the fibrin plate experiments were completed, the recorded
"Urokinase Values" for both human and bovine plates were collected
and tabulated. Using a Hewlett-Packard HP. 45 calculator, the
mean/
FIGURE 2 TEST PLATE CONTROL PLATE
FIGURE 3
TEST SOLUTION
POSITIVE CONTROL. (Urokinase, 5 Ploug units/ml. )
NEGATIVE CONTROL. (Tris buffer. pH7.8, 0.15 M)
All drop volumes were 0. 03 ml.
FIGURE 4
mean and standard deviation for the areas lysed upon human and bovine
plates by 0.03 ml. of urokinase 5 Ploug units/ml. were calculated.
Results:
These are recorded in Tables 4 and 5 (Appendix 1).
Summary of Results:
SHFP Total number of "Urokinase Values" recorded 850
Mean area of lysis 227 sq. mm.
Standard deviation 57.89 (58)
SBFP Total number of "Urokinase Values" recorded 1000
Mean area of lysis 195 sq. mm.
Standard deviation 55
All experimental results were now, retrospectively, corrected to
allow for the variation in sensitivity between different batches of
human and bovine fibrinogen. The correction is most simply
explained by an example.
Test Solution. Average of three areas of lysis. 225 sq. mm.
Urokinase control. Average area of lysis. 289 sq. mm.
"Urokinase Value" upon SHFP. 227 sq. mm.
225 x 227
Therefore corrected value for test solution is 289
= 176. 73 = 177 sq. mm.
Exactly the same procedure applies to bovine plates but using the
bovine "Urokinase Value" of 195 sq. mm.




Object: To demonstrate that the action of MNS upon SHFP is
one of plasminogen activation and not non-specific
proteolysis.
Principle:
Epsilon-amino-n-caproic acid (eACA) is a specific, potent, synthetic
competitive inhibitor of plasminogen activation (Alkjaersig et al, 1959).
Significant competitive inhibition of activation of human and bovine plas¬
minogen by streptokinase, urokinase and tissue activator is seen at
-4
eACA concentrations of 10 M and higher, and at concentrations above
_2
5x10 M eACA is a non-competitive inhibitor of plasmin and trypsin
(McNicol and Douglas, 1964). At a concentration of 3 x 10 ''"M, eACA
non-competitively inhibits the activation of plasminogen by trypsin
_ 2
(Alkjaersig et al, 1959) and at concentrations of about 10 M inhibits
pepsin (McNicol, 1964). If MNS has plasminogen activating activity
then this activity will be significantly blocked by eACA at concent-
-4
rations greater than 10 M but if the action is one of non-specific
proteolysis, the fibrinolytic activity of the MNS will be unaffected.
Materials:
1. MNS. Using the technique of stimulated flow (Methodology,p
XXVI ) twenty samples of MNS, each not less than 10 ml.
were collected from ten males and ten females. All were
healthy dentates aged between 18 and 25 years, none of them
were taking any drugs or showed any clinical evidence of
gingivitis. This latter phrase means throughout this thesis,
that any person with limited oedematous gingivitis (Code 1,
Macphee and Cowley, 1969) or worse was not accepted as an
experimental subject. Each sample was collected between
14.00/
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14. 00 and 14.30 hours and stored at 4°C until used.
2. Epsilon-amino-n-caproic acid (eACA) supplied by BDH
Chemicals Ltd.
3. Human fibrinogen, thrombin, calcium chloride and tris
buffer, as described for the preparation of SHFP.
(Methodology, p. I )
4. Urokinase. 5 Ploug units/ml. in tris buffer, pH 7.8,
0. 15M.
Method:
Preparation of eACA solutions.
A. A molar concentration of eACA in tris buffer was prepared.
From this were prepared the following solutions - M/2, M/4,
M/8, M/16 and M/32.
B. An M/10 concentration of eACA was also prepared. From
this were prepared the following solutions - M/20, M/40,
M/80, M/160 and M/320.
Preparation of the plates. SHFP were prepared as usual, but in¬
corporating in addition eACA in the following manner.
Plate 1. 0.4 ml. of M eACA. In a 10 ml. plate,
this gives an end conc. of M/25.
Plate 2. 0.2 ml. of M eACA. In a 10 ml. plate,
this gives an end conc. of M/50.
Plate 3. 0. 1 ml. of M eACA. In a 10 ml. plate,
this gives an end conc. of M/100.
Plate 4. 0. 1 ml. of M/2. In a 10 ml. plate,
this gives an end conc. of M/200.
This procedure was continued, adding only a 0. 1 ml. volume of eACA
each time until the complete range of eACA plates had been prepared.
In/
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In order of dilution, the full range of dilutions was :
eACA end concentrations : M/25, M/50, M/lOO, M/200, M/400,
M/800, M/1000, M/1600, M/2000, M/3200, M/4000, M/8000,
M/16, 000 and M/32, 000.
Into the final plate was put 0. 1 ml. of tris buffer.
Each of these fifteen plates was prepared in duplicate. Upon one set
was placed MNS, and upon the other, urokinase. Each test solution
was plated in triplicate (3 x 0. 03 ml. ) with a tris buffer negative con¬
trol on each plate and a single urokinase drop on each MNS plate.
After 19 hours incubation at 37°C the plates were read. The whole
experiment was repeated twenty times with ten male and ten female
MNS samples.
Results:
These are recorded in Tables 6 and 7 (Appendix 1) and on Graph 4.
Summary of Results:
The mean value and the standard deviation of the average areas of
lysis in sq. mm. produced by 3 x 0. 03 ml. of MNS (20 samples)
and urokinase (20 tests) upon SHFP incorporating eACA at defined
o
concentrations, after 19 hours incubation at 37 C.
eACA Con¬ MNS Urokinase
centration Mean S.D. Mean S. D
M/25 0 0 0 0
M/50 0 0 0 0
M/100 0 0 * *
M/200 0 0 52 53
M/400 0 0 107 18
M/800 0 0 141 40
M/1000/
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eACA Con¬ MNS Urokinase
centration Mean S. D. Mean S. D
M/ 1000 0 0 149 28
M/1600 0 0 151 31
M/2000 32 45 160 27
M/3200 44 51 170 29
M/4000 58 71 173 24
M/8000 106 57 197 42
M/16000 128 45 228 31
M/32000 132 46 260 33
-ve eACA 150 54 266 35
*Probable lysis
The negative control solution did not produce lysis.
Discussion:
The small number of subjects is justified since previous workers
have produced strong evidence to show that MNS has fibrinolytic
activity (Albrechtsen and Thaysen, 1955: Taylor et al, 1963:
Schulte and Gewalt, 1964: Dolci, 1 965: Nitta et al, 1967: Tortelli,
1967: and Wedgwood, 1970).
The nature of the experiment is justified since MNS does have some
proteolytic activity (Willstatter et al, 1929: Weinmann, 1934: and
Chauncey , 1961 ) and the fibrin plate has been used to determine
non-specific proteolytic activity (Astrup and Alkjaersig, 1952: Brack-
man, 1967: and Haverkate and Traaf, 1974). The fibrin plate has
not been used to measure non-specific proteolytic activity in MNS
as far as the writer can ascertain.
These results suggest that the fibrinolytic activity of human MNS
that is detectable upon a human fibrin plate is due to plasminogen
activation/
Effect of eACA in SHFP upon the fibrinolytic
activity of urokinase and MNS after 19 hours
incubation at 37°C.
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activation and hence the presence of plasminogen activator(s) in
human MNS.
Conclusions:
1. Human MNS has fibrinolytic activity.
2. Within the limitations of the fibrin plate technique, the fibrin¬
olytic activity appears to be brought about by the specific acti¬
vation of plasminogen contained in human fibrin plates and
therefore activator(s) of plasminogen are present in MNS.
3. The system is insensitive to the action of unconcentrated
non-specific proteolytic enzymes in MNS.
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Experiment 5
Object: To obtain an estimate of the normal range of plasminogen
activator activity in human mixed native saliva.
Materials:
1. MNS samples. These were collected by minimal stimu¬
lation from fifty male and fifty female healthy subjects
aged 18-30 who were not taking drugs and who had no
clinical evidence of gingivitis.
SHFP. ( Methodology , p I ).
Tris buffer. Negative control. pH 7.8, 0. 15M.
Urokinase. Positive control in tris buffer, pH 7. 8,





MNS was collected between 14. 00 and 15. 00 hours and after being
vortex stirred, each sample was plated in triplicate upon SHFP.
Control solutions were set up as described in Experiment 3, Fig.
2. The drop volume used throughout was 0. 03 ml. The plates
were incubated at 37°C for 19 hours.
The experiment was repeated until MNS from 100 subjects had been
examined.
Results:
These are recorded in Tables 8 and 9 (Appendix I).
Summary of Results:
Average areas of lysis in sq. mm. produced by 3 x 0.03 ml. of MNS
upon/
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upon SHFP after 19 hours incubation at 37°C.
Male (50) Female (50) Total (100)
Mean 197 216 206
S.D. 100 109 104
There is no significant difference between the values obtained for male
subjects and the values obtained for female subjects (t - test: t = 0. 9).
Conclusions:
1. All MNS samples examined had plasminogen activator acti¬
vity as measured upon SHFP.
2. The range of activity is very considerable and hence in
every experiment in which an alteration to MNS is made
(e.g. freeze-thawing, centrifugation, pH etc.) a control
sample of MNS must always be set up upon SHFP in order
to provide a base line from which to work and against which
to measure the effect of experimental procedures.
3. There is no significant difference in plasminogen activator
activity of MNS between males and females.
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Experiment 6
Object: To determine whether or not the plasminogen
activator activity of MNS is stable under Labor¬
atory conditions.
Comment: The temperatures at which stability was assessed
were : -40°C, 4°C, Room Temperature (RT) and
37°C.
1. -40°C
Collecting saliva is a time-consuming process and some experiments
involve the use of very large quantities of saliva (e. g. analysis using
a Sephadex column) and a "bank" would be extremely useful. The
disadvantage of storing saliva at -40°C is the possible destruction of
some of the organic constituents, in particular leukocytes and epi¬
thelial cells which may contain an activator which might be released
on thawing and therefore give an artificially high reading for the
plasminogen activating activity of MNS. It is possible, however,
that only repeated freeze-thawing would achieve that result and that
a single freeze, as with plasminogen and the commercially available
fibrinogen solutions, would have no significant effect.
2. 4°C
This temperature has been used by many workers for keeping bio¬
logical materials for a short duration prior to examination or analy¬
sis. The refrigerator in which MNS was placed was adjusted to 4°C
and the difference between the top and the bottom of the refrigerator
o
was not detectable with a 0 - 100 C thermometer.
3. Room Temperature
This was the most variable temperature,
over/
The range was 7 - 21°C
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over 24 hours on some days although the day time working conditions
were maintained between 18° and 20°C as far as possible.
4. 37 C
Normal body temperature. The temperature of both incubators (LTE
Water Jacket Type F Mark 2) was maintained between 37°C and 37.5°C.
The stability experiments carried out were as follows :-




0 - 180 minutes.
0 - 360 minutes.
2. Medium Term Stability. Period - 0-96 hours.
3. Long Term Stability. A. Period - 0 - 120 hours.
B. Period - 0-12 months.
Materials:
1. Saliva. MNS was collected from healthy subjects aged 18 - 28,
who were taking no drugs and who had no clinical evidence of
gingivitis. The collection was as for stimulated MNS.
(Methodology, P. XXVI ).
2. SHFP. ( Methodology , p I ).
3. Positive and Negative controls as in Experiment 3, Fig. 2.
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Stability Experiments.
1. Short Term Stability
1A. Short Term Stability: Period 0-90 minutes.
Subjects - Six. Three male and three female.
Temperatures - 4°C and 37°C.
Period - 0-90 minutes. Sampling at 10 minute intervals.
Procedure :-
MNS was collected from six subjects between 14.00 and 14.30 hours.
Volume collected was 3.5 - 5.0 ml. by stimulated flow, per person.
Immediately following collection, a salivary sample was vortex
stirred and then 3 x 0. 03 ml. drops were at once applied to a freshly
made SHFP. This plate was put in a 37°C. incubator and the time
recorded. The remainder of the sample was divided into equal
aliquots, one of which was placed in an incubator at 37°C. and the
other in the refrigerator at 4°C.
At ten minute intervals 3 x 0. 03 ml. samples were taken from each
aliquot (re-stirred) and plated upon SHFP all of which were incubated
for 19 hours at 37°C.
A separate plate was used for each 10 minute sample in order that
all plates could incubate for the same time. Upon each plate was
set up a negative control, and control plates as described in Experi¬
ment 3, Fig. 2 were also set up. Samples were taken up to 90
minutes and each was read after 19 hours incubation at 37°C.
Results : These are recorded in Tables 10 and 11. (Appendix I).
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Stability Experiment
IB. Short Term Stability: Period 0 - 180 minutes.
Subjects - Seven. Four male and three female.
o o
Temperatures - 4 C, 37 C and RT.
Period - 0 - 180 minutes. Sample testing at 30 minute intervals.
Procedure
The procedure was similar to Experiment 1A except that the samples
collected were divided into three aliquots, the third being set up at
RT. In place of ten minute sampling, an interval of 30 minutes was
adopted.
Results : These are recorded in Tables 12, 13 and 14. (Appendix I).
IC. Short Term Stability. Period 0 - 360 minutes.
Subjects - Five. Two male and three female.
o o
Temperatures - 4 C. and 37 C.
Period - 0 - 360 minutes. Sample testing at 30 minute intervals.
Procedure
As above except aliquots were divided into two, 4°C. and 37°C.
Incubation was 19 hours as before for each sample.
Results : These are recorded in Tables 15 and 16. (Appendix I).
Summary of Results
Average areas of lysis (in sq. mm. ) produced by 3 x 0.03 ml. of








0 30 60 90
18 Mean 205 195 194 193
m Ao„
Temp. 4 C.
S.D. 55 53 56 57
18 Mean 205 191 184 179 _ Or7o^Temp. 37 C,
S.D. 55 49 48 46




0 60 120 180
12 Mean 204 202 197 184
Temp. 4°C.
S. D. 43 49 48 50
12 Mean 204 183 163 141
Temp. 37°C.
S.D. 43 40 31 32
Time Stored before Incubation
No. of
Subjects Minutes
0 120 240 360
5 Mean 219 208 206 199
Temp. 4°C.
S.D. 49 55 50 42
5 Mean 219 170 137 108
Temp. 37°C.
S.D. 49 34 37 22
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Stability Experiment
2. Medium Term Stability. Period 0-96 hours.
Subjects - Twenty. Ten male and ten female.
Temperature - 4°C, RT and 37°C.
Period - 0-96 hours. Sample testing at 24 hourly intervals.
Bacteriostat. Crystamycin (Glaxo Laboratories Ltd. ) 400 mg. /
ml. in tris buffer.
Procedure :
Subjects presented themselves at the laboratory between 14. 00 and
14.30 hours in groups of four. Stimulated MNS was collected
(Methodology, pXXVI ) as a minimum of 12 mis. was required from
each subject. Each sample collected was divided into six aliquots
labelled A, A': B, B' and C, C'. 0.03 ml. of Crystamycin (0.6
mg. /ml. end concentration) was placed in tubes A', B' and C'.
A similar volume of tris buffer was added to A, B and C. From
each of the 24 aliquots thus obtained was removed, after vortex
stirring, three drops (0. 03 ml. ) of MNS and plated upon SHFP.
Urokinase and tris buffer controls were set up as in Experiment
3, Fig. 2. These plates were incubated at 37°C for 19 hours.
The aliquots were now stored at the defined temperatures, aliquots
A and A' at 4°C, B and B' at RT (i. e. on a work bench away from
direct sunlight and space heaters) and C and C' at 37°C for 24 hours.
After 24 hours incubation, the aliquots were re-sampled and plated
upon fresh SHFP as before. The whole process was repeated until
samples had been collected following 48, 72 and 96 hours storage.
The/
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The experiment was repeated until MNS from all 20 subjects had been
examined.
Results : These are recorded in Tables 17 - 22 (Appendix I).
Summary of Results
Medium Term Stability Studies at 4°C, RT and 37°C. Average
areas of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. drops of MNS
upon SHFP after 19 hours incubation at 37°C.
Temp, of Subjects Age of Samples
Stored MNS (20) 0 24 48 72 96 hours
+ve Bact. *
Mean 237 227 222 209 202
S.D. 43 49 48 42 40
4°C.
-ve Bact.
Mean 239 220 215 205 198
S.D. 43 50 50 43 44
+ve Bact.
Mean 237 216 188 171 152
S.D. 43 63 49 51 39
R. T. -ve Bact.
Mean 239 214 192 172 156
S.D. 43 65 64 43 35
+ve Bact.
Mean 237 90 29 0 0
S.D. 43 91 55 0 0
37°C. -ve Bact.
Mean 239 88 0 0 0
S.D. 43 93 0 0 0
* Bact. With or without Bacteriostat.
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Stability Experiment
3. Long Term Stability. A. Period 0 - 120 hours.
B. Period 0-12 months.
Experiment A
Subjects - Twenty four. Twelve male and twelve female.
o
Temperature - 40 C.
Period - 0-120 Hours.
Procedure : -
*
Subjects presented themselves at the laboratory between 14.00 and
14. 30 hours in groups of four. Stimulated MNS was collected
(Methodology, p.XXVl) as a minimum of 12 mis. was required from
each subject. Each sample was vortex stirred and then divided in¬
to six 2 ml. aliquots. Of these aliquots, five were immediately deep
frozen at -40°C. From the remaining aliquots for each subject, 3 x
0.06 ml. volumes were removed and plated on SHFP. The plates
were then placed upon level tables in the incubator and incubated for
19 hours at 37°c. Negative and positive controls were set up in
accordance with the method described in Experiment 3, Fig. 2.
At 19 hours, these plates were read and the result recorded as the
plasminogen activator activity of fresh MNS. At 24 hours, a single
aliquot for each subject was removed from the deep freeze and allowed
to thaw at room temperature. Having thawed the aliquots were vortex
stirred and then plated upon fresh SHFP as above. The whole process
was repeated at 24 hourly intervals, the last aliquot having been deep
frozen for 120 hours. The experiment was repeated until twenty-four
different salivas had been examined.
Results:
These are recorded in Table 23 (Appendix I).
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Experiment B
Subjects - Twenty. Ten males and ten females.
Temperature - -40°C.
Period - 0-12 months.
Procedure:
Subjects presented themselves at the laboratory between 14.00 and
14.30 hours in groups of four. Stimulated MNS was collected
(Methodology, pXXVI ) as a minimum of 14 mis. was required from
each subject. Each sample was vortex stirred and then divided >
into .13 x 1 ml. aliquots. Of these aliquots, 12 were immediately deep
frozen at - 40°C. From the remaining aliquots for each subject, 3 x
0.06 ml. volumes were removed and plated on SHFP. The plates
were then placed upon level tables in the incubator and incubated for
19 hours at 37°C. Negative and positive controls were set up in
accordance with the method described in Experiment 3, Fig. 2.
At 19 hours, these plates were read and the result recorded as the
plasminogen activator activity of fresh MNS. Thirty days later, a
single aliquot for each subject was removed from the deep freeze and
allowed to thaw at room temperature. Having thawed, the aliquots
were vortex stirred and then plated upon SHFP (fresh) as above.
The whole process was repeated at 30 day intervals and for a total
of twenty subjects. The last aliquot had been frozen 3 60 days.
Results:
These are recorded in Table 24 (Appendix I).




A. Long Term Stability. Period 0 - 120 hours. Storage at -40°C.
Average areas of lysis (in sq. mm. ) produced by 3 x 0. 06 ml. drops
of MNS upon SHFP after 19 hours incubation at 37°C.
Subjects Age of Sample (in hours)
(24) 0 24 48 72 96 120
Mean 243 225 222 228 232 242
S.D. 65 56 63 57 57 53
B. Long Term Stability. Period 0-12 months. Storage at -40°C.
Average areas of lysis (in sq. mm. ) produced by 3 x 0. 06 ml. drops
of MNS upon SHFP after 19 hours incubation at 37°C.
Subjects Age of Samples (in months)
(20) 0 1 2 3 4 5 6 7 8 9 10 11 12
Mean 235 242 261 247 252 223 220 221 264 269 208 260 283
S.D. 67 69 71 85 95 74 59 52 74 87 60 86 67
Discussion: .
The object of this experiment was to determine whether or not the
plasminogen activator(s) in MNS was stable at defined temperatures,
and if not, how quickly was the activity lost.
The S hort Term experiments may be considered together. By com¬
bining the three experiments, there are readings for 18 subjects from
zero to 90 minutes storage, at ten minute intervals, both at 4°C and
37°C. Over this period, there was no significant drop in activity at
either temperature. At 4°C, t = 0.62 (p< 0.5) and at 37°C, t = 1.49
(p < 0.2). As the time of storage was increased, the pattern became
clearer. After six hours stability had been retained at 4°C but there
had been a significant loss of activity at 37°C, t = 4. 13 (p < .001).
The/
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The short ten minute intervals suggested an initial loss of some
activity within the first ten minutes, but this took place at 4°C as
well as at 37°C, and was therefore probably unavoidable. In the
event, this drop in activity was insignificant.
The experiment in which the effect of RT was assessed (0 - 180 min¬
utes) was carried out first and no significant difference in activity
was detectable over the first sixty minutes. As refrigerators were
used to store solutions between tests and the centrifugations took
place at 4°C, no bench procedure was foreseen that would take longer
than one hour. Therefore no further short term experiments were
conducted at RT.
Medium Term stability. It was expected that some procedures might
take place over two or three days, which while not involving bench
work at RT might necessitate apparatus and MNS being kept at RT
(e.g. Sephadex Fractionation). Storage of several tubes of saliva,
either to be able to set up all samples at the same time, or to pool
them and so form a very large volume of saliva, could take place at
4°C if stability was assured. The use of 37°C in the stability experi¬
ment served to indicate the rate of decline of activity at incubation
temperature. At this stage, it was not known whether or not bacteria
played a significant role in the fibrinolytic activity of MNS. Storage
of MNS at RT or 37°C and incubation of MNS upon fibrin plates might
lead to increased bacterial populations and enhanced activity. The
bactericidal broad spectrum antibiotic Crystamycin was incorporated
in duplicate test samples and comparison between MNS with and with¬
out a bacteriostat was made. Determination of the optimum strength
of Crystamycin is explained in detail in the Bacteriological Experiments
in Part IV.
The results of this part of the experiment are striking. At 4°C, there
was very little loss of activity over a period of four days. There was
no significant difference between the results obtained from samples
containing/
* 300 mg. (500, 000 units) Benzylpenicillin (sodium) B. P. plus
500 mg. Streptomycin sulphate B. P.
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containing a bacteriostat and those without. Comparison of the 24
hour result with the six hour result obtained previously suggested
that any loss occurred mainly in the first few hours. This may re¬
present a highly labile substance in very small quantities. If plas¬
minogen is found to be present in saliva, then it may be that this labile
substance is plasmin. Although the results at RT showed a significant
drop in activity, t = 6. 39 (p < .001) with storage up t o four days, there
was still considerable activity and this indicated qualitative experiments
extending over a period of a day or two may be successful. Again,
there was no significant difference between the samples with bacteriostat
present and those without. At 37°C, the findings were quite different.
After 24 hours storage, only ten out of the twenty samples still showed
activity and all were reduced in activity except one (Sample 2, Table
21) which was slightly increased. At 48 hours, all samples without a
bacteriostat were negative although five with a bacteriostat were still
showing evidence of activity. All activity was lost at 72 hours from
each set of samples.
This loss of activity at 37°C may be due simply to the lability of the
activator at this temperature, but it may also be due to the release
of an inhibitor from the cellular components of the MNS. In vivo
with a salivary clearance time of about twenty minutes, this would
not be important to the fibrinolytic activity of the MNS.
It was apparent from these experiments that MNS can be stored over¬
night at 4°C and analytical work resumed the next day with little loss
of activity. The long term stability experiments were designed to
see whether or not samples of MNS could be stored for a very long
time, if need be in order to build up a saliva 'bank'. The results





1. The plasminogen activator(s) in MNS is stable in vitro at 4°C for
up to at least 96 hours.
2. Storage at RT entails a significant loss of activity over this
period but quite considerable activity remains nevertheless.
3. At 37°C, activity is considerably reduced after 24 hours and in
the absence of a bacteriostat, is lost altogether at 48 hours. This
is probably due to the lability of the activator(s) but may be due to
the release of an inhibitor(s).
4. Long term storage of MNS at -40°C appears to entail no signifi¬
cant loss of activator activity.
Experiment 7
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Object: To examine the intra-personal variation in the
plasminogen activator activity of mixed native
saliva.
Materials:
1. MNS. MNS was collected by minimal stimulation (Methodology,
PXXV) from five male and five female healthy adults, aged 24 -
40, who had no clinical evidence of gingivitis. One male (I.N. )
was a smoker (10 - 15 per day).
2. SHFP. ( Methodology , p I ).
3. Tris buffer. Negative control. pH 7.5, 0. 15M.
4. Urokinase. Positive control in tris buffer, pH 7.5, 0. 15M.
5 Ploug units/ml.
Method:
Collection of salivary samples was standardised and took place
between 09. 30 and 10.00 hours for the morning sample, and between
14. 00 and 14. 30 hours for the afternoon sample. These times were
chosen to ensure an interval of at least one hour from the last meal.
Immediately after collection, each morning sample was stored at
4°C. After the afternoon collection, all samples (a.m. and p.m. )
were vortex stirred and then individually plated (3 x 0. 03 ml. ) upon
SHFP and controlled as described in Experiment 3, Fig. 2. The
plates were then incubated for 19 hours at 37°C. The procedure
was repeated for twenty consecutive working days to give a total

















































































































These are recorded in Tables 25 to 28 (Appendix I).
Summary of Results: ( See facing page ).
Discussion:
The range of readings per person was very considerable. The
smallest range (L. L. , a. m. ) was 93 - 125 and the largest (E. Mc.,
a.m. ) was 100 - 305. There was no significant difference between
morning and afternoon activity. Given such a large range of acti¬
vity for each individual, it is necessary on all occasions to sample
and plate freshly collected MNS before any procedure (e.g. centri-
fugation, or alteration of pH) is carried out in order to obtain a base
line of activity for that single experiment.
Conclusion:
The range of intra-personal activity is too great to allow a single
figure to be used as 'normal' and hence as a base line for future
experiments. A fresh base line must be obtained in every experi¬
ment for every salivary sample to be tested.
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CHAPTER III
SUMMARY OF CONCLUSIONS TO
PRELIMINARY EXPERIMENTS
1. Standard human and bovine fibrin plates would be incubated for
19 hours at 37°C.
2. Standard human fibrin plates would be used for the estimation
of plasminogen activator activity in human mixed native, paro¬
tid and submandibular/sublingual saliva.
3. Standard human fibrin plates can detect as little as 6.25% of a
5 Ploug units/ml. urokinase solution. That is, 0.31 Ploug
units/ml. after 19 hours incubationat 37°C.
4. Standard bovine fibrin plates can detect as little as 12.5% of
a 5 Ploug units/ml. urokinase solution. That is, 0. 62 Ploug
units/ml. after 19 hours incubation at 37°C.
5. Urokinase values for 0.03 ml. of 5 Ploug units/ml. urokinase
upon standard human and bovine fibrin plates have been estab¬
lished retrospectively. They are :-
A. Urokinase value upon SHFP. 227 sq. mm.
(227±58. 850 tests).
B. Urokinase value upon SBFP. 195 sq. mm.
(195-55. 1000 tests).
The method by which these figures are used to "correct" results
is described.
6. Human mixed native saliva has fibrinolytic activity.
7. Within the limitations of the fibrin plate technique, the fibrin¬
olytic activity of MNS appears to be brought about by the specific
activation of plasminogen contained in human fibrin plates and
therefore an activator(s) of plasminogen is present in mixed
native saliva.
8. The standard human fibrin plate system is insensitive to the
action of unconcentrated non-specific proteolytic enzymes in
human mixed native saliva.
9. All mixed native saliva samples examined have plasminogen
activator activity as measured upon standard human fibrin plates.
10. The inter-personal range of activity is considerable (206^104 sq.
mm. ) and hence in every experiment in which an alteration to
mixed native saliva is made a control, unaltered sample of
mixed native saliva must always be set up in order to provide
a base line from which to work and against which to measure the
effect of experimental procedures.
11. There is no significant difference in plasminogen activator acti¬
vity of mixed native saliva between male and female.
12. The plasminogen activator(s) in mixed native saliva is stable at
4°C for up to at least 96 hours.
13. Storage of mixed native saliva at room temperature entails a
significant loss of activity over 96 hours although considerable
activator activity remains.
14. At 37°C plasminogen activator activity in MNS is considerably
reduced after 24 hours and in the absence of a bacteriostat is
lost altogether at 48 hours. This is probably due to the labil¬
ity of the activator(s) but may be due to the release of an inhib-
itor(s).
15. Long term storage of mixed native saliva at -40°C appears to
entail no significant loss of activator activity.
16. The range of intra-personal plasminogen activator activity of
MNS is too great to allow a single figure to be used as 'normal'
for any one person and hence as a base line for future experi¬
ments. A fresh base line must be obtained in every experiment
for every salivary sample to be tested.
PA FT III
INVESTIGATIONS INTO THE SOURCE OF PLASMINOGEN
ACTIVATOR ACTIVITY IN HUMAN MIXED NATIVE SALIVA
Chapter 1. Experiments:
Experiment 1. Comparison of plasminogen activator
activity in MNS , parotid and sub¬
mandibular/ sublingual salivas.
Experiment 2. Centrifugation of MNS and exam¬
ination of the plasminogen activator
activity of various supernatants.
Experiment 3. Comparison of the plasminogen
activator activity of MNS , the
supernatant of MNS , filtered MNS
and the filtered supernatant of MNS.
Experiment 4. The production of a supernatant of
MNS containing no cells or cell
fragments and its examination for
the presence of a soluble activator.
Experiment 5. Investigation of the plasminogen
activator of washed resuspended
salivary pellet.
Experiment 6. Examination of MNS for the presence
of a soluble activator using gel chrom¬
atography ( Sephadex G200 ).




Object: To compare the plasminogen activator activity
of MNS with that of parotid and submandibular/
sublingual salivas from the same subjects.
Materials.
1. Parotid, submandibular/sublingual and minimally stimulated
MNS (Methodology, p. XXIX, XXX and XXV) from 40 adults
(20 male and 20 female) aged 20 - 35 years, all of whom were
in good health, were dentates and had no clinical evidence of
gingivitis.
2. SHFP (Methodology, p. I).
3. Controls. Urokinase, 5 Ploug units/ml. in tris buffer, pH
7.8, 0. 15M.
Tris buffer, pH 7.8, 0. 15M.
Method:
Salivary samples each about 1 ml. , were collected at 14. 00 hours
and stored at 4°C.
When the collection was completed, the MNS samples were vortex
stirred and then plated (3 x 0. 03 ml. ) upon SHFP. Controls of
urokinase and tris buffer were plated as described in Part II, Ex¬
periment 3, Fig. 2. The submandibular/sublingual salivas and
the parotid salivas were also set up in triplicate, but the plating
pattern and controls were those for a weak activator as described
in Part II, Experiment 3, Fig. 3.
All the plates were then/
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then incubated at 37°C and read after 19 hours.
Four subjects were sampled each day until the series was complete.








Male 11 3 6
Parotid Female 6 7 7




Male 0 4 16
Female 3 3 14
Total 3 7 30
Discussion:
Of the 17 specimens of parotid saliva which showed lysis, only 9 showed
activity similar to the value recorded for MNS. However, under con¬
ditions of minimal stimulation, the approximate gland volume contribution
to MNS expressed as a percentage is 66. 6% submandibular and 33. 3%
parotid (Kerr, 1961). Thus activator activity contributed to MNS by
parotid saliva would be diluted by submandibular saliva by a similar
ratio. In only one instance of the parotid being active was the sub¬
mandibular active also, and therefore not acting as a dilutant in res¬
pect of activity.
If the major part of the MNS activator activity was derived from the
parotid/
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parotid, there would be consistently higher readings than in the MNS
provided the submandibular activity was zero or very low. The con¬
verse would also be true for activity derived from the submandibular
gland. Neither of these two circumstances pertain.
Conclusion:
This experiment suggests that while not excluding the possibility of
a plasminogen activator being secreted by the parotid or submandi¬
bular/sublingual glands, these glands are not the major source of




If the activator activity is in solution, then following centrifugation,
the supernatant should retain its activator activity and indeed it may
even appear uianced if the cellular component has no activity since
approximately 10 - 15% of the drop volume of MNS would have been
occupied by inert matter prior to centrifugation.
Object:
Experiment 2: Part A.
To examine the plasminogen activator activity of MNS and that of
its supernatant following low and high speed centrifugation.
Experiment 2: Part B,
To examine the plasminogen activator activity of MNS and that of
its supernatant following short successive episodes of low speed
centrifugation and again after high speed centrifugation.
Part A
Materials.
1. Stimulated MNS (Methodology, p. XXVI) was collected from 40
adults (20 male and 20 female) aged 20 - 35 years, all of whom
were in good health, were dentates and had no clinical evidence
of gingivitis.
2. Controls. Urokinase, 5 Ploug units/ml. in tris buffer, pH 7,8,
0. 15 M.
Tris buffer, pH7.8, 0. 15M.
3./
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3. SHFP (Methodology, p. I).
4. Centrifuge. 1. A universal Junior IKS (Heraeus-
Christ GmbH, West Germany).
2. An MSE Superspeed 40.
Method:
The collection of MNS was begun at 14. 00 hours and a minimum of
5 ml. was obtained from each subject. Following collection, each
sample was vortex stirred and then 1 ml. of MNS was removed and
stored at 4°C. The remaining 4 ml. of each MNS were then centri-
fuged at 4°C for one hour at 4154 g. Thereafter, the supernatant was
decanted from each tube and 1 ml. stored at 4°C. (The salivary
pellet obtained after the low speed centrifugation was deep frozen
at -40°C). The remaining 2-3 ml. of supernatant were then
centrifuged for thirty minutes at 35, 664 g. at 4°C, after which 1 ml.
of supernatant was removed. Thus for each of the eight subjects,
there were now three 1 ml. aliquots: MNS, low speed supernatant
and high speed supernatant. Each specimen was plated (3 x 0. 03 ml. )
upon SHFP and controlled with urokinase and tris buffer (Part II,
Experiment 3, Fig. 2). All the specimens for the day were plated
at the same time as there would have been minimal loss of activity
at 4°C (Part II) and incubated for 19 hours at 37°C.
Results:
These are recorded in Tables 31 and 32 (Appendix 1).
Part B
Materials
Twenty adults, 10 Male and 10 Female) took part in this experiment.





The collection of MNS was begun at 14. 00 hours and a minimum of
5 ml. was collected from each subject. Each sample was vortex
stirred and 1 ml. removed and stored at 4°C as a representative
sample of each subject's MNS.
The remaining 4 ml. of each MNS were then centrifuged at 4154 g.
o
at 4 C. At fifteen minute intervals, the centrifuge was stopped and
0. 5 ml. of supernatant was removed from each tube, placed in a
fresh tube and stored at 4°C. This procedure was continued for up
to one hour. After one hour the remaining supernatant from each
subject was decanted and centrifuged at 3 5, 664 g. for thirty minutes,
after which 1 ml. of the supernatant thus formed was removed from
each tube. For each of the eight subjects, there were then six ali-
quots: MNS, low speed supernatant at 15, 30, 45 and 60 minutes,
and high speed supernatant. Each specimen was plated (3 x 0. 03 ml. )
upon SHFP and controlled with urokinase and tris buffer (Part II,
Experiment 3, Fig. 2). All the specimens for the day were plated
o
at the same time, and read after 19 hours incubation at 37 C.
Results:
These are recorded in Table 33 (Appendix 1 ).
Summary of Results
Part A
MNS. All samples had plasminogen activator activity.
Low speed supernatant; 12 samples (7M, 5F) Lysis
11 samples (6M, 5F) Probable Lysis
17 samples (7M, 10F) No Lysis
40 Total
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High speed centrifugation: 4 samples Probable Lysis
3 6 samples No Lysis
There was no difference in activity which was caused by sex.
Part B
















High speed supernatant: 5 probable lysis.
15 no lysis.
Discussion
This reduction in activator activity of supernatants with increased
centrifugation strongly suggests either the absence of a soluble acti¬
vator or its presence in very small quantities and that the major
activator component resides in the salivary pellet. Furthermore,
it appears that much of the activity can be removed from suspension
at relatively low speed centrifugation which suggests whole cells and
large cell fragments play an important role.
That 23 of the 40 specimens displayed evidence of activity in the low
speed supernatant and that of these, only 4 retained that property
after/
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after high speed centrifugation, is indicative of small active parti¬
cles in suspension.
This was substantiated in samples M4, F8 and 9, where the plas¬
minogen activator activity was actually seen to increase after low
speed centrifugation, but was lost after high speed centrifugation
from samples M4 and F8 and vastly reduced in F9. It is possible
that in these samples there were many cell fragments present re¬
latively diluted by many inert cells in the MNS and consequently
present in higher concentration in the low speed supernatant.
Conclusion:
1. MNS has plasminogen activator activity (Reaffirmed).
2. Activator activity appears to reside predominantly in the
salivary pellet.
3. Activity appears to be associated with large cells and large
cell fragments as w-ell as with small cell fragments and
possibly bacteria and leukocytes.
4. A soluble activator may exist but if it does, its activity at
the concentration it appears to have in MNS is below the
threshold of this system to detect in all but a very few
samples. It would appear to contribute little plasminogen
activator activity to whole MNS.
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Experiment 3
Object: To compare the plasminogen activator activity
of MNS, the supernatant of MNS, filtered MNS
and the filtered supernatant of MNS.
Comment:
It is reasonable to attempt to confirm (or refute) the findings of one
experiment by examining the same problem with a different technique.
It was decided, therefore, to see whether or not activator activity in
MNS could be reduced by filtration.
Subjects and Materials:
40 subjects (aged 19 - 26 years) all of whom were in good health, were
dentates and had no clinical evidence of gingivitis.
1. Stimulated MNS (Methodology,p. XXVI)was collected from 40 subjects.
2. Centrifuge. A Universal Junior IKS, (Heraeus-Christ GmbH,
West Germany).
3. Filters. Millipore, GS 0.22 micron 25 mm. Filter, sup¬
ported in a Micro-syringe, Luer inlet, 25 mm.
Millipore reference No. 30 025 00.
4. Micro-syringe Support and Screw Drive. Custom build in the
Dental Hospital Technical Laboratory. Made
in steel, it is illustrated in Fig. 5.
5. SHFP. Methodology, p. I).
6. Controls: Positive. Urokinase, 5 Ploug units/ml. in tris
buffer, pH 7. 8, 0. 15M.
Negative /
FIGURE 5
Screw drive for filtering saliva through
Millipore filters.
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Negative. Tris buffer, pH 7.8, 0. 15 M.
Method:
The collection of MNS was begun at 14. 00 hours and a minimum of
10 ml. was collected from each subject.
The saliva was vortex stirred and a 1 ml. aliquot removed for plating
on SHFP. Immediately after removing this aliquot, the remainder
was divided into two equal volumes labelled 'A' and 'B'. Sample 'A'
from each of the specimens collected was centrifuged at 4°C for 30
minutes at 4154 g. While samples 'A' were being centrifuged,
samples 'B' were filtered through Millipore filters. The pore size
(0. 22 microns) is very small and the filtering of whole MNS had to
be done very slowly in order not to distort the filter-supporting dia¬
phragm. A steady heavy pressure was required and the steel screw
drive was designed to provide such a force. The filtrates were
o
stored at 4 C. When samples 'A' had finished centrifuging, 0. 5 ml.
was removed from each and stored at 4°C. The remainder was fil¬
tered in the same manner as sample 'B'. Thus was obtained a
specimen of whole MNS, filtered MNS, supernatant of MNS and fil¬
tered supernatant of MNS for each subject. Upon SHFP, one for
each specimen were placed three drops of the test solution and single
drops of urokinase and tris buffer. The drop volume was 0. 03 ml.
Control plates as described in Part II (Experiment 3, Fig. 2) were
also set up, and all plates were incubated at 37°C and read after 19
hours.
Results: These are recorded in Tables 34 and 35 (Appendix 1).
Summary of Results:
Effect of Samples upon SHFP
Probable
Lysis Lysis No Lysis
1 •/
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1. MNS 40 0 0
2. MNS Filtrate 1 10 29




Supernatant 19 7 14
There was no difference in activator activity that was caused by a
difference in sex.
Discussion:
These results were consistent with Experiment 2 in suggesting either
the absence of a soluble activator or its presence in very small
amounts. The one active MNS filtrate may have been due to a faulty
filtering technique allowing some cells through, or it may have re¬
presented some very small particles that were filtrable. This second
suggestion appears probable in the light of the activity found in the
filtrate of the supernatant of MNS. This filtrate had measurable lysis
on a total of 19 occasions and probable lysis an additional seven times.
The activity was always reduced relative to whole MNS and the super¬
natant of MNS.
The difference in activity between the filtrates was probably due to the
occlusion of the tiny Millipore pores by constituents of the salivary
pellet thus allowing only the smallest particles through. The filtrate
of the supernatant of the MNS was easily produced which is indicative
of much less blockage of the filter pores.
The two filtrates considered together suggest the absence of a soluble
activator, but the presence of activator activity which is cell associ¬





The findings of Experiment 2 are confirmed using a different tech¬
nique. The plasminogen activator activity of MNS appears to re¬




Object: To produce a supernatant of MNS that contains no cells
or cell fragments and to examine it for the presence of
a soluble activator.
Comment:
Experiments 1-3 taken together provide little evidence for the pre¬
sence of a soluble activator in MNS. However, it can be argued that
in Experiment 2 (A) four samples and in Experiment (B) five samples
showed probable lysis after high speed centrifugation. In Experiment
3, after filtering MNS supernatant from forty subjects, nineteen dis¬
played lysis and seven probable lysis.
There is no escaping the fact that 0. 22 microns is a very small filter
pore size and, despite the argument laid out in the discussion in Ex¬
periment 3, some doubt still remained as to the presence of a soluble
activator. At least, it would appear that the filter, per se, did not
inactivate the activator, a possibility to be considered had no activator
activity appeared in the filtrate.
Centrifugation at very high speed can destroy cells and this could cause
"false positives" by releasing into suspension, cell associated activ¬
ators whose activity might be construed as being the activity of a sol¬
uble activator. Therefore one more filtering and centrifuging experi¬
ment was undertaken.
Materials:
1. Centrifuges. As described for Experiments 2 and 3.
2. Millipore filters. 0. 22 micron pore size. Filtration method as
described in Experiments 2 and 3.
3. SHFP (Methodology, p. 1).
4./
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4. Minicon B15. A disposable microconcentrator supplied by
Amicon Ltd., Buckinghamshire. The '15' indicates a mole¬
cular weight cut off at 15, 000.
5. Controls. Positive. Urokinase, 5 Ploug units/ml. pH 7. 8,
0. 15M. Negative. Tris buffer, pH 7. 8, 0. 15M.
6. Subjects. Twenty students (10 Male, 10 Female) aged 19 -
26 years, all of whom were in good health and had no
clinical evidence of gingivitis.
7. Collection of saliva. Stimulated mixed native, parotid and
submandibular/sublingual saliva were collected in accordance
with the methods described in Methodology, p. XXVI, XXIX &
XXX.
Method:
MNS. A minimum of 10 - 12 ml. was collected and after vortex-
stirring, 0. 5 ml. was stored at 4°C.
The remaining MNS was centrifuged at 4154 g. at 4°C for thirty
minutes after which a further 0. 5 ml. was removed and stored at
4°C. The remaining supernatant was filtered through an 0. 22
micron Millipore filter. Following filtration, another 0. 5 ml.
aliquot was removed and stored at 4°C. The filtrate was then
finally centrifuged at 35, 664 g. for thirty minutes. From the
supernatant generated, 0. 5 ml. was removed and stored at 4°C.
Finally, all but 0. 5 ml. of the remaining supernatant was gently
removed from the centrifuge tube to avoid disturbing any pellet
that might have been present and 5 ml. was poured into one channel
of a Minicon B15 where it was concentrated 25x at room tempera¬
ture, a process taking about lj hours. The remaining 0. 5 ml. in
the centrifuge tube was vortex stirred and, after making two smears
for cytological examination, was stored at 4°C.




Whole MNS, low speed supernatant of MNS, filtered supernatant,
high speed supernatant, concentrated high speed supernatant. In
addition, a smear for cytology was prepared from the high speed
pellet which itself was resuspended in 0. 5 ml. of high speed super¬
natant.
Parotid and submandibular/sublingual saliva from the same subjects
were subjected to a similar process except that the first low speed
centrifugation was omitted and no smear was made of the high speed
centrifugation 'pellet'. All the plates were set up at the same time
and incubated for 19 hours at 37°C. Control plates as described in
Part II, Expt. 3, Fig. 3 were also set up. The drop volume through¬
out was 0. 03 ml.
Results:
These are recorded in Tables 36 - 39 (Appendix 1).
Summary of Results:
Effect of samples upon SHFP






4. No. 3, centrifuged
at 35, 664 g.

















1. Whole Parotid 6 6 8
2. Filtered Parotid 1 2 17
3. No. 2, centrifuged
at 35, 644 g. 0 0 20
4. No. 3 conc. x 25 0 0 20
C. Submandibular /sublingual
1. Whole submandibular/
sublingual 0 4 16
2. Filtered submandibular/
sublingual 0 0 20
3. No. 2 centrifuged at
35,644 g. 0 0 20
4. No. 3 conc. x 25 0 0 20
Discussion:
The results obtained after filtering the MNS supernatant were lower
than previously obtained and probably reflect an improved filtering
technique. The complete absence of any detectable plasminogen
activator activity following high speed centrifugation and concent¬
ration is very strong evidence to support the proposition that no
soluble plasminogen activator is present in the supernatant of MNS,
parotid or submandibular/sublingual saliva. The result was a little
surprising as concentrating 25x might reasonably have brought about
lysis due to protease activity in the MNS and then it would have been
necessary to examine the concentrate on eACA plates. As it was,
no activity could be detected.
The examination of the consistently active high speed pellets was very
revealing. Not only were tiny cell fragments present, but also much
larger fragments and intact desquamated epithelial cells that must
have been forced round the edge of the Millipore filter. When the
pellets/
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pellets were examined by fibrinolytic autography (Methodology, p.V)
some of the cells and fragments tvere shown to be active, (Fig. 6 - 9)
This emphasized the incomplete nature of the filtering process.
No criticism is being made of the filters themselves, but rather
of the filter holders. It is apparent from these results that the
filter supporting diaphragm and the two washers that support it
must be regularly inspected. The results further illustrate the
necessity to control such procedures by visual examination of the
filtrate.
The finding of such large cell fragments in the filtrate must throw
some suspicion on the findings of Experiment 3 where it was argued
that many of the cell fragments must be very tiny indeed in order to
pass through the filter pores. It was now apparent that this may not
be the case and the previously recorded activity may well have been
due to larger fragments passing around the filter when the super¬
natant was filtered and to even larger fragments preventing such a
passage when whole MNS was filtered.
Nevertheless, the essential finding remains unaltered, namely that
there appears to be no soluble plasminogen activator in MNS, paro¬
tid or submandibular/sublingual saliva and that the activator activity
of MNS is cell and cell fragment associated.
Conclusions:
1. There is no plasminogen activator in solution in MNS,
parotid or submandibular/sublingual saliva within the
capacity of the fibrin plate technique to detect.
2. The plasminogen activator activity of MNS is cell and
cell fragment associated.
FIG. 6 FIG. 7
FIGS. 6 and 7. Smears of high speed pellet follow¬
ing low speed centrifugation and filtering through 0. 22
micron Millipore filter, showing nucleated squamous
epithelial cells and cell fragments.
Stained with Papanicolaou. Mag. x 300.
Fig.8. Fig.9.
Figs. 8 & 9. Fibrinolytic autographs of smears of
high speed pellet showing lysis related to epithelial
cells and cell fragments. Human fibrin incubated
overnight at room temperature followed by 1 hour
at 37°C. Mag. Fig. 8. x 300. Fig. 9. x 120
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Experiment 5
Object: To investigate plasminogen activator activity
of washed resuspended salivary pellet.
Materials:
40 students (20 Male, 20 Female) aged 19 - 26 years, all of whom
were in good health, were dentates and had no clinical evidence
of gingivitis.
1. Stimulated MNS (Methodology,p. XXVI) was collected from 40
students.
2. Centrifuge. A Universal Junior IKS (Heraeus-Christ GmbH,
West Germany).
3. SHFP (Methodology, p. I).
4. Controls. Urokinase, 5 Ploug units/ml. in tris buffer,
pH 7.8, 0. 15M.
Tris buffer, pH 7, 8, 0. 15M.
5. Tris buffer was also used as the washing medium for the pellet
and also for its resuspension.
Method:
The collection of MNS was begun at 14. 00 hours and a minimum of
5 ml. was collected from each subject.
From each sample was removed, 0. 5 ml. which was then stored
at 4°C. The remaining 4. 5 ml. of each sample was centrifuged
for 30 minutes at 4154 g. From the supernatant thus formed, 0.5




The salivary pellet of each specimen was washed by centrifugation
(10 mins. x 4154 g. ) in tris buffer four times. The pellet was then
reconstituted to 4. 5 ml. in tris buffer. A 0. 5 ml. volume of the
final washing, and 0. 5 ml. of the resuspended pellet from each
specimen were stored at 4°C. The washing procedure was re¬
peated a further four times and samples of the final washing and
resuspended pellet were again stored at 4°C.
Thus for each original specimen of MNS, there were now six aliquots
to be tested upon SHFP.
These were :
1. Whole MNS.
2. Supernatant of MNS generated at 4154 g. in 30 minutes.
3. Supernatant of washed pellet after four washes.
4. Resuspended pellet after four washes.
5. Supernatant of washed pellet after eight washes.
6. Resuspended pellet after eight washes.
Upon SHFP were placed three drops of each test solution and single
drops of urokinase and tris buffer. The drop volume was 0. 03 ml.
Control plates as described in Part II, Expt. 3, Fig. 3 were also
set up. All the plates were set up at the same time, incubated at
37°C and read after 19 hours.
Results:







1. MNS. Lysis. 20 20 40
2. Sup. of MNS. Lysis. 20 20 40
3. Sup. of pellet after 4 washes:
a) Lysis. 5 6 11
b) Probable Lysis. 8 3 11
c) No lysis. 7 11 18
4. Resuspended pellet after 4 washes:
a) Lysis. 16 18 34
b) Probable Lysis. 3 2 5
c) No Lysis. 1 0 1
5. Sup. of pellet after 8 washes:
a) Lysis. 0 0 0
b) Probable Lysis. 3 2 5
c) No Lysis. 17 18 35
6. Resuspended pellet after 8 washes:
a) Lysis. 13 16 29
b) Probable Lysis. -5 3 8
c) No Lysis. 2 1 3
Tests 1 and 2 reaffirmed that MNS had activator activity and that
the supernatant of MNS generated at low speed centrifugation was
also active. Therefore, some activator activity resided either in
solution and/or in small particles still in suspension. Test 3 in¬
dicates that 22 of the 40 samples still had evidence of activator
activity in the supernatant.
Possible explanations :
1. A very strong soluble activator in the original test solution.
Most improbable. The highest recording of lysis for supernatant
was 312 (Female No. 2) and after washing the pellet, this was re¬
duced to 'probable lysis' in the supernatant, but in eleven other in¬
stances following the same procedure, the reduction was very much
less,/
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less, and furthermore, the activity of the MNS supernatant in these
eleven was less than that displayed by Female No, 2.
2. It was highly improbable that fresh activator had been released so
quickly into solution from possible reservoirs (epithelial cells or
leukocytes) as the stability studies recorded in Part II did not indic¬
ate anything of that nature nor have substances been used here in
washing the pellet, such as potassium thiocyanate or detergent,
which might have released an activator.
3. An explanation that is consistent with the findings is that the acti¬
vity was associated with small particles, many of which would be in
the pellet following the first centrifugation since the mucus present
in MNS would bring many of them down. Following washing, however,
the mucus became extremely dilute and would "release" many particles
into suspension. The amount of mucus in MNS is very variable as
is the number of cells and cell fragments and, therefore, it would be
quite possible to obtain high readings of activity, by this hypothesis,
until such time as the mucus is so dilute as to be incapable of trapping
any small particles and all such particles are lost in the discarded
washings.
Test 4. Thirty-nine of the samples showed evidence of lysis which
strongly indicates activator activity retained in whole cells and/or
large cell fragments brought down at low speed centrifugation. Test
5 showed only five specimens with activator activity still present in the
supernatant after eight washes and the explanation offered above is ap¬
plicable here also. Test 6. Thirty-seven of the test samples showed
evidence of lysis and, although on scrutiny it will be seen that the lysis
obtained was in most cases reduced, this could be due to loss of cells
and of some of the larger fragments with washing. In retrospect, a
cell count might have been useful but it is very difficult to carry out
an accurate differential count in MNS due to the difficulty in obtaining
a representative drop (the mucus makes even dispersion almost im¬




The results are consistent with the findings obtained in Experiments
1-4. The activator activity appeared to be associated with whole
cells and/or very large cell fragments, and to the cell particles des¬
cribed in Experiment 4. There was no evidence to suggest that a




Object: To examine MNS for the presence of a soluble
plasminogen activator using Sephadex Fraction¬
ation.
Comment:
In the course of examining MNS for the presence of plasminogen (Part
V), pooled supernatant was, after concentration, fractioned on a G200
Sephadex column. The fractions were tested for plasminogen with
streptokinase and tanned red cell haemagglutination inhibition immuno¬
assay and the molecular weight range of the active fractions examined
to ascertain whether or not they were in the same order of magnitude
as might be expected from plasminogen. The full experimental de¬
tails are described in Part V, Experiment 6.
Each fraction was also examined for activator activity by plating upon
SHFP in the manner described in the preceding experiments.
The control solutions of urokinase and tris buffer were set up as des¬
cribed in Part II, Experiment 3, Fig. 4 and in addition 3 x 0. 03 ml. of
the eluant AG azide saline (Aronson-Gronwal). Both the tris buffer
and the eluant proved negative.
Results:
No activator activity appeared in any fraction in the ten runs performed.
Discussion:
The importance of this experiment, in terms of activator activity, lay
in the possibility that an activator and its inhibitor might be separated
by/
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by a molecular weight difference and some evidence of activator
activity become apparent. No such evidence emerged. On two
occasions all the fractions were individually concentrated 25x and
replated upon SHFP but no activator activity was found. It cannot
be concluded with absolute certainty that there is no soluble acti¬
vator in the supernatant of MNS for at least two reasons.
1. As will be discussed in Part IV, 'Salivary Flora', there is
evidence in the literature that proteolytic enzymes of bacterial
origin are present in MNS. No evidence of such proteases was
found in any of the fractions which suggests the system was insensi¬
tive to very weak proteases although, of course, their molecular
weight may have been outwith that examined by a G200 column.
Their presence would have been indicated by lysis of the SHFP and
they would have been differentiated from plasminogen activators by
applying them to SHFP incorporating eACA. It is, therefore, possible
that a soluble plasminogen activator is present but it must be extremely
weak.
2. Stability. In order to carry out this experiment, more than
100 ml. of MNS was required. This was collected in one day, pooled,
centrifuged, and the supernatant concentrated to about 7-8 ml. using
Polyethylene Glycol. From collecting the first MNS sample to start¬
ing the column run, a minimum of 48 hours elapsed. The run was
then carried out at room temperature and the fractions , before being
available for plating, had their optical density measured. At the very
least, a total of 7 2 hours elapsed between collection and plating on
SHFP and most of this at room temperature. In Part II, activity of
MNS was shown to be still present at 72 hours, having been stored at
room temperature, but it was reduced. It was known from the pre¬
ceding experiments that if any soluble activator was present, it must
be in small amounts and, therefore, any loss of activity during an
experimental procedure might falsify the results. At the time of doing
this experiment it was not possible to run the MNS at 4°C but columns
are/
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are now available at this temperature and a further one or two runs
at 4°C should be performed to examine the possibility of a heat labile
soluble activator present in very small concentrations.
Conclusions:
Sephadex fractionation on a G200 column has failed to provide any




From the evidence provided by centrifugation, filtration and gel
chromatography, no soluble activator could be detected in natural
or concentrated MNS using SHFP. The results showed that the
activator was present in the salivary pellet, and suggested that it
was a cell and cell fragment associated activator.
The conclusion that there is no detectable soluble activator within
the sensitivity of this system is important because there is a tacit
acceptance amongst reviewers of 'Fibrinolysis' that saliva (unquali¬
fied) has fibrinolytic activity (Macfarlane, 1964: McNicol and Douglas,
1972). If the activator is not in the secretions of the salivary glands,
there is no reason to believe it is required to help maintain the patency
of the salivary ducts; a function that has been suggested for urokinase
in respect of the ureter (McNicol et al, 1961). The total absence of a
soluble activator has not been established beyond all doubt but if it
does exist, it must be very weak and, therefore, it was necessary
to investigate systematically the contents of the salivary pellet to


















Epithelial Cells in Saliva.
The Relationship between the Components
of MNS in Generating Plasminogen Acti¬
vator Activity.





The evidence presented in Part III strongly suggested the absence
of a soluble plasminogen activator in mixed native, parotid and
submandibular/sublingual saliva, and that the activator resided in
the salivary pellet. Allowing the transient presence of bacterial
pathogens and food debris, the pellet may be considered to comprise
mucus, commensal bacteria, leukocytes, epithelial cells and cell
fragments and these were systematically examined (Chapters 3-6)
Object: To examine whole salivary pellet for fibrinolytic
activity using SHFP.
Materials:
MNS. MNS (Methodology, p. XXVI). was collected from 20 healthy
subjects who had no evidence of gingivitis.
Salivary pellet. From each sample of MNS collected, 8 ml. was
removed and centrifuged at 4154 g. for 30 minutes after which the
supernatant was decanted and the pellet reconstituted in tris buffer
to a volume of 1 ml.
SHFP. (Methodology, p. I)
Tris buffer. Negative control. pH 7. 8, 0.15 M.
Urokinase. Positive control. 5 Ploug units/ml. pH 7. 8, 0.15 M.
Method:
Each salivary pellet was serially diluted in tris buffer to provide
concentrations of 100, 50, 25 and 12.5%. Every dilution was plated
(3 x 0. 03 ml. ) upon SHFP and incubated for 19 hours at 37°C.
Controls /
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Controls of urokinase and tris buffer were set up as described in
Part II, Experiment 3, part 2.
Results:
These are recorded in Table 42, (Appendix 1).
Summary of Results:
Average areas of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. drops
of salivary pellet upon SHFP after 19 hours incubation at 37°C.
100% 50% 25% 12.5%
Mean (20) 170 133 102 *
S.D. 62 37 12 *
* Probable lysis with 5 specimens. Lysis in remainder.
Discussion:
Activity decreased with increased dilution of the pellet. As the
supernatant was known to be inactive then this reduction in activity
must have been caused by the dilution of either mucus or a cell
associated activator. When the salivary pellet was reconstituted
to the original volume of MNS (i. e. 12. 5%) the areas of lysis on
SHFP were less than was normally obtained with MNS. In Part
III it was shown that some of the fibrinolytically active cellular
material in MNS remains in the supernatant after centrifugation at
4154 g. for 30 minutes and so it was not expected that such recon¬





Activator activity is present in the salivary pellet and activity de




Object; To show whether or not plasminogen activator
activity of salivary pellet can be separated out
into a particular density fraction.
Materials:
1. Pellet. MNS was collected by stimulated flow (Methodology, p.
XXVI ) from persons with no clinical evidence of gingivitis.
After centrifugation at 4154 g. for 30 minutes the supernatants
were discarded and the pellets pooled.
2. Density gradient. Equal parts of sucrose (60% w/w) and
Triosil 350, (Intra-venous contrast medium, Nyegaard & Co. ,
Oils; 70% w/w) were mixed (this was called 60% w/w) and then
diluted in saline to give 9 fractions of decreasing density, at
5% intervals from 60% - 20% (density 1.336 - 1.082).
3. SHFP. (Methodology, p. I)
4. Controls. Urokinase, 5 Ploug units/ml. in tris buffer, pH 7.8,
0. 15 M.
Tris buffer, pH 7.8, 0. 15 M.
Gradient medium.
Methods:
1 ml. of the pellet was vortex stirred with 1 ml. of the 20% fraction
and the mixture overlaid on a gradient containing 1 ml. of each of
the other density fractions. The whole was eentrifuged for either
10, 20 or 30 minutes at 4154 g. at 4°C. The fractions were then
removed and from each 3 x 0. 03 ml. drops were plated u£>on SHFP
with controls as described in Part 2, Experiment 3, Fig. 3 and in¬
cubated/
Fig. 10.
Fig. 10. Bacteria , nucleated squamous cell and
anuclear cell in Fraction 1 (Density Gradient).
Stained with Azure. Mag. x 300.
Fig. 11. Anuclear epithelial cell fragments in
Fraction 1 (Density Gradient).












































Figs. 12 & 13. Numerous nucleated epithelial cells
and bacteria in Fraction 9 (Density Gradient).
Stained with Azure. Mag. x 300.
Fig. 14.
Figs. 14 & 15.
Density Gradient Fractions 1 & 2 examined by
fibrinolytic autography. Lysis associated with
anuclear cell fragments. Human fibrin, incub¬
ated overnight at room temperature and 1 hour
at 37°C. Mag. Fig. 14 x 120. Fig. 15 x 300.
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O
cubated at 37 C for 19 hours. Smears of each fraction were covered
with celloidin and stained with Azure and Gram. Smears of the active
fractions were prepared for fibrinolytic autography (Methodology, p. V )
In the later experiments (Nos. 11 - 13), the active fractions were
diluted in equal volumes of saline, centrifuged for 10 minutes at 4154 g.
and the supernatant filtered through an 0. 22 micron Millipore filter
(see Part III, Experiment 3). 3 x 0. 03 ml. drops of the diluted frac¬
tions, the supernatant and the filtrate were placed upon SHFP and in¬
cubated for 19 hours at 37°C.
Results:
These are recorded in Tables 43 and 44 (Appendix 1).
Lysis was only found in the three least dense fractions (20, 25 and
30%). However most of the pellet was present as a well defined mass
below fraction 9 and this was always active. The smears showed an
obvious difference between fractions 1 and 9, there being a much more
gradual change between each of the individual fractions. Fraction 1
contained a few bacteria, odd nucleated epithelial cells and a number
of anuclear epithelial cell fragments (Figs. 10 & 11) Fraction 9 usually
contained numerous nucleated epithelial cells and large numbers of
bacteria (Figs. 12 & 13). Fibrinolytic autography of fractions 1 and 2
showed a suggestion of lysis around some of the anuclear epithelial
cell fragments with occasionally more well defined foci of lysis (Figs.
14 & 15). The supernatants of the diluted fractions after centrifugation
showed reduced activity (with one exception) but after filtration none
of the active fractions showed activity. The concentrated pellet after
centrifugation was always active in the fractions 1 and 2.
Discussion:
This experiment failed to isolate the whole of the plasminogen activator
activity of salivary pellet in one particular density fraction. Part of
the/
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the activity could be separated out in the least dense fractions from
the main mass of the pellet, and this activity in the least dense frac¬
tions appeared to be related to anuclear epithelial cells or fragments.
By examination of smears from fractions 1 and 9, it was obvious that
the activity was not directly related to the total number of bacteria
present, lysis being present in fractions with relatively few bacteria.
The experiment, however, did support the evidence in Part III in
showing the absence of a soluble activator in the salivary pellet. If
a soluble activator were present, it is likely that it would remain in
the least dense fractions and although these were the only fractions
found to be active, this activity was reduced with centrifugation and
totally eliminated with filtration through an 0. 22 micron filter. The
large cell portion that passed right through the gradient was also con¬
sistently active.
Conclusions:
1. The plasminogen activator activity of the salivary pellet is
partly related to anuclear epithelial cells or epithelial cell
fragm ents.
2. No soluble plasminogen activator is present in salivary
pellet.
3. The plasminogen activator activity of the salivary pellet is




1_ The writer can find no reference in the literature to suggest
that salivary mucus has plasminogen activator activity.
2. It has been shown in Part III, Experiment 1 that only occas¬
ionally does lysis occur with a mucus-containing sample of
submandibular/sublingual saliva upon SHFP and that follow¬
ing either centrifugation or filtration, this slight activity
disappears.
3. Fibrinolytic autography. (Human fibrin: Methodology, p. V )
Salivary pellet was obtained by centrifuging 10 ml. of MNS for
3 0 minutes at 4°C at 4154 g. The supernatant was discarded
and the pellet frozen with carbon dioxide and sectioned. Five
micron thick frozen sections were cut and prepared for fibrin¬
olytic autography (see Methodology, p. V ) Prolonged
incubation caused the lysis of the whole film but short incub¬
ation periods brought about lysis that was clearly focal. This
would not have occurred if the mucus had been active for the
whole film would have lysed at the same time, the mucus being
evenly distributed throughout the pellet. Fig. 16 clearly
illustrates foci of lysis and thereby contra-indicates activity in
relation to salivary mucus.
4. Fibrinolytic autography of major and minor salivary mucous
glands showed lysis only related to blood vessels. Figs. 17 &
Conclusion:
Salivary mucus has no plasminogen activator activity.
Fig.16.
Fig. 16. Fibrinolytic autograph of a smear of salivary
pellet showing foci of lysis. Human fibrin , incubated
overnight at room temperature and 1 hour at 37°C.
Mag. x 300.
Fig. 17.
Fig. 17. Fibrinolytic autograph of human submandibular
salivary gland showing foci of lysis unrelated
to the secretory acini. Human fibrin, incub¬
ated 45 mins. at 37°C. Mag. x 30.
Fig. 18.
Fig. 18. Fibrinolytic autograph of human floor of mouth
mucosa showing a focus of lysis (arrowed) related
to a blood vessel. No lysis related to the mucous
gland or epithelium. Human fibrin incubated for





Experiment 1. To study the effect of a bacteriostat
upon the plasminogen activator acti¬
vity of MNS.
Experiment 2. To test the salivary flora and their
filtrates for plasminogen activator
activity using :
a) The Somerville clot lysis technique.
b) SHFP
Experiment 3. To study the plasminogen activator
activity of the salivary flora using
fibrinolytic autography.
Experiment 4. To determine whether or not a quantitative
relationship exists between salivary bac¬
teria and the plasminogen activator activity
of MNS.
6. Experiment 5. To test MNS for the presence of a strep-
tokinase-like activity.
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1. THE SALIVARY FLORA
Morris (1953) states that in excess of 3, 200 different strains of micro¬
organisms have been isolated from saliva while Ross (1971) considers
the oral flora of man to be one of the densest and most varied micro¬
bial populations in the body.
A wide variety of bacteria is known to possess fibrinolytic activi-ty
(Weiss, 1937: Tillett, 1938: Reed et al, 1943: Dixon, 1945: Lewis
et al, 1949: Lewis and Ferguson, 1950 and 1951: Cliffton and Canna-
mela, 1953: Adamis, 1961: . Kopper, 1962: and Yaromyuk and Doma-
radskii, 1963). A census of bacterial categories in saliva carried
out by Richardson and Jones (1958) assists in putting the salivary flora
in perspective and it is possible to construct from this work and the
knowledge of bacteria possessing fibrinolytic activity, a table in which
the salivary flora are ranked and fibrinolytic activity, as far as it is
known, indicated.
Salivary Flora and Fibrinolytic Activity
Count . m -r ■ Fibrinolytic
_ — Bacteria . % Isolation r-——rr
Category Activity
More than 1 x Alpha-haem. strep. 100 - ve
g
10 per ml. Veillonella 100 - ve
Micrococci
(not aureus) 60 - 90 - ve
Corynebacteria 78 -100 - ve
Neisseria
(pharyngis and
catarrhalis) T - 84 - ve
Pneumococci T - 76 - ve
1 x 102 - 1 x
0
10 per ml. Lactobacilli 50-100 - ve





Bacteria % Isolation Fibrinolytic
Activity
Haemophilus in¬
fluenzae T - 24
Beta-haemolytic
























% Isolation: From a survey of the literature these figures,
expressed as a percentage, indicate frequency
of isolation.
T. Transient.
G. 1 Generally present'. Many of the
bacteriological reports do not record
percentage isolation but use terms
such as 'consistently present' or
' generally present'.
Fibrinolytic
Activity: - ve No fibrinolytic activity.
(- ve) Conflicting evidence concerning fibrin¬
olytic activity.
+ ve Fibrinolytic Activity
118
Comment:
There are three confirmed fibrinolytically active bacteria in saliva.
1. Beta - haemolytic streptococcus is unlikely to contribute to the
fibrinolytic activity measured in this work since all persons examined
were in good health with no evidence of suffering from acute strepto¬
coccal sore throat. Most workers consider this organism not to be
a commensal of the mouth and that its presence is only transient.
The highest figure in respect of percentage isolation is 22% (Ross,
1971) and when it was isolated, the mean count was in the region of
5
2x10 per ml. On the basis of the work of Richardson and Jones
(1958), this would represent about 1/800 of the total cultivable sali¬
vary flora.
Fibrinolytic activity was common to all samples of MNS tested upon
SHFP in this work, and therefore present in the 7 8% (minimum) in
which beta-haemolytic streptococci were likely to be absent.
2. Staphylococcus aureus. A similar argument pertains to this
micro-organism. There is a marked discrepancy between the figures
given for percentage isolation, Ross (1971) finding a 2% incidence in
a child population to a 50% isolation by Burnett and Scherp (1968).
5
Both papers agree upon a low mean count however, below 1x10 per
ml.
3. Bacteriodes melaninogenicus. The collagenase producing pro¬
perties of this organism are better recognised than its fibrinolytic
activity and there is a possibility that at least part of its activity is
ppotease rather than plasminogen activating. Burnett and Scherp
(1968) consider that it constitutes about 0. 4% of the cultivable bacteria
from saliva although it may comprise 4. 5% of that cultivable from the
gingival sulcus. This is consistent with the work of Gordon et al
(1965) who suggested that the salivary flora reflected the flora of the




The literature provides little evidence to indicate that the fibrinolytic
activity of MNS is closely related to the salivary flora.
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2. EXPERIMENT 1
Object: To study the effect of a bacteriostat upon the plasmin¬
ogen activator activity of MNS.
Preliminary Experiment
Object: To determine the minimum concentration of Crystamycin
required to inhibit the formation of colony forming units
derived from MNS.
Materials:
1. Crystamycin: 300 mg. (500,000 units) Benzylpenicillin
(sodium) BP. plus
500 mg. Streptomycin sulphate BP. (Glaxo
Laboratories Ltd. )
2. Freshly prepared bullock heart infusion broth, blood agar and
MacConkey plates. (Supplied by the Department of Bacteri¬
ology, Edinburgh University).
3. Gas Paks. Disposable gas generator envelopes which produce an
atmosphere of 95% hydrogen and 5% carbondioxide (Becton,
Dickinson & Co., U. S. A. )
4. Mcintosh and Fildes' anaerobic jars, sterile loops and glassware.
Method:
Day 1. From a healthy subject 1.5 ml. of minimally stimulated
MNS (Methodology, p.XXV) was collected. 10 ml. of
sterile nutrient broth was then innoculated with MNS and
incubated at 37°C for 24 hours.
Day 2. a) The incubated broth was placed into five sterile tubes.
Crystamycin, 400 mg. /ml. was added to 4 of the 5 tubes
to/
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to establish end concentrations of 0%, 10%, 5%, 2.5% and
1. 25%. Each tube was then sealed and incubated for 24
hours at 37°C.
b) The above procedure was repeated except that fresh
sterile broth was used and all the tubes except number 1
were innoculated with MNS after Crystamycin had been
added and before incubation at 37°C for 24 hours.
Day 3. The contents of the ten tubes were plated upon separate
MacConkey and blood agar plates both aerobic and anaer¬
obic and incubated for 24 hours.
Results:
a) Plates innoculated from tube 1. -
Plates innoculated from tubes 2-5.
b) Plates innoculated from tube 1.
Plates innoculated from tubes 2-5.
Conclusion:
The lowest concentration of Crystamycin, 1. 25% (5 mg. /ml. ) was
sufficient to have a bacteriocidal effect on the salivary flora.
The experiment was repeated with lower concentration of Crystamycin
and it was found that a concentration of 0. 6 mg. /ml. was bacteriocidal
and also produced no lysis upon SHFP.
Experiment 1A.
Object: To study the effect of a bacteriostat upon the plasminogen








1. MNS. Minimally stimulated (Methodology, p. XXV)
2. Crystamycin. 200 mg. /ml.
3. SHFP (Methodology, p. I)
4. Controls. As in preliminary experiment.
Method:
MNS was collected from twenty subjects who were in good health,
taking no drugs and who showed no clinical evidence of gingivitis.
From each saliva sample 0. 997 ml. was removed and placed in
separate sterile tubes. To each was added 0. 003 ml. of the Crys-
tamin solution achieving a final concentration of 0. 6 mg. /ml. A
further 0. 997 ml. of each MNS sample was removed and to each was
added 0. 003 ml. of tris buffer. Both sets of samples were now vor¬
tex stirred and then plated (3 x 0. 03 ml. ) upon SHFP and incubated
for 19 hours at 37°C. Controls were set up as described in Part II,
Experiment 3, Fig. 2.
Results:
These are recorded in Table 45 (Appendix 1).
Summary of Results:
Average areas of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. drops













There is no significant difference between the lysis produced by MNS
with Crystamycin and that produced by MNS alone.
Experiment IB.
Object: To study the effect of incorporation of a bacteri-
ostat within an SHFP upon the amount of lysis
produced by MNS.
Materials:
1. MNS. Collection as in Experiment 1A from 20 subjects.
2. Crystamycin, SHFP and controls as in Experiment 1A.
3. Human fibrin plates incorporating Crystamycin at an end con¬
centration of 0. 6 mg. /ml.
Method:
MNS, about 1 ml. , was collected by minimal stimulation from each
subject and after vortex stirring, was plated (3 x 0. 03 ml. ) upon SHFP
and plates containing Crystamycin. Controls were set up as in Ex¬
periment 1A. All the plates were incubated for 19 hours at 37°C.
Results:
These are recorded in Table 46 (Appendix 1).
Summary of Results:
Average areas of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. drops
of MNS upon SHFP and upon human fibrin plates containing Crystamycin
after 19 hours incubation at 37°C.
Subjects/
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There is no significant difference between the areas of lysis produced
by MNS on the SHFP and those of the fibrin plates incorporating Crys¬
tamycin.
Experiment 1C.
After Experiments 1A and B had been completed, the stability experi¬
ments described in Part II were performed. The results are discussed
in Part II.
Discussion and Conclusions:
It was established that under conditions conducive to the growth of
salivary bacteria (i. e. nutrient broth), a concentration of Crystamycin
as low as 0. 6 mg. /ml. was sufficient to prevent the formation of any
colonies on blood agar plates on sub-culture. Incorporation of Crys¬
tamycin into the MNS could have had one of three effects.
1. Bacterial cell death with disintegration of the dead bacteria,
release of endogenous proteolytic enzymes and thus increased
fibrinolytic activity.
2. Bacterial cell death with the prevention of the release of fib¬
rinolytic enzymes and therefore no release of these enzymes
whilst incubating upon the fibrin plates resulting in a reduced
plasminogen activator activity.
3. Possible release of plasminogen activator and/or inhibitor
from the oral flora.
In/
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In the event none of these possibilities appears to have taken place
as the difference in lysis between the system incorporating Crysta-
mycin and the one which does not is insignificant, within the sensi¬
tivity of the technique. The activator activity of MNS measured
in vitro is not significantly altered by killing the bacteria and stor¬
ing MNS at a temperature conducive to bacterial growth results in
a decrease of activity and not an increase.
These findings suggest that the oral flora plays a minor role, if any,
in the plasminogen activator activity of MNS.
3. Experiment 2(i)
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Object: To test the salivary flora and their filtrates for
plasminogen activator activity using
A. The Somerville clot lysis technique.
B. SHFP.
Somerville clot lysis technique (1972). The basis of the test is the
incorporation of bacteria or bacterial filtrate into a fibrin clot and
measurement of the clot lysis time. A reduced clot lysis time relative
to controls indicates some fibrinolytic activity in relation to the in¬
corporated bacteria.
Materials:
1. MNS. MNS was collected by stimulated flow (Methodology, p.
XXVI) from a subject who had no clinical evidence of gingi¬
vitis.
2. Blood agar plates and nutrient broth. Freshly prepared and
supplied by the Department of Bacteriology, Edinburgh Uni¬
versity.
3. SHFP and the reagents required for their preparation, as these
were used for the preparation of the Somerville tubes.
Isolation. 0. 5 ml. of MNS was placed in 5 ml. of fresh nutrient broth.
The tube was rolled after which 0. 5 ml. was placed in a further 5 ml.
of broth and the process continued to dilution number 6. Dilutions 4,
5 and 6 were selected and three blood agar plates were swept with
0. 02 ml. of the innoculated broth at these dilutions. The plates were
incubated aerobically for 24 hours at 37°C. At 24 hours, dilution 5
with approximately 50 colony forming units per plate facilitated iso¬
lation of the colonies for subculture.
The/
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The following bacteria were isolated and identified by their colony
size, shape, colour, texture and ability to lyse blood agar plates and
also by their Gram staining properties and microscopic appearance.
Alpha streptococcus, Micrococcus, Diphtheroid bacilli, Staphylo¬
cocci (citreus), Diplococci, Neisseria, Streptococci (faecalis) and
Gram positive branching filamentous bacteria considered by a bacteri¬
ologist to be probably Lactobacillus.
The isolates were plated upon fresh blood agar plates and into nutrient
broth and incubated aerobically at 37°C for 24 hours as was a broth
culture of Beta haemolytic streptococci (BHS). A further MNS sample
was diluted and plated as above at dilutions 4, 5 and 6 upon blood agar.
One ml. of MNS was placed in 9 ml. of broth and incubated for 24 hours
at 37°C. Therefore, 48 hours from the commencement of the experi¬
ment, there were four sets of preparations for testing, namely :-
1. A set of isolates cultured aerobically on blood agar and in
nutrient broth.
2. A subculture of BHS on blood agar and in nutrient broth.
3. Dilutions of MNS swept over blood agar to give a mixed
aerobic culture.
4. MNS cultured in broth.
Fibrin Plates and Somerville Tubes
1. SHFP. (Methodology, p. I).
2. SHFP containing 0. 1 ml. of molar eACA.
3. Somerville tubes. To an 0. 1% human fibrinogen solution
in tris buffer pH 7. 8, 0. 15M. was added 0. 2 ml. per 10 ml.
of 0. 1M. calcium chloride. The resulting solution was
dispensed in 1 ml. aliquots into 5 ml. test tubes and into





a) SHFP. Each isolate was suspended in nutrient broth after which
the suspension was plated (3 x 0. 03 ml. ) upon SHFP with and with¬
out eACA.
b) Somerville Tubes. 0. 03 ml. of each isolate suspension prepared
above was placed in each of six tubes, 3 with and 3 without eACA.
c) SHFP. Each nutrient broth in which a single isolate had been
cultured was filtered through an 0. 22 micron MiHipore filter and
the filtrate plated (3 x 0. 03 ml. ) upon SHFP with and without eACA.
d) Somerville tubes. Using the filtrates prepared above, 0.03 ml.
was placed into each of six tubes, 3 with and 3 without eACA.
Isolate Controls
1. Sterile nutrient broth. 3 x 0. 03 ml. drops upon SHFP with and
without eACA.
2. Sterile nutrient broth. 0. 03 ml. into each of three Somerville
Tubes with and without eACA.
3. Tris buffer, pH 7. 8, 0. 15M. Negative control. 0.03 ml.
drop per plate, and 0. 03 ml. into each of three Somerville
Tubes with and without eACA.
4. Urokinase. 5 Ploug units per ml. Dispensed as for tris buffer.
Positive control.
2. BHS on blood agar and in nutrient broth.
BHS was treated as one of the isolates. The same controls were used.
3./
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3. MNS. Mixed aerobic culture.
A sterile loop was taken through the various colonies on the plate
as a "sweep". This was repeated several times until a dense sus¬
pension of bacteria was obtained in 0. 5 ml. of nutrient broth.
Thereafter the "sweep" was treated in the same manner as the iso¬
late suspensions.
4. MNS cultured in broth.
The mixed flora growing in this broth would not be present in the
same proportions as those found in MNS, nevertheless they would
be of MNS origin and the filtrate formed may have contained plas¬
minogen activators.
One ml. of MNS was placed in 9 mis. of nutrient broth and therefore
epithelial cells were also present. After 24 hours culture, the in¬
oculated broth was vortex stirred and filtered through 14 micron
Millipore filters which would allow the passage of bacteria but not
epithelial cells. This filtrate was then centrifuged at 4154 g. for
3 0 minutes after which some 7 mis. of supernatant were removed
and filtered through 0. 22 micron Millipore filters to provide a filt¬
rate containing no bacteria but containing any fibrinolytic enzymes
that might have been released. The remaining 3 mis. of broth
containing the pellet of bacteria was vortex stirred and labelled
"bacterial suspension".
This "suspension" and the final filtrate were now treated in the
same manner as the isolates.
All the SHFP, with and without eACA, were incubated at 37°C for
19 hours.
All the Somerville Tubes had added to them 0. 02 ml. of 50 I. U. /ml.
thrombin, were vortex stirred and allowed to clot. These tubes
were/
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were now incubated at 37°C and examined at 19, 24 and 40 hours.
The results are recorded in Tables 47 and 48 (Appendix 1).
Summary of Results:
SHFP.
The isolates, bacterial sweeps and bacterial suspensions caused no
lysis in suspension nor did their filtrates. BHS in suspension caused
2 2
an average lysis of 13 0mm . and its filtrate an average area of 110mm .
Amongst the controls, only urokinase produced lysis.
SHFP with eACA.
No lysis on any plate after 19 hours incubation at 37°C.
Somerville Tubes.
Key: 0 No Lysis.
Lysis + Most of the clot remained but was
floating freely in the tube.
Lysis ++ Most of the clot was lysed but some
clot was still present.
Lysed. Completely fluid. No clot was
visible at all.
SHF Tubes.
After 19 24 40 hours at 37°C
1. All isolates suspension
and filtrates 0 0 Lysis ++
2. BHS. Suspension and
filtrates. Lysed
3. Bacterial sweep. Sus¬
pension and filtrate. 0 0 Lysis ++
4-/
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4. MNS. Bacterial suspension
and filtrate. 0 0 Lysis ++
Lysis ++
Lysis +
5. Controls. Nutrient broth. 0 0
Tris buffer. 0 0
Urokinase. Lysed
SHF. plus eACA.
1. Isolates. As above.
2. BHS. Suspension.
Filtrate.
0 Lysis ++ Lysed.
0 Lysis ++ Lysed.
3. Bacterial sweep. As above.
4. .MNS. As above.
5. Nutrient broth and tris
buffer. As above.
Urokinase. 0 Lysis + Lysed.
Discussion:
The SHFP appeared insensitive to any plasminogen activator activity
that might have been produced by the bacteria. Saliva is a poor
culture medium since it contains many antimicrobial components
such as Lysozyme, the antilactobacillus thiocyanate-dependent
factors, Green's factor, lactoferrin, salivary immunoglobulins and
fluoride (MacFarlane and Mason, 1972). Nutrient broth was used
therefore in this experiment in order not to depress any bacterial
fibrinolytic activity.
The BHS suspension and filtrate both brought about measurable lysis
of the SHFP but failed to produce any lysis on the eACA plates, thus
demonstrating specific plasminogen activator activity.
With the exception of BHS suspension and filtrate, no lysis occurred
with SomerviHe tubes until after 24 hours. The controls suggested
no difference between nutrient broth and any of the bacterial sus¬
pensions /
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pensions prepared in nutrient broth. The tris negative control how¬
ever was considerably less lysed at 40 hours than was the nutrient
broth control. The urokinase control was lysed at 19 hours. In
the tubes with eACA added, the results were the same as those for
tubes without eACA with the exception of the BHS and urokinase posi¬
tive control. With both these tests, no lysis occurred at 19 hours
but by 24 hours, lysis was evident and was complete at 40 hours.
The experiment was repeated three times using different salivas
albeit the same isolates were cultured. Before drawing any con¬
clusions, a further series of experiments was prepared.
Experiment 2 (ii)
The last experiment raised the possibility that the nutrient broth at
least in the Somerville Tube technique might have caused some lysis.
The tris negative control was undoubtedly firmer. The bacteria
had been examined in broth but their normal environment is saliva.
It was decided to repeat all the experiments with the suspensions in
tris buffer and the supernatant of MNS generated at high speed cen-
trifugation (35, 664 g. )
The preparation of all the test solutions was as before except that
the final resuspension was in either the supernatant of MNS or tris
buffer. MNS supernatant alone was added to the controls. Filt¬
rates of bacterial cultures were, of course, in broth.
Summary of Results:
1. SHFP Isolates.
In suspension in tris. No lysis.






In suspension in tris. Lysis; average area 121 mm .
2
In suspension in MNS. Lysis; average area 169 mm .
2
Filtrates. Lysis; average area 110 mm".
3. Bacterial sweep.
In suspension in tris (very dense concentration). Lysis: average
2
area 128 mm .
In suspension in MNS supernatant. Probable lysis.
Filtrates. No lysis.
4. MNS Bacterial suspension.
In tris. No lysis.
In MNS supernatant.
Filtrates. No lysis.
5. Controls. Nutrient broth, tris buffer, MNS supernatant. All
no lysis.
2
Urokinase. Average area of lysis 225 mm .
SHFP with eACA.
1. Bacterial sweep. Suspension in tris (very dense concentration).
2
Lysis: average area 110 mm .
2. Bacterial sweep in suspension in MNS supernatant. Probable
lysis.
When the experiment was repeated (twice), neither of these results
was positive. This may be due to the fact that on the first occasion
recorded above, an extremely dense bacterial suspension was ob¬
tained. (When the plate was read, there was a thin white mat of
cells in the lysed area). The activity appears to have been non¬
specific however, as it occurred also on the eACA plate. An alter¬
native possibility is that in making the sweep, some blood agar was
inadvertently picked up by the platinum loop for Somerville(1972)




All the results were identical to the first series in Experiment 2(i)
both with SHF and SHF plus eACA.
Discussion:
Bacteria, derived from MNS, were cultured and applied to the test
system which so readily demonstrated plasminogen activator activity
in MNS. No activity was detected relative to the negative controls.
That the system will detect such activity has been demonstrated by
the result obtained from testing BHS. However, bacterial produced
plasminogen activator cannot be said to be absent in MNS since it is
well established (Afonsky, 1961: Soder, 1972) that some of the pro¬
tease activity of MNS and dental plaque is almost certainly of bacteri¬
al origin. That no such activity was detected is indicative, therefore,
of a lack of sensitivity in this system.
Conclusions:
The experiment provides no evidence to show that the plasminogen
activator activity of MNS is directly attributable to the oral flora.
However, some contribution from the oral flora cannot be eliminated
since the technique proved insensitive to the presence of small quan¬
tities of protease that might be expected to be present.
Given that the test system used throughout for measuring the fibrino¬
lytic activity of MNS has been the SHFP, then within the limitations
of this system the oral bacteria make no significant contribution to
the plasminogen activator activity.
Experiment 2 (iii)
The experiments were repeated using sweeps from anaerobic plates
and filtrates from anaerobic cultures.
The/
The results were negative.
The conclusion is as stated abov
4. EXPERIMENT 3
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Object: To study the plasminogen activator activity of the
salivary flora using fibrinolytic autography.
Method:
Fibrinolytic autography (Methodology, p. V).
Both human and bovine fibrinogen was used. Smears of the bacteria
grown on blood agar plates in Experiment 2 were covered with fibrin
and suspensions of the same bacteria were included within the fibrin
films. Bacteria were also present on many of the fibrin autographs
of epithelial cells from salivary pellet and dorsal tongue sections and
smears described in Part IV, Chapter 6.
Results:
Foci of lysis developed in human fibrin around clumps of BHS but not
around individual bacteria (Fig. 19 ). This lysis was blocked if eACA
was incorporated in the fibrin film and was not seen on bovine fibrin
film. Lysis was never obtained in association with any of the other
bacteria investigated even after the longest incubation times (Fig. 20)
Although lysis was seen to be related to epithelial cells in the dorsal
tongue smears covered with human fibrin, it was never related to
bacteria even when clumps of bacteria of a similar size to the clumps
of BHS which produced lysis were present on the films (Fig. 21)
Sections of dorsal tongue showed no lysis related to clumps of bacteria
on the surface, although lysis over the connective tissue was present
on the same sections when covered with either human or bovine fibrin
(FigJ.2 ). Frozen sections of salivary pellet showed foci of lysis, in
the centre of which could be seen epithelial cells (Fig. 23 ), while no
foci of lysis related to bacteria were seen.
Discussion and Conclusions:
Fig. 19.
Fig. 19. Fibrinolytic autograph of Beta Haemolytic Strept¬
ococci showing lysis around clumps but not individual
bacteria. Human fibrin , incubated overnight at room
temperature. Mag. x 120.
Fig.20.
Fig. 20. Fibrinolytic autograph of Alpha Haemolytic Strept¬
ococci isolated from saliva shows no lysis , even when in
large clumps. Human fibrin , incubated overnight at room
temperature. Mag. x 300.
Fig.21.
Fig. 22.
Fig. 21. Fibrinolytic autograph of dorsal tongue smear shows lysis
around an anuclear epithelial cell but no lysis around clumps of
bacteria. Human fibrin , incubated overnight at room temperature
and 1 hour at 37°C. Mag. x 300.
Fig. 22. Fibrinolytic autograph of human dorsal tongue showing lysis
around vessels in the connective tissue , but no lysis around the
clumps of bacteria on the surface. Human fibrin , incubated for 18
hours at 4°C. Mag. x 3 6.
Fig.23.
Fig. 23. Fibrinolytic autograph of a frozen section of
salivary pellet showing a focus of lysis related to an
epithelial cell but not to the numerous bacteria present.
Human fibrin , incubated 24 hours at 4°C and 1 hour
at 37°C. Mag. x 120.
Discussion and Conclusions:
These results support the findings in Experiments 1 and 2 that the
oral flora are not the source of the plasminogen activator activity
of MNS. The fibrinolytic autograph technique is sufficiently sensi¬
tive to detect the fibrinolytic activity of clumps of BHS and isolated
epithelial cells. If the normal oral flora are a significant factor in
the plasminogen activator activity of MNS, it is likely that some of
the bacteria (apart from BHS) would have shown evidence of lysis in
these experiments. The BHS produced lysis with human fibrin but
not with the bovine fibrin, thus indicating that the lysis of human




Object: To determine whether or not a quantitative relation¬
ship exists between salivary bacteria and the plas¬
minogen activator activity of MNS.
Comment:
Schiott et al, (1970) examined the extent to which the oral flora was
influenced by repeated chlorhexidene rinses. Subjects rinsed twice
daily with 10 mis. of an 0. 2% solution of chlorhexidene gluconate.
The number of bacteria per ml. of saliva was reduced by 85% after
24 hours reaching a 95% reduction on day five. An 85 - 95% reduc¬
tion was maintained throughout the trial period of 22 days.
Materials:
1. Subjects: Ten subjects, (5 Male, 5 Female) aged 22 - 41, all
of whom were in good health, were taking no drugs and who had no
clinical evidence of gingivitis.
2. MNS. Produced by stimulated flow (Methodology, p. XXVI)
3. SHFP. (Methodology, p. I)
4. Blood agar plates. Freshly prepared and supplied by the Depart¬
ment of Bacteriology, Edinburgh University.
5. Nutrient Broth Transport Medium. Supplied as above.
6. Mcintosh and Fildes' anaerobic jars.
7. Gas Paks.
Method:
For four days prior to the first saliva collection, all the subjects
maintained their normal oral hygiene procedures and in addition
rinsed their mouths three times a day with 10 mis. of water. On
the fifth and sixth day, whilst still rinsing with water, 4-5 mis.
of MNS was collected by stimulated flow at 09. 00 and 14. 00 hours.
The/
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The specimens were vortex stirred, after which 1 ml. was removed
and transferred to a sterile bottle containing 9 ml. of nutrient broth.
Logarithmic serial dilution was continued until seven dilutions had
been prepared. From each of the last four dilutions, 4, 5, 6 and
7 were removed five drops (0. 02 ml. ) of broth which were plated
upon blood agar. The plates were prepared in duplicate to provide
for anaerobic and aerobic culturing and incubated at 37°C for 24
hours.
The saliva samples from which the dilutions had been prepared were
stored at -40°C.
After 24 hours incubation, the agar plates were removed from the
incubators and read.
The appearance of such a plate is illustrated in Fig. 24.
Reading the plate.
At each dilution there were five sets of colony forming units. Every
colony in each set was counted. The total count for each set was
recorded and then the five totals were added together and divided by
five to give the average colony count for that dilution.
For each saliva sample, there was obtained an average colony count
at dilutions 4, 5, 6 and 7.
At the end of day six there had been obtained from each subject, four
samples of MNS, most of which had been deep frozen for testing at
a later date in respect of plasminogen activator activity and from
which also had been made serial dilutions for bacterial culture and
subsequent counting. The bacteriological investigations were com¬
menced as soon as the saliva was collected.
On day seven and for the next ten days, each subject rinsed his mouth
with 10 mis. of 0. 2% chlorhexidene gluconate in place of water.
On the ninth and tenth days of this regime, samples of saliva were




Aerobic blood agar plate with five drops (0. 02 ml. )
of broth at dilutions 4 (top) and 5 (bottom) showing
isolated colonies of bacteria after 24 hours incubation
at 37°C.
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for when the subject was on mouth rinses of water. Thus four sets
of saliva per subject were collected for immediate bacteriological
investigation and later plasminogen activator assessment.
Following the ten days of chlorhexidene washes, there was a period
of seven days on the original regime using water. At the end of
this period, on the last two days, saliva samples were again collected.
For every subject there should have been twelve sets of saliva deep
frozen for later fibrinolytic investigation and twelve sets of bacterio¬
logical data.
In the event six complete sets of twelve were obtained. Two people
became unwell with colds during the trial period and dropped out.
One so disliked the taste that he refused to continue and one subject,
having completed the chlorhexidene rinses, did not return for the
final part, the return to water rinses. Nevertheless, for every
specimen of saliva (98) collected, there was also a bacteria count.
Preliminary trials had been conducted within the Laboratory to estab¬
lish the degree of dilution that would be required in order to obtain
accurate counting and all specimens had been kept and the bacterio¬
logical data recorded. It was, therefore, possible to add a further
66 readings to the 98 obtained on the trial and thereby obtain 164
results from which to establish whether or not a quantitative relation¬
ship existed between bacteria per ml. of MNS and the plasminogen
activator activity of MNS.
Plasminogen activator activity was assessed upon SHFP. Freshly
thawed and well stirred saliva was plated (3 x 0. 03 ml. ) for each
specimen. All the samples were tested at the same time on the
same batch of fibrin plates. All were incubated for 19 hours at
37°C. Controls of urokinase and tris buffer were set up as des¬




These are recorded in Tables 49 - 52 (Appendix 1).
Calculation of Results:
1. The correlation coefficient, r, may be calculated from the.follow¬
ing formula.
Sum (X -"X)(Y - Y)
r =
xy / Sum (X - X? Sum (Y - Y)2
r = mean of all the values of ( (observation of X minus mean of the
observations of X) -4- standard deviation of X x (corresponding
observation of Y minus mean of the observations of Y) 4* standard
deviation of Y
Let X = average area lysed by MNS.
Let Y = average count of bacteria, at a defined dilution, contained
in sample of MNS producing the lysis, X.
2. Standard error l/n - 1 where n is the number of individuals in
the sample.
Summary of Results:
Evidence was sought for an association between :-
a) Activator activity of MNS and the number of aerobes present.
b) Activator activity of MNS and the number of anaerobes present.
c) Activator activity of MNS and the total number of bacteria,
aerobes plus anaerobes.
a) r 0.32. Standard error 0.08. Therefore r = 4x standard
error.





c) r = 0.29. Standard error. 0.08. Therefore r = 3.6x stan-
xy
dard error.
The three results indicate a low but significant correlation between
the amount of lysis produced by a sample of MNS and the number of
colony forming units grown from it (Hill, 1961).
Discussion:
The ratio of cultivable organisms in saliva to countable is about 1:4
(Socransky et al, 1963) and this ratio does not allow for numbers of
dead organisms which may be present. In absolute numbers, there¬
fore, a rise in the number of colonies counted on a plate signifies a
very much greater increase in the total number of bacteria. A very
large increase in the number of bacteria then may be necessary to
bring about an increase in fibrinolytic activity. MacPheeand Cowley
(1969) state that the quantitative change in the oral flora which is as¬
sociated with gingivitis and periodontitis is such that the concentration
of organisms in deposits on the teeth is of the order of 2 x 10^ organ¬
isms per gramme weight of plaque: approximately the same concen¬
tration of organisms as a pure culture of streptococci. They further
state that there is an increase in the bacterial enzymes of saliva as
a result of this change. This statement is not inconsistent with that
of Gordon et al (1965) in which they state the flora of saliva reflects
the microbiota of the tongue rather than the gingival crevice for it is
the enzymes in the saliva, not necessarily the organisms themselves
to which MacPheeand Cowley refer. The chlorhexidene mouthwashes
used here to depress the salivary flora reduce the oral flora non-
selectively (Loe and Schiott, 1970) to bring about the inhibition of
plaque and so prevent gingivitis. Although none of the subjects in
this experiment had clinical evidence of gingivitis (as defined in Part
II) plaque would be present and hence the enzymes produced by it.
Thus/
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Thus, while reducing the oral flora and hence the viable flora in saliva,
the plaque flora and therefore the enzymes released from it would also
be reduced.
Amongst the enzymes produced by plaque and present consequently in
saliva are proteinases, peptidase, urease and collagenase.
Although the SHFP plus eACA cannot detect non-specific proteolysis
in MNS, this may be because the technique is not sufficiently sensitive
to show such activity. Any non-specific proteolytic activity in MNS
may enhance the plasminogen activator activity while not being suffici¬
ently powerful to cause lysis on its own in the fibrin plate technique.
In addition, of course, the presence of plaque and some gingivitis
necessarily means the presence of some inflammatory exudate with
the ingress of leukocytes and plasminogen into saliva.
Another consideration is the action of bacterial endotoxins upon other
cellular particles. Wunschmann-Henderson et al (1972) discuss the
effect of bacterial toxins upon human leukocytes and how the release
of small amounts of plasminogen activator is enhanced by the presence
of bacterial toxins. Leukocytes are present in the saliva of all sub¬
jects and in greater numbers where gingivitis is present. A complex
inter-relationship between bacteria - gingivitis - gingival fluid - leuko¬
cytes - activator release may operate. The salivary flora are also
found firmly bound to epithelial cells, and might be instrumental in
producing an epithelial cell associated activity.
Against all this must be laid the evidence of the bacteriostat experiments,
the SHFP, Somerville tubes, and the fibrinolytic autographs. On balance,
it appears that although an association between quantities of bacteria
and fibrinolytic activity exists, this is not evidence of causation. The
reduction of gingivitis, the overall reduction of bacterial enzymes
eminating from plaque, the unknown effect of bacterial endotoxins upon
other cells present, all obscure the issue. What is clear is that a
massive reduction in salivary flora does not prohibit fibrinolysis, no
direct/
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direct causal relationship exists and this, taken in context with the
previous experiments, strongly suggests that while not stating that
the oral flora produce no plasminogen activator, their contribution
of activator to the MNS activator activity can only be very minor.
Conclusion:
1. A low but significant correlation exists between the amount
of lysis produced by a sample of MNS and the number of
bacteria colony forming units grown from it.
2. While it has not been demonstrated that the oral flora pro¬
duce no plasminogen activator, any contribution they do




Object: To test MNS for the presence of a streptokina'se-
like activity.
Materials:
1. Reagents normally used to prepare standard bovine fibrin plates
(Methodology, p. IV)
2. Human plasminogen (Lyophilized. 25 caseinolytic units, 10 -
15 cu. /mg, protein A. B. Kabi, Sweden).
3. Streptokinase 2, 500 units/ml. in tris buffer, pH 7.8, 0.15M.
4. Urokinase. 5 Ploug units/ml. pH 7. 8, 0. 15M.
5. Tris buffer. pH7.8, 0. 15M.
6. MNS. MNS was collected by stimulated flow (Methodology, p. XXVI)
from 15 persons, 7 female and 8 male, who were in good health,
taking no drugs and who had no clinical evidence of gingivitis.
Method:
Five sets of bovine fibrin plates were prepared. They were prepared
as for SBFP except that four also contained human plasminogen with
end concentrations of 0.1, 0.05, 0.025 and 0.012 cu. /ml. respectively.
The fifth plate was an SBFP and functioned as a control.
Upon each of these five plates were plated 3 x 0. 03 ml. of MNS and
the control solutions of urokinase and tris buffer (Part II, Experiment
3, Fig. 3 ). The plates were incubated for 19 hours at 37°C. Strep¬
tokinase was similarly applied to the same types of bovine plate at a
concentration of 2, 500 units/ml. and serially diluted to 0. 07 5 units/ml.
on bovine plates containing human plasminogen 0. 1 cu. /ml.
Results:




MNS - no lysis produced.
Streptokinase - at a concentration as low as 0. 075 units/ml.
lysis of 100 sq. mm. was readily recorded.
Discussion:
MNS appears to have no streptokinase - like activity within the sensi¬
tivity of the system described. The apparent absence then of an
enzyme which is of bacterial origin and in an area rich in strepto¬
cocci is further evidence of the very small role the oral flora must
play in the fibrinolytic activity of human mixed native saliva.
The result of this experiment is extremely important since the be¬
haviour of MNS upon fibrin plates in one respect is identical to that
of streptokinase. That is that both MNS and streptokinase lyse
human fibrin plates and do not lyse bovine fibrin plates. It was,
therefore, fundamental to demonstrate that the apparent plasmino¬





1. The salivary leukocytes.
2. Experiment 1.
To study the plasminogen activator activity of
leukocytes suspended in saline and MNS super¬
natant and the effect of freeze-thawing on this
activity.
3. Experiment 2.
To compare the plasminogen activator activity .
in MNS of a dentate population with that of an
edentate population.
4. Discussion and conclusions.
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1. SALIVARY LEUKOCYTES
The oral micro-organisms contribute only 16 - 34% of the total
metabolic activity of MNS (Eichel and Lisanti, 1964). The re¬
mainder appears to be accounted for largely by the oral leukocytes
(Hoffman, 19 66). The gingival sulcus is the major site of entrance
of leukocytes into the oral cavity (Sharry and Krasse, 1960: Wright,
1964: Schroder, 1970: Frank and Cimasoni, 1970 and Lange and
Schroder, 1971). While the edentulous mouth is almost devoid of
leukocytes (Calonius, 1958: Wright, 1962: Klein, 1962: Lantzman
and Michman, 197 0), Klinkhamer (1968) has shown a close cor¬
relation between the number of teeth present and the number of
salivary leukocytes. In the healthy edentulous mouth, 1, 000 -
143, 000 leukocytes/ml. ; in the healthy dentulous mouth, 110, 000 -
1, 364, 000 leukocytes/ml. ; and in the mouth where gingival inflam¬
mation is present 770, 000 - 11,896,000 leukocytes/ml. (Calonius,
1958). The upper limit found by Calonius occurred in a single case
presenting with a "suppurating fistula" and the second highest count
he records is 5, 912,000 leukocytes/ml. Calonius examined only
thirteen chronically inflamed mouths and if the count of 11, 89 6, 000
is excluded, the mean of the remaining twelve is 2, 389, 000 leuko¬
cytes/ml. This figure conveys a more accurate indication of the
number of salivary leukocytes in inflamed mouths.
In the gingival tissue and gingival fluid most leukocytes have the
appearance of intact cells resembling those in the blood (Lange,
1967: Gavin, 1968: Frank and Cimasoni, 1970: Attstrom, 1970:
Lange and Schroder, 1971). In saliva, however, neutrophil poly¬
morphonuclear (PMN) leukocytes appear as cells, and Raeste (1972)
has demonstrated that a mononuclear degenerated cell form is pre¬
dominant. Furthermore, she has shown that in salivas of differ¬
ing pH (pH 7.20 and 6.76) the morphological appearance of the
degenerating PMN leukocytes is identical. Lymphocytes resemble
those/
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those seen in blood as do also monocytes, but eosinophils are also
degenerate (Raeste, 1972). The morphologic appearance and size
of PMN leukocytes in MNS generally corresponds to the changes ob¬
served in degenerating leukocytes of the blood (Koeffler, 1950).
The degenerate state develops when the cells come in contact with
saliva because those in the gingival fluid resemble those in the blood.
Kwaan and Astrup (1964) observe that PMN leukocytes contain a lysis
producing protease but no activator of plasminogen, although Gans
(1963) from his experiments with human, dog and rabbit leukocytes
suggests an activator might be present. Astrup et al (1967) using
plasminogen rich bovine plates and fibrinolytic autography demon¬
strates that washed intact leukocytes do not produce lysis although
occasional weak activity is related to degenerate cells. Freeze-
thawed PMN leukocytes lyse both plasminogen rich and plasminogen
free substrates, from which result they conclude the lysis must be
caused by a non-specific leukoprotease. Potassium thiocyanate
extracts failed to demonstrate any measurable amount of stable
activator.
However Goldstein et al (1971) (with Astrup) demonstrate normal
viable human PMN leukocytes to contain small amounts of plasmin¬
ogen activator, the release of which is enhanced by bacterial endo¬
toxins.' Wunschmann-Henderson et al (1972) report a comparative
study of the fibrinolytic response to endotoxin of leukocytes. They
found the number of fibrinolytically active cells increase following
exposure to endotoxin (lipopolysaccharide B from Salmonella abor¬
tus) and approached the total leukocyte count. They also found
during their work that complete destruction of leukocytes by freeze-
thawing leaves the cells devoid of activator activity which may ex¬
plain why in 1967, Astrup et al report no plasminogen activator in
PMN leukocytes.
It appears then from the literature that PMN leukocytes contain
small/
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small quantities of plasminogen activator and larger amounts of a
non-specific activator, a leukoprotease. The release of the speci¬
fic activator is enhanced by endotoxin without apparently decreasing
the number of viable leukocytes. Salivary leukocytes are in various
stages of degeneration and exist in a fluid containing many bacteria
which may or may not affect their plasminogen activator activity.
It is necessary, therefore, to ascertain whether or not these saliv¬
ary leukocytes have any specific activator activity upon human fibrin
substrates. All the work of Astrup and his colleagues was performed
upon bovine fibrin upon which MNS has no activator activity although
such activity is consistently shown by MNS upon human fibrin, and so
much of their work has been repeated here with human fibrin.
2. EXPERIMENT 1
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Object: To study the plasminogen activator activity of leuko¬
cytes suspended in saline and MNS supernatant, and
the effect of freeze-thawing on their activity.
Materials:
A. Collection of leukocytes.
1. Heparin: (20 i.u./ml.) diluted in saline 0.9% NaCl. from
25, 000 i.u. /ml. solution supplied by Weddel Pharma¬
ceuticals Ltd. , London.
2. 'Lomodex' 70: A sterile solution containing 6% w/v dextrans
in 5% w/v Dextrose Injection B. P. (Fisons Ltd. , England)
3. Blood: 10 mis. of freshly collected peripheral venous blood.
To 8 mis. of heparin solution (20 i.u. /ml. ) were added 4
mis. of Lomodex 70. Into each of two sterile test tubes
was put 5 mis. of this mixture. Ten mis. of peripheral
venous blood, freshly collected, was divided evenly between
the two tubes and gently mixed with the heparin-saline-
dextrose (HSD) solution. After mixing the tubes were
placed at an angle of 45° in a 37°C incubator for 30 - 40
minutes. The supernatant that formed was largely free
from erythrocytes but contained leukocytes in suspension.
B. MNS supernatant.
Stimulated MNS (Methodology, p. XXVI) was collected from
one of the laboratory staff who was in good health and who
had no clinical evidence of gingivitis. The saliva was
centrifuged at 20, 000 r.p.m. (35, 644 g. ) for 30 minutes
and the resulting supernatant stored at 4°C.
C. Fibrin films.
Fibrinolytic autography (Methodology, p. V )
D./
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D. SHFP and SBFP with and without eACA (0. 1ml. M. eACA
per plate).
E. Controls - tris buffer, pH 7.8, 0.15 M.




The supernatant from both tubes of heparinised blood was removed,
pooled, and gently rolled to resuspend evenly the leukocytes. Two
mis. were then gently centrifuged (2 minutes at 800 - 1000 r.p.m. )
and the resulting concentrated pellet of leukocytes washed three times
in HSD. The cells were then resuspended in their original volume
of saline and stored at 4°C ('A').
A further 2 ml. of cells was removed and washed as above. After
resuspension in their original volume of saline, the cells were sub¬
jected to rapid freeze-thawing for three times at -40°C. After the
final thaw, the cell suspension was stored at 4°C ('B').
A final 2 ml. of cell suspension was removed and the cells washed as
above. The final resuspension, however, was in the supernatant of
MNS generated as described. These cells also were stored at 4°C
('C').
Thus were prepared suspensions of washed leukocytes, viz.
A. Suspended in saline.
B. Suspended in saline and freeze-thawed.
C. Suspended in MNS supernatant.
A cell count was made of every suspension using an Improved Neubauer
counting chamber. From each of these suspensions, the following
procedures were carried out.
1./
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1. Leishman stained films.
2. Fibrinolytic autography with the cells suspended in the fibrin.
3. Plating (3 x 0. 03 ml. ) upon SHFP and SBFP (with and without
eACA) and incubation for 19 hours at 37°C. Controls were
plated in accordance with Part 2, Experiment 3, Fig. 3.)
Results:
These are recorded in Tables 55 - 57 (Appendix 1).
Summary of Results:
A. Saline suspended leukocytes.
The concentration of washed leukocytes in saline ranged from 4870 -
250 per cu. mm.
For comparison, the upper limits of leukocyte counts in saliva record¬
ed in the literature and discussed in the Introduction are :-
Healthy edentulous mouths 143 per cu. mm.
Healthy dentulous mouths 1, 3 64 per cu. mm.
Chronically inflamed mouth 2, 389 per cu. mm.
None of the suspensions produced lysis or probable lysis upon SHFP
or SBFP either with or without eACA, and none showed lysis with
fibrinolytic autography (Fig. 25)
B. Freeze-thawed leukocytes.
The concentration of freeze-thawed leukocytes in saline ranged from
35, 000 - 288 per cu. mm.
The fibrinolytic activity of the suspensions can be described in three
bands.
1. 35,000 - 16,000 per cu. mm. With one exception, all
these concentrations displayed lysis upon SHFP and SBFP
both with and without eACA. The eACA readings were
consistently/
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consistently lower with the human plates but very
similar with the bovine plates.
2. 16, 000 - 2,750 per cu. mm. Variable activity
which is approximately proportional to concent¬
ration. The eACA readings are again consist¬
ently lower with the human plates, but very
similar with the bovine.
3. 2,750 - 288 per cu. mm. With one exception
(1600) none of these suspensions produced lysis
upon SHFP or SBFP with or without eACA.
None of the suspensions showed lysis with fibrinolytic autography (Figs.
2 6 and 27. ) although the cells showed varying degrees of disruption.
C. Washed leukocytes resuspended in the supernatant of MNS.
The concentration of washed leukocytes resuspended in the super¬
natant of MNS ranged from 20, 000 - 250 per cu. mm.
At 20, 000 measurable lysis occurred upon SHFP both with and without
eACA. There was no lysis of the SBFP either with or without eACA.
From 18.000 - 2, 250 occasional areas of probable lysis appeared on
SHFP and SBFP, but only once on SHFP and SBFP with eACA.
Below a concentration of 2, 250 per cu. mm., no lysis or probable
lysis occurred at any time upon any plate.
None of the suspensions showed lysis with fibrinolytic autography
(Figs. 28 & 29) although the cells showed varying degrees of disruption.
Discussion and Conclusions:
In the healthy dentulous mouth, an upper limit of leukocytes has been
placed at about 1, 364 per cu. mm. (Calonius, 1958). In this experi¬
ment washed leukocytes resuspended in the supernatant of MNS pro¬
duced no lysis below a concentration of 2, 250 per cu. mm. and no
clear measurable lysis below 10, 000 per cu. mm. and then the area
2
produced was only 80 mm .
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After freeze thawing, three times, no lysis upon SHFP occurred below
a concentration of 2, 7 50 per cu. mm. which is twice the concentration
of the suggested upper limit.
Examination of the tables suggests there was some plasminogen acti¬
vator present in addition to a leukoprotease as evidenced by the re¬
duced lysis upon eACA plates, but the amount is very small and most
of the activity is non-specific proteolysis.
It may be argued that the leukocytes resuspended in the supernatant
of MNS would be no different than washed leukocytes which displayed
no activity. However, cytological preparations of washed, freeze-
thawed and MNS - resuspended leukocytes demonstrate the relatively
normal appearance of the washed cells (Fig. 25 ) and the varying
degrees of disruption associated both with freeze-thawing (Figs. 26 & 27)
and the supernatant of MNS (Figs. 28 & 29).
Although the MNS supernatant (generated at 3 5, 664 g. ) used in this
experiment was cell free, it might have retained in solution some
endotoxin of salivary bacteria origin and indeed might contain rather
more than in vivo since centrifugation at this force will tend to break
up any cells left after the preliminary centrifugation at 4154 g. The
complete absence of any fibrinolytic activity at cell concentrations
commensurable with those of MNS is strongly suggestive that no endo¬
toxin - leukocyte interaction takes place in MNS and that salivary
leukocytes, at the concentrations normally present in healthy dentu-
lous mouths, play no significant role in the plasminogen activator
activity of MNS.
Astrup et al (1967) using bovine fibrinogen did achieve lysis with
freeze-thawed leukocytes on their autographs both with and without
eACA, thus demonstrating the presence of a protease. Astrup
manages to achieve a satisfactory autograph using 0.7% bovine fib¬
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Fig. 26. Fig. 27.
Fig. 25. Fibrinolytic autograph of suspension of
leukocytes in saline showing no fibrino¬
lysis. Human fibrin, incubated over¬
night at room temperature and 1 hour
at 37°C. Mag. x 480.
Fig. 26. Smears of freeze-thawed suspensions
of leukocytes in saline showing dis¬
rupted leukocytes. Stained with Leishman .
Mag. x 480.
Fig. 27. Fibrinolytic autograph of freeze-thawed sus¬
pension of leukocytes in saline showing dis¬
rupted leukocytes but no lysis. Human fibrin,
incubated at room temperature overnight and
1 hour at 37°c# Mag> x 480>
Fig. 28.
Fig. 28. Smears of leukocytes suspended in MNS
supernatant showing disrupted leukocytes.
Stained with Leishman. Mag. x 480.
Fig. 29.
Fig. 29. Fibrinolytic autograph of leukocytes suspended
in MNS supernatant showing disrupted leuko¬
cytes but no lysis. Human fibrin, incubated
overnight at room temperature and 1 hour at
37°C. Mag. x 480.
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able bovine fibrinogen, the writer and his colleagues in the Labor¬
atory have never successfully produced a film at this concentration
that was satisfactory and when such a dilution was approached, it
would not adequately stain to demonstrate a differential between
lysed and non-lysed areas. Wunschmann-Henderson et al (1972)
using Astrup's techniques now find that smears prepared from frozen
and thawed suspensions show no fibrinolytic cells on either plasmino¬
gen rich or plasminogen free fibrin. They conclude from their data
that complete disruption of suspended cells leaves the stroma devoid
of plasminogen activator although not necessarily a protease and
thereby imply the presence of an activator they did not previously
(1967) demonstrate. In 1972 they found that the leukoprotease acti¬
vity of individual cells was too little to detect, although in 1967 this
was what they found and illustrated.
In order to increase the sensitivity of their techniques, Astrup writes
". . . and the rinsing in tap water of the formaldehyde-fixed slides
was extended to 20 hours to make the zones of weak lysis around the
individual cells more visible. " Given that he is starting with a very
thin film, the danger of an artifact presenting as lysis is considerable.
Evidence is presented in the next Chapter of this work of "cell shrink¬
age" during autography and its appearance as lysis. It cannot be
stated that lysis by leukocytes using fibrinolytic autography cannot
be achieved, but rather that this writer has been unable to reproduce
satisfactorily the conditions under which Astrup has occasionally
demonstrated fibrinolysis with freeze-thawed leukocytes.
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3. EXPERIMENT 2
Object: To compare the plasminogen activator activity in
MNS of a dentate population with that of an edentate
population.
Materials:
1. Minimally stimulated MNS (Methodology, p. XXV) was collected
from 20 male and 20 female edentulous adults who were attending
the Prosthetic Department of Edinburgh Dental Hospital. The oral
mucosa of each subject was examined for any evidence of oral ulcer¬
ation or palatal stomatitis and only those persons in whom there was
no clinical sign of stomatitis and who were in good health were asked
to contribute.
2. SHFP. (Methodology, p. I).
3. Controls. Urokinase. Positive. 5 Ploug units/ml. pH 7.8,
0. 15 M.
Tris buffer. Negative. pH 7.8, 0.15 M.
Method:
The samples of MNS were collected between 14.00 and 14.30 hours.
Three 0. 03 ml. drops of each saliva were set up on SHFP controlled
as described in Part II, Experiment 3, Fig. 2 , and incubated at 37°C
for 19 hours.
Results:
These are recorded in Table 58 (Appendix 1).
Summary of Results:
Average area of lysis (in sq. mm. ) produced by 3 x 0. 03 ml. drops
of MNS upon SHFP after 19 hours incubation at 37°C.
158
Male Edentates Female Edentates
201 197
76 80
These results may be compared with those recorded in Part II, Experi¬
ment 5 where the lysis recorded is that produced by 50 male and 50 fe¬
male dentates. Male dentates - Mean (50) 197. S.D. 100. Female




There is no significant difference between these two sets of figures.
The important difference between the two populations in respect of
the presence of leukocytes is, as discussed in the introduction to
'Salivary Leukocytes', their almost complete absence from the saliva
in edentates with healthy mouths. As no significant difference exists
between the two populations in respect of fibrinolytic activity, it seems
highly improbable that salivary leukocytes could be making a major
contribution to the plasminogen activator activity of MNS.
159
4. DISCUSSION AND CONCLUSION
It is apparent from the literature that PMN leukocytes contain small
quantities of plasminogen activator and larger amounts of non-specific
activator, a leukoprotease. It is also apparent that the release of
activator is enhanced by certain endotoxins.
In the experimental work described above, no activator activity has
been demonstrated in PMN leukocytes by fibrinolytic autography.
However, using the fibrin plate technique^ concentrations of leukocytes
in excess of 27 50 per cu. mm. when freeze-thawed brought about lysis
upon SHFP, and leukocytes freshly harvested and resuspended in the
supernatant of MNS also lysed SHFP but only caused measurable lysis
when in excess of 10, 000 per cu. mm. Fresh leukocytes resuspended
in saline did not lyse SHFP. The results support the previous pub¬
lished evidence that there is some plasminogen activator present in
addition to a leukoprotease as evidenced by the reduced lysis upon
eACA plates, but the amount is very small.
The lowest concentration of leukocytes producing lysis of SHFP occurred
with the freeze-thawed preparations but even this concentration was
about twice the upper limit of the concentration of leukocytes found in
the healthy dentulous mouth. This finding, taken in consideration
with the fact that no significant difference between dentate and edentate
MNS could be found in respect of fibrinolytic activity, strongly suggests
that although salivary leukocytes do have plasminogen activator activity,







To study the fibrinolytic
activity of oral epithelial
cells by fibrinolytic auto¬
graphy.
To study the fibrinolytic
activity of oral epithelial
cells using SHFP.
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1. ORAL EPITHELIAL CELLS
Large numbers of desquamated epithelial cells are found in MNS.
The number of epithelial cells in the saliva of ten adults (Deakins
et al, 1941) ranged between 2620 and 18, 500 per ml. Higher
counts in the very young are paralleled by increased cell counts
in edentulous persons (Calonius, 1958). These high counts may
be due to the friction on the oral mucosa of foods and sucking
which rubs off the cells (Klein, 1962).
Desquamated oral epithelial cells carry a variable burden of closely
adherent bacteria, which in some cases may completely cover the
surface (Bradley, 1948) and in a few cases may be within the cyto¬
plasm (Montgomery, 1951).
These adherent bacteria are very resistant to being washed off
and therefore when fibrinolytic studies of salivary epithelial cells
are carried out, the bacteria are an unavoidable contaminant.
Birn and Fejerskov (1971) and Wunschmann-Henderson and Astrup
(197 2) have described human oral epithelium as having fibrinolytic
activity. Both studies used buccal smears examined by fibrinolytic
autography. Birn and Fejerskov (1971) describe a "minority" of
cells causing lysis, the cells being derived from all layers of the
epithelium including anuclear superficial cells. Wunschmann-
Henderson and Astrup (1972) describe up to 36% of cells as causing
lysis. They found the superficial cell layers to be inactive, only
the younger cells from the deeper layers of the epithelium being
active, giving an inverse relationship between epithelial cell matur¬
ation and fibrinolysis. Unless the oral mucosa is inflamed or
ulcerated, cells from the deeper layers of the epithelium are not
present in saliva in large numbers. Surprisingly, fibrinolytic auto¬
graphy of frozen sections of human oral mucosa does not show lysis
in relation to the epithelium (Harris and Pannell, 1973).
To/
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To assess the importance of the fibrinolytic activity of epithelial
cells in saliva, the fibrinolytic activity of naturally desquamated
epithelial cells in salivary pellet, as well as the fibrinolytic acti¬




Object: To study the fibrinolytic activity of oral epithelial
cells by fibrinolytic autography.
Materials:
1. Pellet. In excess of 12 ml. of MNS (stimulated flow, Method-
ology, p.XXVI) was collected from a healthy dentate with no evidence
of gingivitis. The MNS was centrifuged at 4154 g. for 20 minutes
at 4°C and the supernatant discarded leaving approximately 1 ml. of
pellet.
2. Smears. After ensuring the subject had no gingivitis or throat
infection, buccal, palatal and tongue smears were made by gently
scraping the relevant tissue with wooden tongue spatulas and then
suspending the scrapings in tris buffer (pH 7.8, 0. 15 M). In order
to obtain sufficient cells from the palate, it was necessary to pool
scrapings.
3. Materials for human fibrinolytic autography (Methodology, p.V)
Method:
Pellet. From the fresh pellet, smears were made for autography
and thereafter the pellet was divided into two. One half was snap
frozen with carbon dioxide and five micron sections cut and placed
on glass slides for autography. The other half was washed 4 times
with 20 ml. volumes of tris buffer at 4°C by centrifugation at 4154 g.
Smears were made from the washed pellet as above. For descrip¬
tive purposes, these preparations were called, pellet, frozen pellet
and washed pellet respectively.
Smears. The cell suspensions prepared as above were centrifuged
at 4154 g. for ten minutes at 4°C and the pellet generated washed




The smears were labelled according to the cell type, e. g. buccal
smears. Human fibrin films both with and without eACA
were prepared for each smear or section. (Methodology, p.V).
Results:
The fibrin autographs of salivary pellet showed isolated foci of lysis
(Fig. 30) which with prolonged incubation times became confluent
(Fig. 31). When eACA was incorporated in the fibrin film, no lysis
occurred even with a similar incubation time (Fig. 32) and this
provided further evidence of the specificity of the fibrinolytic acti¬
vity of MNS demonstrated in Part II.'
When examined more closely, the cell in the centre of each focus of
lysis could be seen under the microscope, but could only be demon¬
strated photographically by adjusting the exposure of the negative
(Figs. 33 and 34). The active cells appeared to be both nucleated
squamous epithelial cells (Figs. 35 and 36), and anuclear epithelial
cell fragments (Figs. 37 and 38). Similar foci of lysis developed
in smears from the cheek and tongue (Figs. 39 and 21). Because
of technical difficulties, it was impossible to give a very accurate
figure for the percentage of active cells, but not more than 2% of
the buccal cells were active and the impression was that even fewer
tongue cells were active. No lysis was seen associated with the
keratinised cells in the palatal smears.
Discussion:
The frozen pellet sections clearly demonstrated foci of lysis but were
too dense to accurately locate the source. The pellet smears washed
and unwashed showed epithelial cells in the centres of the lytic foci.
Bacteria were also present on the same preparations unrelated to the
foci of lysis and it is, therefore, unlikely that the bacteria attached
to the epithelial cells were responsible for the lysis although the
possibility/
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Fig. 30. Fibrinolytic autograph of a frozen section of
MNS pellet showing isolated foci of lysis, the
larger foci becoming confluent but with small
foci of lysis also present. Human fibrin, in¬
cubated overnight at room temperature and for 1
hour at 37°C. Mag. x 30.
Fig. 31. Fibrinolytic autograph of a frozen section of MNS
Human fibrin,pellet showing confluent lysis,
incubated 18 hours at 37°C. Mag. x 30.
Fig. 32. Fibrinolytic autograph of serial section to Fig.
31 showing no lysis when eACA was incorporated
Human fibrin, incubated for
Mag. x 30.
in the fibrin film.
18 hours at 37 C.
Fig. 33.
Figs. 33 & 34. Fibrinolytic autograph of a smear of a pellet
(MNS) showing a well defined focus of lysis , which when the
negative was over exposed shows an anuclear cell in the
centre. Human fibrin , incubated overnight at room temperature
and 1 hour at 37°C. Mag. x 48.
Fig. 35. Fig. 36.
Figs. 35 & 36.
Fibrinolytic autographs of smear of MNS pellet showing nucleated
squamous epithelial cells in the centres of the foci of lysis. Human
fibrin, incubated overnight at room temperature and 2 hours at 37 C .
Mag. x 300.
Fig. 37. Fig. 38.
Figs. 37 & 38.
Fibrinolytic autograph of smear of MNS pellet showing anuclear
epithelial cell fragment in the centres of the foci of lysis. Human
fibrin, incubated overnight at room temperature and 2 hours at





Fig. 3 9. Fibrinolytic autograph of a buccal smear showing
lysis related to a nucleated squamous epithelial cell. Human
fibrin , incubated overnight at room temperature and 1 hour






Fig. 40. Fibrinolytic autograph of a buccal smear with bubbles
made in the fibrin. The fibrin was not incubated before fixation
and no cells are present in the centres of the clear circles.
Human fibrin. Mag. x 120.
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possibility that they might enhance the epithelial cell activity cannot
be ruled out since Wunschmann-Henderson et al (1972) have drawn
attention to endotoxin induced fibrinolytic activity in suspensions of
leukocytes. The writer was unable to determine the degree of ma¬
turity of the pellet cells using Papanicolaou's staining method because
the fibrinolytic autographs were too thick. The writer was unable to
prepare adequate human fibrin films using a concentration of fibrin¬
ogen less than 2% while Wunschmann-Henderson and Astrup achieve
a film using 0. 7% bovine fibrinogen.
Fibrinolytic activity was shown by approximately 2% of the buccal
cells in any one smear and by lesser numbers of cells from the
tongue. This is consistent with Birn and Fejerskov (1971) who
describe occasional cells causing lysis but compares unfavourably
with Wunschmann-Henderson and Astrup (1972) who record activity
associated with up to 36% of buccal cells. The latters films are
much thinner than the writers, the fibrinogen solution used is 0.. 75%
and made from plasminogen rich bovine fibrinogen and, furthermore,
the autographs are washed in water after fixation to increase the
visibility of lysis, a most hazardous procedure (Chapter 5). The
writer has observed several hundred autograph preparations and has
found that there is a real danger of misinterpreting artefacts and
wonders whether such artefacts might partly account for the high
percentage of fibrinolytically active cells described by Wunschmann-
Henderson and Astrup (1972).
Two main types of artefact have been noticed. One was an air bubble
in the film which was distinguished by a well marked line (sometimes
double) around the periphery (Fig. 40). A clear focus of lysis some¬
times had a similar line but not as well marked. The other artefact
was a form of distortion where a well delineated clear area appeared
around the periphery of the cell which was not circular, and the size
of which was not related to incubation time (Figs. 41 and 42). Such
areas/
Fig. 41. Fig. 42
Fibrinolytic autographs of buccal smear showing clear areas
around the cells which are not circular and the development
of which was not related to incubation times. Human fibrin,
incubated at 37 C. for 2 hours. Mag. Fig. 41 x 48. Fig.
42 x 300.
Fig. 43. Fig. 44.
Figs. 43 & 44.
Fibrinolytic autographs of buccal cells with eACA in the
fibrin showing similar clear areas around the cells to those
seen in Figs. 41 & 42. Human fibrin, incubated overnight
at room temperature. Mag. Fig. 43 x 150. Fig. 44 x 120.
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areas were also seen when eACA was included in the fibrin (Figs. 43
and 44). This latter type of artefact was particularly apparent to¬
wards the edges of films from where contraction might have occurred
during polymerisation of the fibrin. However, deliberate attempts
to increase the incidence of this artefact by preparing thinner films
failed. It was frequently related to apparently folded and misshapen
cells, and so might be due to changes in the cell per se, possibly
accentuated by fibrin contraction moving the cells during polymeris¬
ation.
Conclusions:
1. Spontaneously desquamated epithelial cells in saliva show fibrin¬
olytic activity when examined by fibrinolytic autography, both nuc¬
leated cells and anuclear cells and fragments showing activity.




Object: To study the fibrinolytic activity of oral epithelial
cells using SHFP.
Materials:
1. Washed pellet. 12 ml. of MNS was collected by stimulated flow
(Methodology, p. XXVI ) from each of 20 persons who were in good
health and who had no evidence of gingivitis. Each MNS sample
was centrifuged at 4154 g. for ten minutes at 4°C after which the
supernatant was discarded and the pellet washed four times by centri-
fugation also at 4154 g. with tris buffer. The pellet was finally re- .
suspended in 0.75 ml. of tris buffer which would represent a cell
concentration of 16x that of the original MNS provided there, was no
cell loss. The concentrated pellet was considered to be at a con¬
centration of 100% and serial dilutions of 50, 25 and 12. 5% were pre¬
pared from it using tris buffer as dilutant. A count was carried
out upon each 100% concentrated sample.
2. Cell suspensions. Using wooden tongue spatulas buccal, palatal
and tongue cells were gently scraped from their respective sites and
collected in tris buffer. The suspensions of each cell type were
3 .
pooled to ensure counts in excess of 10 /ml. Each suspension then was
washed as above. After washing, a cell count was made of each speci¬
men.
3. SHFP (Methodology, p. (Methodology, p. I).
4. Counting chamber. Improved Neubauer.
5. Controls. Positive. Urokinase. 5 Ploug units/ml. in tris




Concentrated and serially diluted pellet and the three cell suspensions
were plated (3 x 0. 03 ml. ) upon SHFP and incubated for 19 hours at
37°C. Controls were plated as in Part II, Experiment 3, Fig. 3.
Results:
These are recorded in Tables 59 and 60 (Appendix 1).
Summary of Results:
Salivary pellet. The epithelial cell count, if the cells had been re-
suspended in their original volume of saliva gave a mean figure of
16, 578. S. D. 3,248 per cu. ml. In the concentrated pellet, the
mean cell count was 265, 000. S. D. 52, 239 per cu. ml.
Lysis was reduced with decreased cell concentration, the mean
area lysed at each concentration being 158, 141, 117 and 100 sq. mm.
respectively.
Cell suspensions. Fibrinolytic activity decreases with reduced cell
"concentration with a suggestion that the buccal epithelial cells are the
more active.
Discussion and Conclusion:




Object: To examine the relationship between the components
of MNS in generating plasminogen activator activity.
Comment:
This experiment was conducted after work on proactivator (Part V)
had established the presence of plasminogen in saliva. It is inc¬
luded here in order to maintain continuity in the activator discussion.
Materials:
1. MNS. Stimulated MNS (Methodology, p. XXVI) was collected
from twenty persons who were in good health, were taking no drugs,
and who had no clinical evidence of gingivitis.
2. Centrifuge. Universal Junion IKS.
3. Millipore Filter system. Millipore GS 0.22 micron 25 mm.
filter supported in a Micro-syringe, Luer inlet, 25 mm.
4. Plasminogen. Lyophilized. 25 caseinolytic units (C. U. )
A. B. Kabi, Sweden.
5. Fibrin plates. SHFP. (Methodology, p. I).
6. Control solutions. Urokinase. Positive. 5 Ploug units/ml.
in tris, pH 7. 8, 0. 15 M.
Tris buffer. Negative. pH 7. 8, 0.15 M.
Tris/plasminogen solution. Concentration of plasminogen, 0.05
CU/ml.
Method:
A minimum of 11 mis. of MNS was collected from each subject.
After vortex stirring, 0. 5 mis. was removed and stored at 4°C.
This sample was representative of the whole MNS (A).
From/
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From the remaining MNS, 10 mis. was removed and centrifuged at
4154 g. for thirty minutes at 4°C. 8 mis. of supernatant was then
removed and the pellet resuspended in the remaining 2 mis. of fluid.
From the 8 mis. of supernatant, 2 mis. was removed (B) and stored
at 4°C. The remaining 5 ml. of supernatant was then filtered through
a 0. 22 micron millipore filter. From the filtrate obtained, 2 mis.
was removed (C), and stored at 4°C.
The 2 mis. of resuspended pellet was then washed ten times in tris
buffer, for ten minutes at 4154 g. The washing volume was 20 ml.
After the final wash and centrifugation, the pellet was once more
resuspended in 2 mis. of tris buffer and then divided into four 0. 5
o
ml. aliquots. One of these was stored at 4 C (D).
The remaining three were centrifuged for ten minutes at 4154 g.
after which the supernatant was removed. To one was added 0. 5 ml.
of MNS supernatant (E). To one was added 0. 5 ml. of MNS super¬
natant (E). To another was added 0. 5 ml. of filtered supernatant
(F). To the last was added 0.5 ml. of the tris/plasminogen solu¬
tion (0.05 CU/ml. )(G). (The supernatant and filtered supernatant
added here were taken from the samples B and C respectively).
There were then seven test solutions.
A. MNS.
B. Low speed supernatant of MNS.
C. Filtered supernatant of the MNS.
D. Washed pellet resuspended in tris buffer.
E. Washed pellet resuspended in supernatant of MNS.
F. Washed pellet resuspended in filtered supernatant of MNS.
G. Washed pellet resuspended in a tris/plasminogen solution
of a strength equal to that of plasminogen in the average
saliva (0. 05 CU/ml. )
Each of these samples was vortex stirred to resuspend evenly its
constituents /
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constituents and then plated 3 x 0. 03 ml. upon SHFP. Controls
were as illustrated in Part II, Experiment 3, Fig. 3.
Results:
These are recorded in Table 61 (Appendix 1).
Summary of Results:
A. MNS. 20 lysis.
B. Sup. / MNS. 17 lysis.
2 probable lysis.
1 no lysis.
C. Filt. /sup. 10 lysis.
6 probable lysis.
4 no lysis.
D. Pellet/tris. 7 lysis.
8 probable lysis.
5 no lysis.
E. Pellet/ sup. 15 lysis.
5 probable lysis.




solution 1 probable lysis.
Discussion:
This was a very artificially contrived experiment designed to be
indicative rather than quantitative.
There are two major objections :-
1. The mucus in MNS prevented the completely even suspension
of particulate matter.
2. There would be a loss of cells and especially cell fragments
in/
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in the washing of the pellet. Furthermore, the cell com¬
position must have undergone an alteration in relative com¬
position such that epithelial cells would be proportionately
increased relative to the much smaller leukocytes and bac¬
teria, some of which would have been lost in the washings.
For these two reasons, the washed pellet cannot be simply
regarded as the cells found in saliva without the salivary
secretions.
Nevertheless, an examination of the results is interesting.
The results can be considered in two groups :- A - C and D - G.
A - C:
The results here are consistent with those recorded in Part III,
Experiment 3.
A. All samples show lysis. (Experiment 3, all samples showed
lysis).
B. Evidence of lysis in 19/20 samples. (Experiment 3, all
samples showed lysis).
Activity reduced in 18/20 samples. (Experiment 3, reduced
in 34/40 samples).
C. .Evidence of lysis in 16/20 samples. (Experiment 3, 26/40
samples).
D - G:
There is little difference between the results for E and F. D and
G are very interesting. D consisted of thoroughly washed cells
resuspended in tris and in a concentration (if no cells had been lost
with washing) 5x greater than in whole MNS. There was evidence
of lysis in 15/20 of the samples but lysis in only seven. The acti¬
vator activity then of this suspension was very low.
G consisted of thoroughly washed cells suspended in a tris and plas¬
minogen/
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minogen solution which was prepared to a strength equivalent to that
calculated for plasminogen in saliva. This then was the strength of
plasminogen (approximately) also in E and F. There was little dif¬
ference between D and G. (Mean values, and hence tests of signif¬
icance cannot be made due to the presence of probable lysis. )
The plasminogen solution (0. 05 CU/ml. ) applied to all human plates
upon which solution G was being tested were negative. The only dif¬
ference between D and G was the presence of plasminogen in solution.
D and G together strongly suggest the ability of salivary pellet cells
to activate plasminogen and to produce lysis in the same order of
magnitude as that produced by incubating similarly washed cells with
the supernatant of saliva. This is indicative (no more) that the sali¬
vary plasminogen activator was derived from cells and these together
with their derived fragments in the presence of plasminogen can pro¬
vide the great majority of the total plasminogen activator activity of
MNS.
Conclusion :
Results are presented that confirm the findings of the preceding experi¬
ments in Part III and IV. A solution of plasminogen in tris buffer pre¬
pared at the same concentration as that found in the average saliva was
found to produce no lysis upon an S HFP when applied alone, but when
used to suspend washed salivary pellet cells, predominantly epithelial
cells, produce lysis similar to that produced by suspending the cells
in the supernatant of MNS. The washed cells suspended in tris buffer
alone also produced evidence of lysis, but of a considerably smaller
magnitude. These findings are interpreted as providing further evi¬




It has been shown that whole salivary pellet has plasminogen acti-
vitator activity and that it is highly improbable that any of this acti¬
vity is contributed by salivary mucus, bacteria or leukocytes. In
Part III, evidence was presented that strongly indicated the absence
of a soluble activator. The only remaining major component of
the pellet is desquamated epithelial cells.
Evidence has been presented in this Part confirming the findings
of Birn and Fejerskov (1971) and Wunschmann-Henderson and Astrup
(1972) that some oral epithelial cells have activator activity. In
preferring to use human fibrinogen for the preparation of fibrinolytic
autographs, it has not been possible to stain the cells with Papa¬
nicolaou's technique since the thickness of the human film prevents
adequate penetration of the stains and, therefore, no comment can
be made upon the degree of cornification of the active cells. Up
to 2% of the cells were active and this compares unfavourably with
the figure of 36% found in non-smokers by Wunschmann-Henderson
and Astrup (1972). This matter has been discussed more fully in
the section concerned with autography.
It has'also been clearly shown that washing of the pellet results in
a considerable loss of activity which in view of what has been said
concerning non-active components, must most probably reflect a
loss of epithelial cells or cell fragments. The whole epithelial
cell is very large and it is unlikely that many of them are lost dur¬
ing washing. However, in the density gradient experiment, the least
dense fractions were also fibrinolytically active and photographic
'evidence was presented showing the presence of epithelial cell frag¬
ments and bacteria. With the strong evidence that bacteria play
little/
little part in the fibrinolytic activity of saliva, this suggests that it
was the epithelial cell fragments that were responsible. This is
further indicated by the results of fibrinolytic autography and photo¬
graphs have been presented illustrating epithelial cells in the centre
of foci of lysis.
In Part III, it was demonstrated that after low speed centrifugation,
4154 g. , the supernatant of MNS was still showing evidence of acti¬
vator activity but that after high speed centrifugation, 3 5, 664 g. , this
activity was removed completely not even being suggested upon SHFP
after concentrating 25x. However, pellet was collected from twenty
separate high speed centrifugations and tested for activator activity.
All twenty samples were active and photographic evidence of the nature
of the pellet was presented displaying once again a predominance of
epithelial cell fragments.
Therefore from the evidence provided by the salivary pellet generated
at high speed centrifugation, fibrinolytic autography and density gradi¬
ent separation, the writer concludes that plasminogen activator activity
is associated with cell fragments of epithelial cell origin. This de¬
duction must be seen in context since bacteria were present in all
three preparations described above, but the bacteriological experiments
failed to provide any convincing evidence of activator activity that
could be detected within the sensitivity of the systems used here whilst
epithelial cells have been clearly indicted. Of course, the activator
activity is not confined to epithelial cell fragments, fibrin plate experi¬
ments and fibrinolytic autography with washed pellet and buccal epith¬
elial cell suspensions have demonstrated intact cell activity. The
reconstitution experiment (Chapter 7) demonstrated the ability of washed
epithelial cells to activate plasminogen. The findings with whole cells
are consistent with the findings of Birn and Fejerskov (1971) and Wunsch-
mann-Henderson and Astrup (1972). One specifically contradictory
statement occurs in the literature. In the paper written by Wunschmann-
Henderson/
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Henderson and Astrup (1972) there appears this paragraph :-
"A possible correlation of cellular fibrinolytic activity with the
fibrinolytic activity in saliva was studied by collecting samples
of saliva from two non-smokers over a period of five weeks, yield¬
ing twenty-five samples from each individual. After centrifugation
for thirty minutes at 1000 g. the fibrinolytic activity was determined
by placing 0. 025 ml. of the clear supernatant on preformed fibrin
slides which were then incubated for 120 minutes at 37°C. The
sediment was resuspended in saline to half the original volume and
the number of epithelial cells and leukocytes was determined by
standard procedures. The presence of bacteria or cellular debris
was also recorded".
Nowhere in the paper does a statement of lysis associated with any
of the above samples occur. There is no statement of the cell counts
made or indeed any result produced at all. However, in the 'Dis¬
cussion ' there occurs this sentence, "Cellular fibrinolytic activity
was not correlated with the fibrinolytic activity of the saliva. " In
their section 'Results', General Observations, they state "As previ¬
ously reported (Albrechtsen and Thaysen, 1955) human saliva showed
only traces of fibrinolytic activity, unrelated to the number of free
epithelial cells, leukocytes, bacteria, amounts of debris or the fib¬
rinolytic activity of corresponding buccal smears. " This statement
is misleading as it can be construed as suggesting that Albrechtsen
and Thaysen examined a relationship between the fibrinolytic activity
of saliva and salivary cells etc. They did not. Not a single word
about cells occurs in their paper. The writer believes that Wunsch-
mann-Henderson and Astrup (1972) do not mean to be misleading, but
are agreeing with Albrechtsen and Thaysen (1955) in so far as to state
that there are only traces of fibrinolytic activity in saliva. After
centrifuging for thirty minutes at 4154 g. , the writer has presented
evidence of a trace of activity and this is surely consistent with
Wunschmann/
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Wunschmann-Henderson and Astrup's findings of a trace of activity
after centrifuging for thirty minutes at only 1000 g. Had they sub¬
jected the supernatant to high speed centrifugation and examined the
subsequent supernatant generated, they might have found no activ¬
ator in solution and the necessity therefore to find an alternative
source.
There remains the question of from where in the epithelial cell, the
plasminogen activator activity arises. The writer has made no
original investigations into this problem. Lack and Ali (1964) and
Tice and Worth (1968) have presented evidence suggesting that the
source of cellular fibrinolytic activity is the lysosomes and there¬
fore one might expect that all cells containing lysosomes would be
fibrinolytically active, i. e. probably all the epithelial cells, but it
is known that plasminogen activators responsible for the local fib¬
rinolytic activity are firmly attached to the structural proteins and
not liberated under normal conditions (Albrechtsen, 1958). This
type of activator is liberated only after injury to the cell (Ungar,
1952: Astrup, 1956). However, when it is liberated as may happen
under the conditions of fibrinolytic autography, the amount may be
very small, just enough to generate some plasmin and bring about
focal lysis. It could also be labile once released, although stable
within the cell. The writer at one stage collected 110 ml. of sali¬
vary pellet (equivalent to about 1 litre of MNS) homogenised it manu¬
ally, subjected it to freeze-thawing and sonication and then attempted
a fractionation of the supernatant of this "soup" on a G200 sephadex
column. High speed centrifugation had not been applied to the super¬
natant and it therefore displayed a little activity but on fractionation,
no activity emerged that could be measured upon SHFP. This was
a crude attempt to extract an activator and characterize its mole¬
cular weight but it failed and a more refined approach to the problem
will have to be evolved. Potassium thiocyanate extraction and further
cell disintegration with separation of particles by centrifugation are




The activator activity of human mixed native saliva is associated with
epithelial cell and epithelial cell fragments. The source of the acti¬
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CHAPTER 1
Streptokinase-activated Proactivator Activity in Saliva
The nature of proactivator has been discussed in Part 1. It was
concluded that most streptokinase-activated proactivator is plasmin¬
ogen. (No attempt will be made in this work to determine the pre¬
sence or absence of a proactivator that is not activated by strepto¬
kinase).
It is established that the fibrinolytic activity of saliva, mixed native,
parotid and submandibular/sublingual is considerably enhanced with
the addition of streptokinase (Albrechtsen and Thaysen, 1955: Schulte
1965: Nitta et al, 1967 and Tortelli, 1967). The only known bio¬
chemical effect of streptokinase is to bring about the conversion of
human plasminogen to plasmin (McNicol and Douglas, 1972). Thus
it seems probable that salivary proactivator is plasminogen.
Plasminogen has not been demonstrated directly in saliva. Albrecht¬
sen and Thaysen (1955) and Taylor et al (1964) were unable to demon¬
strate its presence and claim its absence from saliva. Nitta et al
(19 67), using standard bovine fibrin plates and heated bovine fibrin
plates demonstrate streptokinase-activated fibrinolytic activity upon
both plates when saliva was mixed with 2, 500 units/ml. streptokinase
in a 1:1 v/v ratio. They conclude from these results the "presence
of large amounts of proactivator and small amounts of plasminogen"
in saliva. Gustafsson and Nilsson (1961) used the same technique to
demonstrate the presence of plasminogen in gingival fluid. From
these indirect experiments, there emerges the suggestion that plas¬
minogen may be present in MNS and could be derived in part at least
from the gingival fluid.
experiment 1.
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Object: To obtain an estimate of the normal range of strep-
tokinase-activated proactivator activity in MNS.
Comment:
This experiment was conducted with the same specimens of MNS as
Part II, Experiment 5. , but no direct comparison between results
obtained upon SHFP and SBFP can be made.
This is because :-
1. The sensitivity of the two types of plates is different (Part II,
Experiment 2. )
2. The writer has been unable to record lysis of a n SBFP by
MNS without the addition of streptokinase. All MNS
samples collected have shown activity upon SHFP which
suggests some other factor, perhaps species difference,
is operating in addition to sensitivity.
3. MNS is combined with streptokinase in the ratio of 1:1 in
the following experiment and is, therefore, diluted whilst
the results of MNS upon human plates record undiluted
saliva.
Materials:
1. MNS samples. These were collected by minimal stimulation
(Methodology, p. XXV) from 50 male and 50 female subjects
aged 18-30 who were not taking drugs and who had no clini¬
cal evidence of gingivitis.
2. SBFP. (Methodology, p. IV).
3. Streptokinase, 2500 units/ml. in tris buffer, pH 7. 8, 0. 15M.
4./
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4. Controls. Urokinase. Positive. 5 Ploug units/ml. in tris
buffer, pH 7.8, 0. 15M.
Tris buffer. Negative. pH 7.8, 0. 15M.
Streptokinase (SK) - as above.
Method:
From each MNS sample stored at 4°C in the refrigerator, 0. 5 ml.
was removed and mixed 1:1 (v/v) with streptokinase.
This mixture was vortex stirred and plated 3 x 0. 03 ml. upon SBFP.
Control solutions were plated as described in Part II, Experiment 3,
Fig. 2. All the plates were then incubated for 19 hours at 37°C.
Results:
These are recorded in Tables 62 and 63 (Appendix 1).
Summary of Results:
Average areas lysed in sq. mm. by 3 x 0. 03 ml. of MNS/SK upon
SBFP after 19 hours incubation at 37°C.
Male Female Total
Mean 167 - 46 S.D. 162 - 51 164.4 - 48
All samples were plated upon SBFP without the addition of strepto¬
kinase and no lysis was recorded with any sample. Streptokinase
applied to the SBFP alone never produced lysis. All controls were
valid.
Conclusions:
1. MNS contains a streptokinase-activated proactivator.
2. The range of streptokinase induced activity is considerable, 90
- 333 sq. mm.
3. There was no significant difference between the streptokinase-
activated proactivator activity of MNS from males and females.
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EXPERIMENT 2.
Object: To compare the streptokinase-activated proactivator
activity of mixed native, parotid and submandibular/
sublingual saliva.
Materials:
1. This experiment was carried out in conjunction with Part III,
Experiment 1 using the same samples of MNS, parotid and
submandibular/sublingual saliva.
2. SBFP. (Methodology, p. IV).
3. Streptokinase, 2500 units/ml. in tris buffer, pH 7. 8, 0. 15 M.
4. Controls: Urokinase, positive, 5 Ploug units/ml. in tris buffer,
pH 7.8, 0. 15M.
Tris buffer, negative, pH 7. 8, 0. 15M.
Streptokinase - as above.
Method:
Collection of salivas as described in Part III, Experiment 1. Each
saliva was plated 3 x 0. 03 ml. upon SHFP and SBFP. From the
remaining saliva in each sample 0. 5 ml. was removed, mixed 1:1
(v/v) with streptokinase, and plated 3 x 0. 03 ml. upon SBFP.
Controls were set up as described in Part III, Experiment 1, but in
addition 2x0.03 ml. drops of streptokinase were placed upon each
SBFP.
o
All the plates were then incubated at 37 C for 19 hours.
Results:








































There is no significant difference between the male and female
results in any of the salivas tested. There is a significant dif¬
ference between the activity of MNS and both parotid and sub¬
mandibular/sublingual saliva.
"t" Test for Significance:
Male. MNS and Parotid.
MNS and Submandi¬
bular/sublingual.
Female. MNS and Parotid.
MNS and Submandi¬
bular/ sublingual.
Total. MNS and Parotid.
MNS and Submandi¬
bular / sublingual.
't" = 5. 12











As the MNS was produced by minimal stimulation, the major




The submandibular secretions being present in the ratio of 2:1 re¬
lative to parotid might lead one to expect a lower or very similar
figure for the streptokinase-activated proactivator activity of MNS.
The consistently and considerably higher activity of the MNS must
therefore be accounted for by other factors.
The major difference between combined salivary secretions, gingi¬
val fluid and MNS is the presence in MNS of cells (epithelium, bac¬
teria and leukocytes), and the secretions of the minor salivary glands.
The gingival fluid has been shown to contain plasminogen (Gustafsson
and Nilsson, 1961) and a later experiment in this work compares the
plasminogen levels in MNS of a dentate with an edentate population.
A higher level of plasminogen in the dentate population would strongly
suggest a significant contribution from the gingival fluid. Dawes and
Wood (197 3) have reported that the contribution of the minor salivary
glands (i. e. labial, lingual, buccal and palatal mucous glands) to
whole saliva during rest and when stimulated with sour lemon drops
is 8% and 7% respectively. If these glands are responsible for the
difference in activity between combined salivary secretions and MNS
their secretions must contain very concentrated proactivator. This
seems improbable as the secretions are almost entirely mucus, and the
literature does not appear to contain any work demonstrating strepto¬
kinase-activated proactivator in mucus.
The more probable explanation is that the difference in activity is a
result of the action of streptokinase upon the cellular components of
MNS. If this is demonstrated to be true, then MNS contains at least
two streptokinase-activated proactivator components, one in solution
and one cell associated.
Conclusion:
1. MNS is shown to contain streptokinase-activated proactivator(s).
2. All parotid and submandibular/sublingual secretions collected
demonstrate/
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demonstrate streptokinase-activated proactivator activity.
The activity of both these secretions is significantly less
than that of MNS.
3. It is suggested that at least two streptokinase-activated pro-
activator components are present in MNS, one in solution
and the other cell associated.
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EXPERIMENT 3 .
Object: To examine the supernatant of mixed native, parotid
and submandibular/sublingual saliva for streptokinase-
activated proactivator.
Materials:
1. MNS, minimally stimulated, parotid and submandibular/sub¬
lingual salivas were collected (Methodology, p. XXV ) from
20 healthy persons, aged 18 - 30 who were taking no drugs
and who had no clinical evidence of gingivitis.
2. SBFP. (Methodology, p. IV).
3. Controls. Urokinase, positive. 5 Ploug units/ml. in tris
buffer, pH 7. 8, 0. 15M.
Tris buffer, negative. pll 7. 8, 0. 15M.
Streptokinase (SK) 2, 500 units/ml. in tris buffer,
pH 7.8, 0. 15M.
Method:
From each salivary sample, 0.5 ml. was removed and mixed 1:1 (v/v)
with streptokinase. The mixture was then plated 3 x 0. 03 ml. upon
SBFP. Control solutions were set up as described in Part II, Experi¬
ment 3, Fig. 2.
The remaining MNS was centrifuged at 4154 g. for 30 minutes and from
the supernatant 0. 5 ml. was removed and the above process with strep¬
tokinase repeated. The remaining supernatant was centrifuged at
35, 664 g. for 30 minutes and the supernatant processed and plated
as above.
The remaining parotid and submandibular/sublingual salivas contain¬
ing minimal (if any) cellular material were centrifuged at 35, 664 g.
the/
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the supernatant combined with streptokinase and plated as above.
All the plates were then incubated for 19 hours at 37 C.
Results:









Supernatant of Supernatant of
Saliva: 4154 g. Saliva; 35664 g.




















There was a significant difference between the mean activity gener¬
ated by whole MNS with streptokinase and the mean activity generated
by the supernatant of the MNS with streptokinase both at low speed
centrifugation ("t" 3. 27 x p < 0. 005) and after high speed centrifug-
ation ("t" 5. 64 p < 0. 001). The difference between the low speed
supernatant activity and the high speed supernatant activity was also
significant, ("t" 3.23 p< 0.005).
There was a significant difference between the mean activity generated by
whole parotid saliva with streptokinase and the mean activity generated
by submandibular/sublingual saliva with streptokinase ("t" 2.46, p<0. 025)
However, after high speed centrifugation, there was no significant dif¬
ference between the activity generated by these salivas. There was a
significant/
190
significant difference between the mean parotid activity before and
after centrifugation ("t" 2. 68 : p < 0. 01). If reference is made to
the result table 67 (Appendix 1, p. 97 ) four results, numbers 2,
9, 10 and 11 show a very pronounced drop in activity before and
after centrifugation and this suggests that these four were not col¬
lected cleanly and that some cellular particles that have come down
with centrifugation contaminated the secretion. Without these four
results, the difference was only significant at a very low level ("t"
1.5: p< 0. 2). With the mean submandibular/sublingual activities
there was no significant difference before and after centrifugation.
Comparison of the readings achieved with the high speed supernatant
of MNS and those of both parotid and submandibular/sublingual saliva
was very interesting. Comparing parotid and MNS supernatant, the
difference was significant ("t" 5.09, p< 0.001) and comparing sub¬
mandibular/sublingual saliva with MNS supernatant the difference
was also significant ("t" 3. 8 : p.< 0. 001). These two results sug¬
gest that even when all the cellular components of MNS had been
removed, the activity was still greater than that produced by either
parotid or submandibular/sublingual salivas alone. It would appear
then that some streptokinase-activated activity was present in the
supernatant of MNS that was not present in either parotid or sub¬
mandibular/sublingual saliva. There are four possible sources.
1. Gingival fluid. Although every care was taken to ensure that
all the subjects had no clinical evidence of gingivitis, some
gingival fluid may have been present in some instances. The
gingival fluid is known to contain plasminogen (Gustafsson and
Nilsson, 1961).
2. The secretions of the minor salivary glands. With the excep¬
tion of the serous glands of von Ebner, these are mucus sec¬
reting glands which provide only 7 - 8% of the total volume of
MNS (Dawes and Wood, 1973) and therefore are unlikely to




3. Diffusion of plasminogen through the mucous membrane of the
mouth. This would be extremely difficult to establish and was
unlikely to have been a major source because the quantity of
parotid and submandibular saliva in even minimally stimulated
MNS would have so greatly diluted it.
4. Plasminogen may be adsorbed from saliva on to the surface of
buccal epithelial cells or even produced by the epithelial cells
and when MNS is collected and centrifuged, some of this plas¬
minogen may pass into the solution. Epithelial cells are the
most likely 'additional' source and further evidence of such cell
associated activity is given in Chapter 3.
Conclusions:
The results (confirming those of Experiment 2) suggest a cell associ¬




Object: To investigate the presence of plasminogen in mixed
native, parotid and submandibular/sublingual saliva
using two dimensional immunodiffusion.
Two dimensional double diffusion.
Bechhold (1905) first observed immunoprecipitates in a gel medium
but the potential for serologists was not appreciated. Well stand¬
ardised techniques for immunodiffusion were not established until
Oudin (1946) gave his first report on the principles and application
of the simple diffusion technique in tubes and Ouchterlony (1948)
introduced double diffusion. Given a known antiserum, double
diffusion allows the direct identification of the corresponding anti¬
gen in an unknown mixture.
Principle.
Antigen and antiserum are placed in separate wells cut out of agar
in a Petri dish (see Methodology, p. VII ). Concentration gradients
of both of the reactants are established in such a way that some¬
where in the medium, antigen and antibody are present in 'Optimal
Ratio' (OR) the concentration at which immunoprecipitation takes
place in the shortest time. The precipitation line thus formed will
then extend, the rate of extension being inversely proportional to the
square root of the time of diffusion.
Comment.
1. pH. 6. 5 - 8.2. Outside this range, immunoprecipitation may
be retarded and a non-specific precipitation may be induced
(Ouchterlony and Nilsson, 1973).
2./
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2. The Optimal Ratio. At an excess of the antigen or anti¬
body, the reaction time is increased and the formation of
the precipitate is partially or totally inhibited. Where
there is an excess of one of the reactants, there may be
a reverse of antigen-antibody binding and newly formed
aggregates are more sensitive to this dissolving effect
than well established precipitates. The double diffusion
technique overcomes this problem by allowing the react¬




1. Two agarose plates were prepared (Methodology, p. VII )
and four sets of wells were cut into each plate and
labelled A, B, C, and D commencing in the top left
corner and proceeding clockwise.
2. Plasminogen. Solution prepared from 'Plasminogen
Kabi', a lyophilized powder prepared by affinity chroma¬
tography. Supplied in vials each containing human plas¬
minogen equivalent to 25 C. U. (caseinolytic units) and
having a purity grade of about 15 CU/mg. protein.
3. Anti-plasminogen serum. Prepared from rabbits by
Berhringwerke Laboratories, Germany and supplied
in 1 ml. vials.
Method:
A 2. 5 CU/ml. solution of plasminogen in tris buffer was prepar
and deemed 100%. Serial dilutions in tris were made to 10%.
The wells were filled, 0.01 ml. , according to the scheme illus


















A. Antiplasminogen B. Antiplasminogen C. Antiplasminogen
1. Plasminogen 100 1. Plasminogen 40 1. Plasminogen 40
2. 90 2. 30 2. 30
3.. 80 3. 20 ocsiCO
4. 70 4. 10 4. 10
5. 60 5. Tris buffer 5. Tris buffer








Undiluted anti-plasminogen, 0.01 ml., was placed in the centre well
of each set.
After 30 minutes, a further 0. 005 ml. of the appropriate solution was
added to every well on the plate.
The plates were now placed in a damp chamber at room temperature.
The plates were examined twice a day and it was found that no dis-
cernable/
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cernable extension of the precipitin lines took place after 3 days.
Results:
These are illustrated in Figs. 45 and 46.
In all four tests, the lowest concentration at which a precipitin line
was detectable was 3 0%.
The trial was repeated and the same result was achieved.
Discussion:
At a plasminogen concentration of 100% (2.5CU/ml. ) the precipitin
line was clear as the aggregates were concentrated in a narrow band
at the position of O. R. The line was about 3 mm. from the centre
well. As the dilutions progressed, so the precipitin band formed
closer to the weaker reactant: the distance from the centre well was
4 mm. at a concentration of 50% and was 5 mm. at 3 0%. The aggreg¬
ates were necessarily much fewer at the weaker O. R. and the band
correspondingly fainter. When the concentration of the reactants at
the precipitin band exceeds the threshold of visibility, a precipitin
band can be seen and if the system is balanced, the line remains
stationary and its density increases. If the system is considerably
unbalanced, the initial precipitate will gradually grow in the direction
of the diffusion of the reactant present in excess. Figs. 45 and 46
indicate that at weaker dilutions of plasminogen, the system became
progressively unbalanced and the initial precipitate had grown, shown
here by a widening of the band. The widening of the band coincided
with a progression towards the threshold value for visible aggregation
which here occurred at 30%.
When a trial was conducted in which the antiplasminogen in the centre
well was doubly diluted to concentrations of 50% and 25%, the precip¬
itin bands were all fainter and the last visible band occurred again in











Figs. 45 & 46.
Ouchterlony immunodiffusion plates set up as in Diag. 3
and showing a threshold of visibility occurring at 30% of
the plasminogen solution.
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plasminogen solution was used, the last band (which was extremely
faint) was in relation to a plasminogen concentration of 50%. Thus
no increase in sensitivity of the system was achieved by lowering the
concentration of the anti -plasminogen.
Conclusion:
The lowest concentration of plasminogen that provides a visible pre¬
cipitin line in this system is 30% of a 2. 5 CU/ml. preparation. This
is 0. 75 CU/ml.
Part 1. Sensitivity (Contd, )
A more sensitive immunodiffusion technique is illustrated in Diag. 4
and is a demonstration of Ouchterlony's Type 1 reaction.
Diagram 4.
Reaction type 1 and variations when identical antigens at varying
concentrations are compared.
In reaction type 1, the precipitin lines from each side deviate and
make a complete fusion in the centre area. For balanced systems,
this arc formed by the fusing lines is symmetrical. The reaction
indicates the presence of identical antigenic determinants in the com¬
pared reactants. An asymmetric arc of fusion is seen when the
compared reactants are present in distinctly different concentrations
in the two wells. When the concentration of one of the compared re¬
actants is below the threshold value for the formation of a visible pre¬
cipitate, its presence might be revealed by the deviation induced in
the pattern on the opposite side. A 'hook' at the end of the precip¬
itin band may be seen curving in towards the antigen of identity.
Ouchterlony. Reaction type 1 and variations.
Materials:/
Diagram 4.
OUCHTERLONY REACTION TYPE 1 AND VARIATIONS






(a) = concent ration of antigen less than a
((a))=concentration of antigen less than (a)
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Materials: '
Agar plates were prepared as before.
Plasminogen and anti-plasminogen solutions as before.
Method:
A solution of plasminogen was prepared at a concentration of 2. 5 CU/
ml. (100%) and further dilutions were prepared from 100 - 10% at 10%
intervals. The dilutant tris buffer was used as a negative control.














































Figs. 47 & 48. Ouchterlony immunodiffusion plates set up as







Figs. 47 and 48 illustrate the results obtained from two separate
trials.
A faint precipitin band was still visible at 3 0% and the deviation of
the adjacent precipitin band formed in relation to a concentration of
100% was clearly seen.
The dilutions were, therefore, extended to 10% plasminogen sol¬

























A faint precipitin line was visible at 30% (Fig. 49) a slight deviation




Ouchterlony immunodiffusion plate set up as in Diag. 6.
showing a slight variation/deviation of the adjacent pre¬
cipitin line at 20% but not at 10% of the plasminogen solu¬
tion.
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was visible at 10%.
Conclusion:
No accurate quantitative estimation of plasminogen can be made
using this technique, but a concentration of plasminogen equiv¬
alent to 20% of 2. 5 CU/ml. (0. 5 CU) may be detected.
2.00
Part 1. Sensitivity (continued).
The Gradient Plate Technique. (Feinberg 1957)
Principle:
This technique was devised for quantitative analysis. In a standard
agar diffusion plate small circular wells are placed circumferent-
ially around a larger circular well. The antiserum is poured into
the centre well and the plate is preincubated for 1-3 days, a time
estimated for the establishment of an antibody gradient extending
beyond the peripheral wells and the plates are incubated for 24 hours.
The highest antigen concentration giving a complete ring around the
well is noted as the end point of the titration.
Diag. 7.
GRADIENT PLATE TECHNIQUE FOR QUANTITATION.
TWO-DIMENSIONAL DOUBLE DIFFUSION PLATE
TECHNIQUE
KEY




Two standard agar diffusion plates were prepared and into each were
cut two well patterns.
Antiplasminogen (0. 66 ml. ) was placed in the centre wells. The plate
was put into a damp chamber at 4°C and left for 48 hours. At 48 hours
a 2. 5 CU/ml. solution of plasminogen was prepared in tris buffer and
from this solution concentrations of 50, 25, 12.5, 6.25, 3.125 and 1.56% we
were prepared by double dilution and were then applied to the wells as
indicated in Diag. 8.
Diag. 8
100 50
tris buffer A 25
6.25 12.5
Prepared in duplicate (Fig. 50)
Result:
The results are shown in Figs. 50 and 51.
The highest antigen concentration giving a complete ring around a well
was 6.25% of a 2.5 CU/ml. plasminogen solution. This was equiv¬
alent to 0. 156 CU/ml. and illustrates the end point of the titration.
Part 1. Conclusion
1. The threshold of visibility using the technique of double diffusion
without preincubation is 30% of a 2. 5 CU/ml. plasminogen solution
(i. e. 0.7 5 CU/ml. ) and using the Ouchterlony Typel reaction variant
the sensitivity is 20% of a 2.5 CU/ml. plasminogen solution (i. e.
0. 5 CU/ml. )
2. Using the gradient plate technique, the end point of the titration
was determined as 6. 25% of a 2. 5 CU/ml. solution of plasminogen.
That/
100 12.5
tris buffer A 6. 25
1.56 3.125
Prepared in duplicate (Fig. 51)
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That is 0. 156 CU/ml.
3. Qualitative evidence, therefore, for the existence of plasmin¬
ogen in an unknown mixture can be provided by double diffusion pro¬
vided it is present in a concentration in excess of 0. 156 CU/ml.
Fig.50. Fig.51.
Figs. 50 & 51. Ouchterlony immunodiffusion plates set up as
in Diag. 8 . showing the highest concentration of the plasminogen




Object: To test for the presence of plasminogen in MNS
supernatant of MNS, parotid and submandibular/
sublingual saliva using immunodiffusion techniques.
Materials: '
1. Standard agar immunodiffusion plates (Methodology, p. VII)
2. Parotid, submandibular/sublingual and minimally stimu¬
lated MNS was collected (Methodology, p. XXV ) from
12 healthy adults, aged 18-24 who were taking no drugs
and who had no clinical evidence of gingivitis. Half of
each MNS sample was centrifuged at 4154 g. for 3 0 min¬
utes to obtain a supernatant.
3. Antiplasminogen serum as described.
4. Human plasminogen (2.5 CU/ml. ): positive control.
5. Tris buffer pH 7. 8, 0. 15M.
Method:
Four sets of wells were cut into each of twelve standard agar plates.
Each sample was set up in duplicate and dispensed into appropriate
wells after the manner described in diagram 9. The volume dis¬









P Plasminogen. Positive control .
T Tris buffer. Negative control.
A Anti-plasminogen.
The prepared plates were placed in a damp chamber and left at room
temperature for 3 days.
Results:
A. MNS. No precipitin lines were visible in relation to any
of the twelve tested.
B. MNS supernatant. No precipitin lines.
C. Parotid saliva. No precipitin lines.
D. Submandibular/sublingual saliva. No precipitin lines.
E. Positive control. All 48 sets of positive controls displayed
clear precipitin lines. No precipitin line deviated towards
a test sample well.
As the results were negative, the plates were left a further 3 days in
damp chamber but no precipitin lines appeared.
Conclusions:
1. No plasminogen is present in MNS, supernatant of MNS, parotid
or submandibular/sublingual saliva.
OR
2. Plasminogen is present in the above substances but is present at
a concentration below 0. 5 CU/ml. , the concentration at which
some deviation of the precipitin line of the positive control
should occur.
OR
3. The average pore diameter of a 2% agar gel has been estimated
at/
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at 3 microns. (Ouchterlony and Nilsson, 1973). It is , there¬
fore, possible that the cellular and mucoid components of sal¬
iva may impede the diffusion of plasminogen.
OR
4. A combination of 2 and 3.
Procedure 2.
The experiment was repeated using pre-inoubated gradient plates
in the manner earlier described.
No positive results with the test solutions.
Conclusions:
1. No plasminogen is present in MNS, supernatant of MNS,
parotid or submandibular/sublingual saliva.
OR
2. Plasminogen is present in the above substances but is present
at at a concentration below 0. 156 CU/ml.
OR
3. Diffusion impeded, as above.
OR




Object: To test for the presence of plasminogen in concen¬
trated mixed native, parotid and submandibular/
sublingual saliva and in the concentrated supernatant
of MNS.
Preliminary experiments were carried out to compare the effective¬
ness of various concentrating techniques on a solution of plasminogen
(0. 3125 CU/ml. ) and also MNS.
A. Dialysis tubing:
The test solutions were separately enclosed in dialysis (Visking)
tubing and concentrated either by evaporation or by osmotic pressure
difference by immersing the tubes in Polyethylene Glycol (P. E. G. )
Concentration was estimated by weight difference before and after
t hese procedures. Various combinations of time and temperature
were experimented with and it was found that evaporation was very
slow and the MNS became a thick sludge, which was difficult to handle
with both methods. The plasminogen test solution concentrated ef¬
fectively but with considerable loss of detectable plasminogen as
measured upon a Feinberg gradient plate. A volume reduction of
lOx only showed a 3 x concentration of plasminogen. With P. E. G.
the concentrating process was swift, cheap, and capable of concen¬
trating large volumes of saliva and, therefore, may be useful where
only qualitative information is required.
B. Lyphogel: (Polyacrylamide Gel, produced by Gelman Instrument
Company and distributed by Hawksley & Sons Ltd. )
Each test solution was placed in a test tube and the granules of
Lyphogel were added, sufficient to bring about a concentration of
ten times. The concentrating took 5 hours at 4°C. As before, the
MNS/
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MNS concentrate was unsuitable for pipetting, but the plasminogen
test solution was examined as in A and found to have concentrated
only two times. Whether plasminogen is partly absorbed or par¬
tially inactivated cannot readily be determined, but in either case
the method cannot be used for concentrating saliva in order to exa¬
mine for the presence of plasminogen.
C, Minicon, B15: (Amicon Corp., Lexington, Mass., U.S.A.)
The ' Minicon' B15 is designed to concentrate 5 ml. of test solution
to a maximum of 100 times. It is calibrated such that concentrates
of 5x, lOx, 25 x, 50x and lOOx can be prepared.
After placing 5 mis. of each test solution in separate channels, the
Minicon was stored at 4°C and regularly examined. The plasmin¬
ogen was concentrated 25x in about one and a half hours but the MNS
took about two and a quarter hours to reach this concentration. Of
the concentrating techniques described, this was the only one in
which it was possible to remove concentrated saliva in a form cap -
able of being pipetted and this was because the Minicon channels
permitted the MNS cellular components to settle into a button. The
substance removed from the MNS channel was supernatant containing
small cellular particles. The MNS concentrate and the plasminogen
concentrate were set up in gradient diffusion plates.
Results:
1. MNS. Distinct but faint precipitin line surrounding the well
of maximum concentration (Fig. 52). The line corresponded
approximately to that produced in the sensitivity experiment
by a known plasminogen concentration of 0. 156 CU/ml. .
2. Plasminogen. The precipitin line of maximum concentration
was very similar to, but perhaps a little weaker than, the
positive control. The positive control was 2.5 CU/ml. Thus
in this test, an attempt to. concentrate 25X, a 0.3125 CU/ml.
solution/
Fig. 52. First evidence of any plasminogen in MNS. Distinct
but very faint line surrounding the wells of maximum
concentration.
1. MNS x 25.
2. MNS x 12. 5.
3. MNS x 6. 25.
4. MNS x 25.
5. MNS x 12. 5.
6. MNS x 6. 25.
(. > < l
Key:
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A Antiplasminogen.
Fig. 53. Concentration control. Test plasminogen solution was








1. PI. 2. 5 CU/ml.
2. TP1. x 25.
3. TP1. x 12. 5.
4. TP1. x 6. 25. A Antiplasminogen.




Plasminogen solution. 2.5 CU/ml.
Test plasminogen solution (0. 3125 CU/ml. ) concentrated
25 x. i. e. 7. 8 CU/ml.
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solution resulted in an actual concentration of about 2. 5 CU/ml.
or 0. 3125 x 8. There was then a considerable loss of plasmin¬
ogen (Fig. 53).
The threshold of visibility for plasminogen was shown to be
about 0. 156 CU/ml. in this system. If the effective concen¬
tration as suggested by the plasminogen test solution is about
8x then the concentration of plasminogen in MNS, before con¬
centrating, would be approximately 0. 15 6/8. That is 0. 0195
or about 0. 02 CU/ml. The average pore diameter of 2% agar
gel has been estimated at about 3 microns (Weir, 1973) and,
therefore, there may have been some inhibition of immuno¬
diffusion due to the many particles in suspension when the MNS
was placed in the wells.
Conclusion:
1. Using the Minicon B15 to concentrate a test plasminogen
solution, an 8 fold concentration was achieved instead of
the calculated 25x.
2. This figure was only approximate as plates would vary in
sensitivity and the methods of comparison against positive
controls were crude.
3. A precipitin line was formed in relation to concentrated MNS.
4. This precipitin line was distinct but faint and close to the
threshold of visibility. The threshold of visibility was about
0. 156 CU/ml. Assuming from the control that the concen¬
tration of plasminogen in the MNS was also about 8 x, then
the estimated concentration of plasminogen in MNS would be
in the order of 0. 02 CU/ml.
5. The actual level of plasminogen would be higher as diffusion




Preliminary Experiments A - C.
1. Qualitative evidence for the presence of plasminogen in MNS
has been presented.
2. No accurate quantitative estimation of plasminogen in MNS
was made by this technique as the amount present was very
small and the amount lost in concentrating could not be asses¬
sed accurately.
3. For the concentration of small quantities of saliva, the Minicon
B15 technique was the preferred method whilst dialysis with
P. E. G. appeared to be effective in concentrating quickly
large quantities of saliva, but the degree of concentration
could only be crudely assessed.
Preliminary Experiments (Contd. )
The techniques for concentrating plasminogen were all repeated
twice in order that each process would be assessed three times.
On the last occasion the gradients were prepared in the same plate
in order that experimental error due to difference in plate sensi¬
tivity might be minimised, and also that the results might be photo¬
graphed under the same conditions, thus enabling a visual compari¬
son of the effectiveness of each method.
The result is described below and illustrated in Fig. 54.
Results:
Experiment Al. Dialysis and evaporation.
Evidence of plasminogen in well 2 and 3
relative to control well 1.
Plasminogen in well 2 should have had a
concentration of 3. 125 CU/ml. but was evi¬






1 in which plasminogen had a concentration
2. 5 CU/ml.
Dialysis and P. E. G.
Evidence of plasminogen in all test wells.
Plasminogen in well 2 should have had a con¬
centration of 3. 125 CU/ml. but was evidently
less concentrated than in well 1 in which plas¬
minogen has a concentration of 2. 5 CU/ml.
Lyphogel.
Evidence of plasminogen in all test wells but
as above, evidence of a considerable loss of
plasminogen.
Minicon, B15.
Evidence of plasminogen in all test wells.
In well 2, the concentration of plasminogen
was 25 x 0.3125, i.e. 7.8 CU/ml.
It appeared, however, to have a concentration
similar to that of the positive control, 2. 5 CU/ml.
suggesting a concentration of about 8x rather than
25x.
Conclusions:
Confirmed conclusions established for preliminary experiments, A -
Fig. 54.
Comparison of the effectiveness of four techniques for concentrating
a 0. 3125 CU/ml. plasminogen solution assessed by the gradient
plate immunodiffusion technique.
01 02 01 02
06 A 03 (B) 06 A 03 (C)
05 04 05 04
01 02 01 02
06 A 03 (A ) 06 A 03 (A^
05 04 05 04
Key. ( Ax & Ag) (B) (C)
1. PI. 2 . 5 CU/ml. 1. PI. 2.5 CU/ml. 1. PI. 2 . 5 CU/ml.
2. TP1. x 10 2. TP1. x 10 2. TP1. X 25
3. TP1. x 5 3. TP1. x 5 3. TP1. X 12. 5
4. TP1. x 2. 5 4. TPL. x 2. 5 4. TP1. X 6. 25
5. TP1. x 1. 25 5. TP1. x 1. 25 5. TP1. X 3. 125
6. Tris. buffer. 6. Tris. buffer. 6. Tris. buffer.
A Antiplasminogen.




Object: To achieve more definitive immunological
evidence of plasminogen in MNS.
Materials:
1. Gradient plates. As described.
2. MNS was collected by stimulated flow (Methodology, p. XXVI)
from people working in the Laboratory. All subjects were
in good health and had no clinical evidence of gingivitis.
Method:
Freshly collected MNS was centrifuged at 4154 g. for 30 minutes
at 4°C. The supernatant was removed and 5 ml. run into one chan¬
nel of a B15 Minicon. Concentration time varied but on average
took two hours to concentrate 25 times.
Gradient plates were prepared two days previous to each test and
kept at 4°C. This was to minimize the risk of the antiplasminogen
degenerating.
Into the peripheral wells were placed : plasminogen 2. 5 CU/ml. ,
positive control: tris buffer, negative control: concentrated MNS
supernatant. Each solution was set up in duplicate and, therefore,
all peripheral wells were filled. Peripheral wells were refilled
after 30 minutes and thereafter the plates were left at 4°C for two
to three days.
Results:
Precipitin lines to the plasminogen controls were sometimes visible
within a few hours but those formed from plasminogen in the MNS
were never seen before 24 hours and often not until the second day.
All the MNS precipitin lines were faint although consistently present.
In/
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In an attempt to improve their clarity a "topping up" procedure was
tried. As described after 30 minutes, all the peripheral wells were
refilled but, in additon, last thing in the evening of the first and first
thing in the morning of the second day, the MNS plus one of the plas¬
minogen wells were again refilled from aliquots of the test solutions
kept at 4°C. There was no improvement in the MNS plasminogen pre¬
cipitin lines and the plasminogen precipitin line from the plasminogen
well simply became two precipitin lines.
Fig. 55 illustrates the effect of "topping up" and, in addition, illus¬
trates the faint but very clear plasminogen precipitin lines formed
from plasminogen diffusing from MNS supernatant. These experi¬
ments, clearly demonstrated the presence of plasminogen in MNS
but gave very little reliable information concerning its normal con¬
centration which as suggested before was probably in the order of

















PI. 2.5 CU/ml. showing
the effect of "topping-up"
Cf. well 1.
Tris buffer.




Experiment 1. Part 4. (continued)
Object: To examine parotid and submandibular/sublingual saliva
for the presence of plasminogen.
Materials
Stimulated parotid and submandibular/sublingual saliva were collected
( Methodology, p XXIX & XXX) from Laboratory staff all of whom
were in good health and who had no clinical evidence of gingivitis.
Method
The method was as described for the supernatant of MNS.
Fig. 56. Submandibular/sublingual saliva.
D < > .0






1. PI. 2.5 CU/ml.
2. Tris. buffer.
3. Submandibular/sublingual x 25.
4. Tris. buffer.
5. Tris. buffer.
6. Submandibular/sublingual x 25.
Result
Clear precipitin lines formed in relation to test wells (took two days
to appear) and therefore provided evidence of plasminogen in sub¬
mandibular/sublingual saliva. No accurate quantitative estimation
could be made.
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1. PI. 2.5 CU/ml.
2. Tris. buffer.
3. Parotid saliva x 25
4. Tris. buffer.
5. Tris. buffer.
6. Parotid saliva x 25.
Result:
Clear precipitin lines formed in relation to test wells. They
took three days to appear.
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Discussion:
The precipitin lines in relation to submandibular/sublingual saliva
were not always as clear as those illustrated in Fig. 56. However,
plasminogen was demonstrated to be present in both submandibular/
sublingual, and parotid saliva albeit the lines were faint and the
incubation times very long. The inaccuracy of the concentrating
method and the length of incubation together with intra plate vari¬
ation made quantitative estimations by this method unreliable.
Parotid plasminogen was not consistently demonstrated after con¬
centrating 25x but parotid saliva took much longer to concentrate
than either the submandibular/sublingual or MNS supernatant and
there may have been a greater loss of plasminogen. To obtain
sufficient parotid saliva for concentration, a minimum of 5 mis. per
test was required. In practical terms, this meant collecting from
known good secretors who were readily available and so parotid
saliva was frequently collected from the same person. Sometimes
a precipitation line was obtained and sometimes not, and there
appeared to be no rhythm about the occasions when it was 'positive'.
A probable explanation is that after the concentrating process, the
amount of plasminogen present was only on the threshold of visi¬
bility at precipitation.
Conclusion:
Plasminogen has been demonstrated to be consistently present in MNS
and submandibular/sublingual saliva, and frequently present in paro¬
tid saliva. The inconsistency of the parotid results have been dis¬
cussed and it is concluded that plasminogen is present in MNS and
owes its origin to submandibular/sublingual and parotid saliva with
a suggestion that the major contribution may be from the submandi¬
bular/sublingual saliva. A more sensitive technique is required be¬
fore quantitative results can be obtained.
216
Experiment 2.
Object: To confirm the presence, and to make a quantita¬
tive estimation of, plasminogen in human mixed
native , parotid and submandibular/sublingual
saliva.
Method: Tanned Red Cell Haemagglutination Inhibition
Immunoassay (TRCHII).
Principle:
An antigen may be titrated in solution by its capacity to react with
antibody and so inhibit the antibody from agglutinating red blood
cells coated with the antigen.
Part 1. Introduction.
Part 2. A. Development of TRCHII for the measurement







The limitations of the immunodiffusion techniques have been dis¬
cussed. From these experiments it was concluded that plasmin¬
ogen was present in mixed native, parotid and submandibular/sub-
lingual saliva and at a concentration less than 0. 1 CU/ml. It was
necessary to confirm these findings using a different technique to
eliminate the possibility of false positive results and to obtain a
more accurate quantitative result.
The sensitivity of the caseinolytic technique is approximately 0. 1
CU/ml. (Ludlam and Das, 1971) and is, therefore, unsuitable.
For radioimmunoassay plasminogen must be isotopically labelled,
the antigen-antibody mixture must incubate for 7 2 hours and an expen¬
sive scintillation counter is required (Hererlein and Barnhart, 1967:
Rabiner et al, 1969). In the absence of the necessary apparatus, an
alternative method was required. Haemagglutination inhibition
techniques have been used to assay many proteins and are based on
the original work of Salk (1944) and Boyd en (1951). Merskey et al
(1966) and Das (1970) used the method to detect fibrin/fibrinogen
degradation products (FDP) and Ludlam and Das (1971) modified the
process for plasminogen assay. They were able to demonstrate a
sensitivity of 0. 013 CU/ml. and a reproducibility that compared
favourably with that of the other techniques. The sensitivity that
Ludlam and Das achieved is in the correct order of magnitude for
an assay of plasminogen in saliva and, in addition, the method is





Object: To develop the Tanned Red Cell Haemagglutination
Inhibition Immunoassay (TRCHII) technique for the
measurement of plasminogen in saliva.
For clarity, the complete sequence of events in the modified TRCHII
from preparation of reagents to the final calculation of plasminogen
in saliva is contained in one sequence in the Methodology, p. X.
The following is a summary of the experiments which led to the
modified TRCHII referred to as 'double adsorption'.
1. Experiment.
Object: To perform an antibody titration on plasminogen coated
red cells.
Materials:
Microtitre 'V' plate. Cooke Microtiter System, Cooke Engineering
Co. , Virginia.
Antiserum. Plasminogen antiserum (rabbit). Behringwerke A. G.,
West Germany.
Diluting Fluid (DF). 2% Bovine serum Albumin. (Methodology, p. X)
Cells. 2.5% suspension of sensitized cells (Methodology, p. XII)
Method:
Two drops of 1 /50 antiserum were placed in the first well of a micro¬
titre 'V' plate and one drop of DF placed in the next eleven wells. The
antiserum was then serially diluted across the plate. In the second
row, one drop of DF was placed in each well to act as a negative con¬
trol. One drop of cells was added to each well. After gentle shaking
the plate was covered, left overnight at 4°C. (Drop volume through¬
out/
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out was 0. 025 ml. )
Result: l/l l/2 lA i/s l/|6 1/32 l/64 l/ 2S i/£ss l/il? ISO 1/2043
-h + -h -h -t -t -h -r ~
Key: (-) No agglutination. (+) Agglutination (-) Intermediate
reaction.
The strength of antibody which was the weakest found to agglutinate
the cells was 1/64 of 1/50 antiserum, i. e. 1/3200.
Reading the plates. After about 2 to 3 hours, the plate could be
read but the result was clearer if a longer time was allowed. The
plates in this work were all left overnight and read at about 19 hours.
2. Experiment
Object: To calculate the sensitivity of the assay by per¬
forming a haemagglutination inhibition assay
using purified plasminogen of known concentrations
as a standard.
Method:
Five dilutions of plasminogen solution (Methodology, p. X )
were made and two drops of the first dilution added to well Al, two
drops of the second to well B1 and so on through to the last dilution
in well El. The solutions were then serially diluted across the
wells, one drop of diluting fluid having previously been added to all
the other wells. Rows F and G were used as controls. Each well
in these two rows contained one drop of diluting fluid.
One drop of antiserum (1/1600) was added to each well except for
those in row G, which was used as a negative control, row F being
the/
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the positive control. The plates were covered and left for 4 hours
at 4°C before addition of one drop of 2. 5% cells to each well. The












The end point was taken as the well with the highest dilution of sample
in which no agglutination could be seen.
Sensitivity = concentration of purified plasminogen of standard x titre
of standard.
Row A 0.019 Row B 0.016 Row C 0.02 Row D 0.03
Row E 0. 06 CU/ml.
Conclusion:
Sensitivity of assay was found to be between 0. 016 and 0. 06 CU/ml.
As the sensitivity of the assay was in the correct order of magnitude
(Ludlam and Das, 1971 achieved a sensitivity of 0. 013 CU/ml. ) it
was hoped that greater consistency of results would be obtained with
practice and that an assessment of the effect of saliva upon the pre¬
pared cells could be made at once.
-A i/? i/q i/a 1/16 1/32 1/64 l/UA l/?S6. 1/51 ? J/IQ24 1/2DAa
~h
+ +
+ + -+ +
+ -f- + +
-+ -i- + +■
-h + + + +




Object: To assess the effect of saliva on sensitized cells.
Method:
Using a 'V' plate as described, two drops of saliva were placed in
well Al. One drop of diluting fluid was placed in the remaining
wells of row A and in every well in row B. The sample was serially
diluted across the plate and one drop of cells then added to each well.
The plate was covered and incubated at 4°C overnight.
Result:
Even very dilute samples of saliva (1/2048) caused the cells to ag¬
glutinate due to the presence of some non-specific agglutinin. All
the cells in row B ( negative control) remained unagglutinated.
Conclusion:
The agglutinin in saliva must be absorbed out or consideration given
to the creation of a euglobulin which has been so successful in the
estimation of plasminogen in plasma (Ludlam and Das, 1971).
4. Experiment.
Object: To assess the effect of adsorbed saliva upon sen¬
sitized cells.
Method:
Details of saliva adsorption are contained in Methodology, p. XIV
At this stage in the development, only a single adsorption was




The agglutinin was diluted out at 1/64 (cf. 1/2048 above) but the
suggestion from the immunodiffusion experiments was that if plas¬
minogen was present, it was so at a concentration of less than 0. 1
CU/ml. and therefore, a dilution of 1/64 would be too great for this
assay system (0. 01 - 0. 06 CU/ml. ) to detect any plasminogen.
All the preceding experiments were repeated several times and it was
concluded that :-
a) the sensitivity of the technique must be increased
b) the agglutinin(s) must be removed completely or
c) a combination of both.
5. Experiment.
The sensitivity of the TRCHII can be increased by decreasing the
cell concentration.
A series of experiments were performed in which antibody titrations
were carried out (as in Experiment 1 above) using varying cell con¬
centrations.
Method:
As in Experiment 1, but in duplicate for each cell concentration.
One series being set up in Microtitre 'V' plates and the other in
1 U' plates. 'V' and 'U' describe the shape of the vertical section
through one of the wells. It was not known at this stage which shape
of well would allow the agglutination or inhibited agglutination re¬
actions to be seen most clearly.
Results:
Averaged results from six trials. Strength of antiserum 1/50 (Row 1)


















There was a limit below which the cells could not be accurately read
(simply due to there being so few) and this was 0. 5% with optimal
results occurring at 1%. The 'U' plates were not satisfactory as
the negative controls did not display clear 'buttons'.
6. Experiment
A series of experiments in which the antibody concentrations was
also reduced.
Method:
As above. A short series of six. Antibody concentrations starting
at 1/8 of the concentration used above, i.e. starting with 1/400 anti¬
serum and not 1/50.
Results:














Starting with a weaker concentration of antibody the results were
easier/
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easier to read and less debatable.
7, Experiment.
The sensitivity of the TRCHII was now re-assessed making use of
the information obtained above.
Method:
Microtitre 'V' plate. A 1/20 solution of 2.5 CU/ml. plasminogen
was prepared and two drops (each 0. 025 ml. ) were placed in all the
wells in row l^below^t One drop of diluting fluid was added to
all remaining wells on the plate and the plasminogen solution then
serially diluted across the plate as far as row 10. Rows 11 and 12
acted as controls containing at this stage only diluting fluid. Anti¬
serum was now added, one drop in every well except those in row 12,
negative control. The strength of antiserum used was :-
Row A 1/3200, Row B and E 1/6400, Rows C and F 1/12800, Rows
D and G 1/51200 and finally in Row H 1/102400. The plate was then
covered and left for four hours at 4°C before the addition of one drop
of cells to every well. After four hours, one drop of 1% cells was
added to every well in Rows A - D and one drop of 0. 625% cells to
every well in Rows E - H.
The plate was gently tapped, incubated overnight at 4°C, and the





1/3200 A — — -t- -h t +• + 4- ■+ -
1/6400 B — — — ■+ -h -f -t + -t -y -
1/12800 C - - — — -h ~h +" ■+" + -
1/51200 D - - — — — +■ ■t -t •f 4- -
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1/6400 E — — — 4- 4 -f- -t + -t- -
1/12800 F — - — — -f- -h -t + ■+ —
1/51200 G ~h -f~ 4- —
1/102400 H — — — — - -b —b ■f ■+* -h —
(-) No agglutination (+) Agglutination
(-) Intermediate reaction.
Sensitivity = concentration x titre (titre is the value of the last -ve well)
Therefore the sensitivities of the systems A - H are
A 2.5/40 0.0625 CU/ml.
B 2.5/80 0. 03125 CU/ml.
C 2.5/160 0. 0156 CU/ml.
D 2.5/320 0. 0078 CU/ml.
E 2.5/80 0. 03125 CU/ml.
F 2.5/160 0. 0156 CU/ml.
G 2.5/320 0. 0078 CU/ml.
H 2. 5/320 0. 0078 CU/ml.
Conclusion:
The sensitivity of the assay could be increased by using weaker anti¬
serum and a weaker concentration of cells.
The problem now arose that the system might also have been more
sensitive to non-specific agglutinins in saliva.
8. Experiment.
A short series of seven experiments was carried out to assess the
effect of adsorbed saliva on different concentrations of cells.
The method was that described in Experiment 4 above. The results
were disappointing demonstrating no difference between 2% and 1%
cells and no difference from those achieved in Experiment 4. It was
apparent/
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apparent that although the system had been made more sen¬
sitive, it was also more sensitive to non-specific agglutinins in
saliva and these were not going to be diluted out and still permit
the measurement of plasminogen. The approach had to be chan¬
ged towards removing the non-specific agglutinins.
A typical result of this experiment is recorded below. The agglut¬
inin is diluted out at 1/64. Even if the system could be kept con¬
sistently at a sensitivity of 0.0078 CU/ml. (the greatest sensitivity
achieved in Experiment 7) then at least 64 x this amount would re¬
quire to be present in saliva before it could be detected. This is
equivalent to 0.499 CU/ml. and as has been indicated before, plas¬
minogen in saliva is present in concentrations of less than 0. 1 CU/
ml.
Saliva >





B -t +• -h -h + -t
A . Sample of saliva + 2% cells.
B . Sample of saliva + 1% cells.
Discussion:
A highly significant reduction in quantity of non-specific agglutinin
in saliva was achieved with a single adsorption. Consideration was
given to a second adsorption. If the cells were properly coated with
plasminogen, the loss through adsorption of plasminogen in the test
sample should be minimal. Ludlam and Das (1971) warn, however,
that in estimating plasminogen levels in plasma, the result achieved
by haemagglutination inhibition correlates poorly with a caseinolytic
assay. Nevertheless, the writer still had to establish qualitatively
the presence of plasminogen to confirm the immunodiffusion results
rather/
227
rather than to be able to accurately estimate individual variation,
and the method of adsorption was now practiced. Furthermore, pro¬
viding an estimation of the loss of plasminogen through adsorption
could be made a result could still be achieved. The alternative was
to attempt to create a euglobulin, precipitate out the plasminogen,
redissolve it and then carry out a TRCHII. When this is done with
plasma, the plasminogen content of the precipitate is approximately
equal to that in plasma (Kline, 1966) and it does not require to be
adsorbed since the agglutinin is diluted out before the end point is
reached. The method therefore had considerable appeal. The
writer digressed from saliva, at this stage, to attempt the euglobulin
technique with plasma and compare his results with those obtained
by the staff of the coagulation laboratory of the Blood Transfusion
Service. At first, poor cprrelations were obtained, but gradually
the technique improved until results were achieved in the same order
of magnitude as those results obtained by experienced operators. A
decision had to be made at this stage because although the euglobulin
technique was improving, there was still the development of a salivary
euglobulin to be undergone and materials were expensive and the ex¬
periments very time consuming. There was also the worry that even
if a result was obtained, it would still have to be evaluated against
another technique and thus finally the decision was made to return to
adsorption, attempt a double adsorption of saliva and control it as care¬
fully as possible. If this proved successful, then in the certain know¬
ledge that plasminogen was present in saliva and with a clearer indic¬
ation of the amount present, then would be the occasion to develop a
still more accurate quantitative system. The writer considered, at
this stage, that the objective of the work was to investigate the fibrin¬
olytic system in MNS in its entirety and to establish knowledge of its
component parts and, where possible, their relative contributions.
Detailed physiological analysis with the accent upon quantitation rather





Full experimental details are contained in Methodology, p. XIV
Summary:
A small sample of MNS (about 1. 5 ml. ) was collected by minimal
stimulation from a subject working in the Laboratory. It was centri-
fuged at 4154 g. for 3 0 minutes at 4°C and the supernatant was then
removed. Diluting fluid was removed from a 2.5% aliquot of cells
and to the cells was added 0. 125 ml. of salivary supernatant. The
saliva and cells were gently mixed, covered and left at room temper¬
ature for one hour. During this time, they were periodically, gently
mixed. After one hour, the cells and saliva were transferred to a
small centrifuge tube and spun down at 4154 g. for ten minutes.
Whil e this was in progress, diluting fluid was carefully removed from
a second aliquot of cells. After centrifugation, the saliva supernatant
was carefully removed and added to the second aliquot of cells with
which it was thoroughly mixed. As before, the saliva and cells were
covered and left at room temperature with occasional further mixing.
After an hour, the mixture was centrifuged as before and the final
supernatant then removed was ready for assay, having been adsorbed
twice.
A microtitre plate was prepared and the result is recorded below and
illustrated in Fig. 58.
'// l/X 1/4 1/6 l/lt> il 3a '164 ///ie i/zsrt 11st*. 1/lozt, i/iO40
A — - 1 — — -h -t- -h -t -t ~h
B — •+- -t- -h "h ■r -+• -t" -h -h
C
— — — •— - - — — — — — —







Well B1 no agglutination , a clear button of cells was present in
the bottom of the well. This indicates that the antiplasminogen must
have been neutralized by plasminogen and that must have been
present in the test sample.
Row C shows that saliva that has been doubly adsorbed no longer





















Sensitivity = Standard x titre
2- 5
x I = 0.0078 CU/ml.
20 16
Concentration of plasminogen in saliva is sensitivity x l/titre
On repeating this experiment with the same person's saliva, a result
of 0.016 CU/ml. was obtained.
It was noticed at once how very sensitive the system was compared
to previous occasions using 2.5% cells and 1/3200 antiplasminogen.
At the time, the writer had no explanation other than that with prac¬
tice, the preparation of cells and the conducting of the experiment
had improved. Retrospectively, having prepared many batches of





cells varies often quite considerably from another in respect of
sensitivity and that the sensitivity appears to improve with time.
If a batch of sensitized cells is divided up into 2. 5 ml. aliquots in
diluting fluid, they should not be used for at least four days. In
later work, this became a week. The use of fresh diluting fluid
at every step was essential. Complete failure to obtain any
results with one whole batch of cells was eventually traced to con¬
taminated diluting fluid.
With a positive result being obtained with the very first double ad¬
sorption, it was essential to repeat the experiment at once. A
comparison of MNS from different individuals was performed.
Each sample was controlled as above and set up in duplicate.
Results:






As a consequence of this pilot study, it was concluded that sufficient
evidence existed to suggest that plasminogen was indeed present in






The following experiments were carried out in order to evaluate the
method of double adsorption.
1. Specificity.
2. Inhibition of the agglutination reaction, (1) and (2).
3. To carry out a TRCHII on known concentrations of purified
plasminogen and compare the results obtained following
single and double absorption.
4. To test for the reproducibility of results obtained by the
TRCHII system following double adsorption and to make an




Ludlam and Das (1971) list the substances they used to test the
specificity of the TRCHII.
These substances were used to test the specificity of this system
with exception of heparin which was omitted since it would not be
present in any assay in this work.
The substances listed below failed to demonstrate any interference
with the reaction. They were added to the haemagglutination in¬
hibition system in concentrations similar to those found physiologi¬
cally or used pharmacologically. They neither inhibited the aggluti¬
nation reaction at an antiserum concentration of 1/400 nor did they
cause agglutination of the sensitized cells in the absence of antiserum.
A further test was the incorporation of these substances into a 1/20
and 1/15 concentration of 2.5 CU/ml. plasminogen solution upon
which a TRCHII double adsorption was carried out. There was no
interference with the assay relative to control plasminogen solutions





1 g. /100 ml.






These substances did not interfere with haemagglutination inhibition
assay in the concentrations stated'.
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Experiment 2.
Inhibition of the agglutination reaction (1).
Method:
From a 2. 5 CU/ml. solution of plasminogen concentrations of 2. 0,
1. 5 and 1. 0 CU/ml. were prepared and thereafter further dilutions
by serial dilution as far as a concentration of 0. 0156 CU/ml.
Following the placement of one drop of diluting fluid in every well
of a 'V' microtitre plate (except row 1 from A - J) two drops of •
the prepared plasminogen solutions were placed in wells A - J, one
concentration in each well, and then serially diluted across the plate.
One drop of antiplasminogen was then placed in all wells except those
in row L (negative control). After 4 hours at 4°C, one drop of
2. 5% cells was added to every well on the plate. The plate was
read after incubating overnight at 4°C.
Result:
Row 1. Plasminogen Concentration ^ ^ 8 ^ ^
2.5 CU/ml. A
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Calculation of results. Sensitivity = concentration x titre.
Plasminogen Concentration
(CU/ml. )
A. 2. 5 Not less than 0. 019 CU/ml.
Not less than 0. 016 CU/ml.



















These results are consistent with those described in Experiment
5, Part 2 (A), Experiment 2.
There are two important findings
1. The inhibition titre was proportional to the plasminogen con¬
centration.
2. The sensitivity had remained constant.
The experiment was repeated four times and the same result was
achieved. Given that the concentration of a test plasminogen solu¬
tion is equal to the sensitivity x 1/titre, then provided that the in¬
hibition titre is proportional to plasminogen concentration and that
the sensitivity of the system remains constant, an accurate result
will be obtained.
The system described above tested purified solutions of plasminogen
carefully diluted and no adsorption was carried out. However, the
constancy/
235
constancy of the sensitivity of the system is a function of the sen¬
sitized cells and the antiserum concentration. Therefore, provided
that for every test, the antiserum strength is known and the sen¬
sitivity of cells tested by setting up known plasminogen standards
a reliable calculation of plasminogen in a test solution can be made.
Inhibition of the agglutination reaction (2)
To determine whether or not the inhibition titre will vary in pro¬
portion to the antiserum concentration given a constant concentration
of plasminogen in the test solution.
Method:
One drop of diluting fluid was placed in each well of rows A - H (except
row 1) and two drops in every well of row L. Drop volume was 0. 025
ml. A plasminogen solution of 1 CU/ml. was prepared and two drops
placed in each well of row 1 from A - H and well LI. The plasmino¬
gen in row 1 was now serially diluted across the plate using the Micro-
titre mixer. Antiplasminogen serial dilutions were now prepared from
1/50 to 1/6400. Into every well of row A was placed one drop of 1/6400
antiserum, into every well of row B one drop of 1/3200 and similarly
as far as row H into which was placed the 1/50 dilution. The plate
was gently tapped and then placed at 4°C for four hours. After four
hours, 0. 025 ml. of 2. 5% sensitized cells was added to every well in
rows A - H and L. The plate was again gently tapped and then placed
at 4°C, left overnight, and read the following morning.
The result was as follows :-
Variation of inhibition titre with antiserum concentration using a con¬
stant amount of plasminogen.
Antiserum/
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Antiserum Concentration , yx y4 </g >/|6 i/3a //^
1/6400 A.
1/3200 B.
1/1600 C. — — — — — - 'A -P
1/800 D. •h ■h •y-
1/400 E. — — — — ■f- -t- -p
1/200 F. — — — T -t -t -r -y-
1/100 G. — -t- ~h + -+■





Plasminogen Concentration in row 1: 1. 0 CU/ml.
Conclusion:
Using known solutions of purified plasminogen the degree of haemag-
glutination inhibition has been shown to be proportional to the casein-
olytic activity of the standard plasminogen solution. The inhibition
titre varied in direct proportion to the antiserum concentration using
a constant amount of plasminogen.
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Experiment 3.
Object: To carry out a TRCHII on a known concentration of
purified plasminogen and compare the results obtained
following single and double absorption.
Materials and Methods:
1. Plasminogen standard. A 0. 2 ml. aliquot of plasminogen solu¬
tion, 2. 5 CU/ml. was thawed and 1 1/15 (0.1666 CU/ml. ) and
1 1/20 (0. 125 CU/ml. ) solutions prepared using diluting fluid.
2. From a similar aliquot of plasminogen and also using diluting
fluid three test solutions of concentrations 0. 025, 0. 050 and
0.075 CU/ml. were prepared.
3. Adsorption of test solutions.
Single adsorption. Diluting fluid was removed from a 2. 5 ml.
aliquot of cells. To the cells was added 0. 125 ml. of one of
the test plasminogen solutions. The cells and test solution
were now gently mixed and left at room temperature for one
hour with occasional mixing. After one hour, the cells and
test solution were transferred to a small centrifuge tube and
spun down at 4154 g. at 4°C for 10 minutes. The supernatant
generated was then removed and stored at 4°C until it was time
to prepare the Microtitre plate. This test solution was now
regarded as having been adsorbed once.
The process was repeated for the other two test solutions.
Double adsorption. The same process as above was carried
out upon further samples of the test solutions as far as the
generation of the supernatant. The supernatant formed was
now added to a second aliquot of cells, gently mixed, covered
and left at room temperature for one hour with occasional
mixing. After one hour, the cells and test solution were trans¬




ten minutes at 4 C. The supernatant generated was then removed
and stored at 4°C. These test solutions were now regarded as hav¬
ing been adsorbed twice.
4. Preparation of the plate.
A. Diluting fluid. Vol. 0. 025 ml. One drop in every well of iows
A - E, and G - I except in every case well 1. In rows K and L
two drops of diluting fluid in every well.
B. Samples. Two drops of the test solutions were placed in row 1
in the following manner.
Well Al, Plasminogen solution standard 0. 125 CU/ml.
Well Bl, Plasminogen solution standard 0. 166 CU/ml.
Well CI, Plasminogen Test Solution 1. 0.025 CU/ml.
Well Dl, Plasminogen Test Solution 2. 0.050 CU/ml.
Well El, Plasminogen Test Solution 3. 0.075 CU/ml.
Into wells Gl, HI and II were also placed two drops of Test
Solutions 1, 2 and 3 respectively.
C. The plasminogen solutions both standards and Tests were now
serially diluted across the plate.
In series 'A' the Test Solutions were singly adsorbed.
In series 'B' the Test Solutions were doubly adsorbed.
In each series, as may be deduced from above, the Test
Solutions were set up in duplicate upon each plate.
D. One drop of antiplasminogen 1/3200 was now added to every well
in rows A - E, G - I and to row K.
E. The plate was gently tapped and left at 4°C for four hours.
F. After four hours, one drop of cells was added to every well
in rows A-E, G - I, and rows K and L.
G. The plate was gently tapped, covered, left at 4°C overnight.
It was read the following morning.
The/
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The single adsorption series together with the unadsorbed plasmin¬
ogen standards was performed four times and, therefore, every
Test Solution was set up eight times.
The double adsorption series was set up in a similar manner.
Microtitre Plate for the comparison of single and double adsorption.












- - — - -t -h +■ ■h
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— "f + + ■+* +■ + +
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— — -t + -t- -h + +-
— -f- •f* -f- -h -h -h ~h
— — -h -h -t ■r
— — "t" -h -+- -h -h -h
-h +- -f- -h -h -h -P
Well Al. Plasminogen 0. 125 CU/ml.
Bl. Plasminogen 0. 166 CU/ml.
CI. Test Plasminogen:
1. 0.025 CU/ml.
Dl. Test Plasminogen :
2. 0.050 CU/ml.
El. Test Plasminogen :
3. 0.075 CU/ml.
Gl. Test Plasminogen :
1. 0.025 CU/ml.
HI. Test Plasminogen :
2. 0.050 CU/ml.





The litre displayed above was that obtained where the Test plasmin¬
ogen solutions had been singly adsorbed. The plasminogen solutions
in rows A and B had not been adsorbed.
For both single and double adsorption, plasminogen standards, unad¬
sorbed/
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sorbed, were set up on every plate. Therefore because the strength
of every solution on the plate was known, it was possible to deter¬
mine the effect of single or double adsorption of purified plasminogen
solutions in terms of plasminogen loss.
It esults:
Sensitivity = Concentration x titre.
Concentration = Sensitivity x l/titre.
Plasminogen standard; 1. Sensitivity 0.125 x 1/8 0.0156 CU/ml.
2. Sensitivity 0. 166 x 1/8 0. 0207 CU/ml.
Test Plasminogen Solutions ; (average of 8 tests).
Concentration Concentration Concentration
Known Value Single Adsorption Double Adsorption
1. 0.025 CU/ml. 0. 016 - 0. 02 CU/ml. 0. 016 - 0. 02 CU/ml.
2. 0.050 CU/ml. 0. 0312 - 0. 0414 Cu/ml. 0. 016 - 0. 04 CU/ml.
3. 0.075 CU/ml. 0. 0312 - 0. 0414 CU/ml. 0. 0312 - 0. 04 CU/ml.
Discussion:
The accuracy of the technique was controlled by the sensitivity of the
system and the limitations imposed upon it by serial dilution.
This was well illustrated in Test 3.
The sensitivity of the system calculated from the titre obtained with
the 0. 166 CU/ml. plasminogen standard was 0.0207 CU/ml. This
was poor compared to sensitivities achieved previously of 0.007 8
CU/ml. In Test 3, as concentration equals sensitivity x l/titre, a
negative at titre 1/2 would give a concentration of 0. 04 CU/ml. whilst
the next titre, 1/4 would give a concentration of 0, 08 CU/ml. which
was clearly impossible given the known, prepared, concentration.
Thus the best obtainable value, with this sensitivity, was a little over
half the actual concentration. Intermediate results were obtained
at 1/4 titre in Test 3 on five occasions, three with single adsorption
and/
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and two with double adsorption. These had to be disregarded when
it came to calculating the concentration, but suggested that even a
slight improvement in sensitivity would have achieved a much more
accurate result. For example, in Test 3 with a sensitivity of 0.0156
CU/ml. (obtained with the 0. 125 CU/ml. standard) and a negative
reading at titre 1/4 (five intermediates were obtained) then the cal¬
culated concentration of plasminogen would have been 0. 0156 x 4, i. e.
0.062 CU/ml. or 83% of the known value (cf. 55% actually obtained).
It was not possible to state that there was no loss of plasminogen from
the Test Solutions with a second adsorption relative to the first ad¬
sorption because of the lack of sensitivity in the system. It was
permissible, however, to suggest that plasminogen could still be
detected following the second adsorption and the loss that may take
place was insufficient to be recorded by the system when the sensi¬
tivity was between 0.0156 - 0.0207 CU/ml.
242
Experiment 4.
Object: To test for the reproducibility of results obtained
by the TRCHII system following double adsorption
and to make an estimate of the amount of plasmin¬
ogen lost in the process.
Materials and Method:
1. Plasminogen standards. A 0. 2 ml. aliquot of plasminogen
solution, 2.5 CU/ml. was thawed and 1/15 (0. 166 CU/ml. ) and
1/20 (0. 125 CU/ml. ) solutions prepared using diluting fluid.
2. From a similar aliquot of plasminogen and also using diluting
fluid three test solutions of concentrations 0. 1, 0. 2 and 0.4
CU/ml. were prepared.
3. MNS. 2 ml. of fresh MNS was collected from a member of the
Laboratory staff who had no clinical evidence of gingivitis. The
MNS was centrifuged at 4154 g. , at 4°C for 30 minutes and then
the supernatant was removed and the process described in the
previous experiment for double adsorption was carried out.
The final adsorbed supernatant was stored at 4°C.
4. The test solutions were doubly adsorbed and stored at 4°C.
5. Preparation of the plate.
A. Diluting fluid: 0. 025 ml. One drop was placed in every
well of rows A - J except in each case well 1. In rows K
and L, two drops of diluting fluid were placed in each well.
B. Samples. Two drops of the test solutions were placed in
row 1 in the following manner.
Well Al. Plasminogen standard: 0. 125 CU/ml.
Well Bl. Plasminogen standard: 0. 166 CU/ml.
Wells CI, El




Wells Dl, F1 Two drops each 0. 025 ml. of the
and HI.
adsorbed plasminogen solutions,
0.4, 0.2 and 0.1 CU/ml. respectively.
C. Into all wells in row 1, was placed one drop of adsorbed MNS.
D. Into all wells in row J was placed one drop of adsorbed 0.4
CU/ml. plasminogen solution.
E. Into all the wells in rows A - H and in row K was. added one
drop of antiplasminogen, 1/3200, after which the plate was
gently tapped, covered and placed at 4°C for four hours.
F. After four hours, one drop of cells was added to every well
in every row. The plate was gently tapped, left overnight
at 4°C and read the following morning.
The plate is diagrammatically represented below
/ l/z 1/4- i/8 J/i6</33i/Mi/us-
A. — — — ■r -t- i- -t -t" Well 1. Plasminogen 0. 125 CU/ml.
B. — — - — -t -h •h -h 1 . Plasminogen 0. 166 CU/ml.
C. — -f- -h ~h ~h -h -h Adsorbed MNS.
D. — — — — -h -h + Adsorbed plasminogen, 0.4 CU/ml.
E. —
-h
-h -t- -h +- ■+- Adsorbed MNS.
F. - — — -Y •+ -h -h Adsorbed plasminogen, 0.2 CU/ml.
G. —
-H
+ -+■ -h -t- + Adsorbed MNS.
H. — — -h -t -F ~h +- -t Adsorbed plasminogen, 0. 1 CU/ml.
I. — — Row I.' Adsorbed MNS negative control.
J. Row J. Negative control, adsorbed plasmin
ogen.
Positive control, reagent.K. -t- + +- -h +■ ■h Row K.
L. Row L. Negative control, reagent.
Key: (-) No agglutination (+) Agglutination (*) Intermediate reaction.
MNS. The same specimen set up in triplicate.
Antiplasminogen, 1/3200.
R esults:




Row B. Sensitivity is Cone, x titre. 0. 166 x 1/8: 0. 0208
CU/ml.
The average sensitivity was therefore 0. 026 CU/ml.
The last negative agglutination for MNS appeared in all three in¬
stances in row 1, although an intermediate reaction occurred in each
case in row 2. This suggests a level of plasminogen in excess of
that indicated by the titre 1, but less than that if the titre were 1/2.
However, the criteria for reading the plate includes the requirement
to accept the last negative as the titre and therefore the value for the
plasminogen concentration of MNS must be taken at titre 1 and was
therefore 0. 026 CU/ml.
The last negative occurred at titre 1/8. This was equiv¬
alent to 8 x 0. 026 CU/ml. (0. 208 CU/ml. )
The actual concentration before adsorption was 0.4 CU/
ml. The titre gave a value of 52% of the actual value.
The last negative occurred at titre 1/4. This was equiv¬
alent to 4 x 0. 026 CU/ml. (0. 104 CU/ml. ) The actual
concentration before adsorption was 0. 2 CU/ml. The
titre gave a value of 52% of the actual value.
The last negative occurred at titre 1/2 with an inter¬
mediate value at 1/4. The actual concentration before
adsorption was 0. 1 CU/ml. The titre gave a value of
0. 026 x 2 (0. 052 CU/ml. ) 52% of the actual value.
All negative controls were valid.
This experiment was repeated eight times using varying concent¬
rations of plasminogen. The calculated titres in all cases gave a







The stipulation that the last negative reading must be considered
the titre for any one sample means that unless there is absolutely
no loss of plasminogen at all, then the highest titre obtainable will
give a reading approximately 50% of the actual figure since the titres
are prepared in serial dilution. Therefore, the above experiment
indicates a loss of plasminogen not exceeding 50% of the actual am¬
ount present and may disguise a loss of considerably less.. It is
not, therefore, surprising that the apparent loss in each case is
the same.
The technique of double adsorption may very well incur a greater
loss than single adsorption, but it is not detectable provided the
loss is not greater than 50% of the actual amount present. In no
case did such a loss occur. The consequence of this is that a
calculation of twice the amount estimated from the titre would re¬
present the upper limit of plasminogen concentration in any given
sample. It would, therefore seem more accurate to state a range
of values rather than a single figure.
e. g. In the test described above, the plasminogen concentration
for the MNS is between 0. 026 - 0. 052 CU/ml.
This experiment was repeated in principle, but with a minor vari¬
ation. In place of adsorbed purified plasminogen solutions, adsorbed
(doubly) solutions of MNS and purified plasminogen in the ratio 1 : 1
(v/v) were prepared. The actual amount of plasminogen added to
the MNS before adsorption would be precisely known. The amount
of plasminogen in the MNS would be calculated from control MNS
by calculation for the titre of the control MNS. In the light of the
last series of experiments, the minimum value for the MNS would
be known and, therefore, the minimum value for the mixture could
be calculated. A result in the order of 50% of this calculated value
would substantiate the preceding experiment and suggest that the
presence of MNS did not greatly interfere with the plasminogen added
to it.
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Preparation of the plate:
The preparation of the plate was as described in the preceding experi¬
ment. The plate is diagrammatically represented below
! Jjz 1/4-1/9 lilt ihi ilb* 1/1Z8
A. - - - b b b -b + Well 1. Plasminogen 0.125 CU/ml.
B. — — — — -t + + -+■ 1. Plasminogen 0. 166 CU/ml.
C. - b b b ■r b + 1. MNS
D. — — b + +- -h -h 1.
MNS plus plasminogen (0.1
CU/ml.)
E.
— b + -h -t -h -h b 1. MNS




— -b -t -b ~h -h b 1. MNS
H. — — — + -f- -t -b
1. MNS plus plasminogen (0.4
CU/ml. )
I. Row I. Adsorbed MNS negative control.
J.
— — — — — — — —
Row J. Adsorbed MNS plus plasminogen
control.
K. b -b b -h -h +" b Row K. Reagent positive control.
L. — — — — — — — — Row L. Reagent negative control.
Key:
(-) No agglutination. (+) Agglutination. ("t) Intermediate Result.
MNS. The same specimen used in triplicate.




Sensitivity. Row A. Calculated as before. 0.0312 CU/ml.
Row B. 0.0208 CU/ml.
The average sensitivity was, therefore, 0. 026 CU/ml.
MNS/
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MNS. Concentration is sensitivity x l/titre and, therefore, the
value for the concentration of plasminogen in MNS was
0.026 CU/ml. (minimum).
Row D. The last negative occurs at 1/2 and, therefore, the con¬
centration of plasminogen was not less than 0.052 C-U/ml.
Calculated value. MNS: Plasminogen, 1:1.
0.026 ,0.1 _ 0.013 ,0.05 n „„0
—2~ 2 " + = _0_1_063_1
Estimated concentration was about 0. 052 , nnni
"o.W x 100 = 82%
of calculated concentration.
Row F. The last negative occurs at 1/2 and, therefore, the con¬
centration of plasminogen was not less than 0.052 CU/ml.
Calculated value. MNS : Plasminogen, 1:1.
0. 026 0.2
„ ,,„
2 ' 2~ =
Estimated concentration was about 0.052 A nr.
Q llg x 100 = 46%
of calculated concentration.
Row H. The last negative occurs at 1/4 and the concentration of
plasminogen was not less than 0. 104 CU/ml.
Calculated value. MNS : Plasminogen, 1:1.
0. 013 + 0. 2 - 0. 213 CU/ml.
Estimated concentration was V"l x 100 = 49% of
U • Z 1 o
calculated concentration.
All negative controls are valid.
This experiment was also repeated eight times using varying con¬
centrations of plasminogen and different specimens of saliva; MNS




The results varied compared to those in the preceding experiment.
This was due in part to the fact that the 'calculated' value was an
estimation based upon the MNS titre which was indicative of about
50% of the plasminogen concentration in a sample of MNS.
From the series of experiments, the mean estimated concentration
of plasminogen derived from the titres and the sensitivity of the plates
was 55% of the calculated value. In the light of the preceding series
of experiments, this is probably too high. A practical working
figure, until such time as a more sensitive mechanism than double
adsorption is evolved, is 50%.
Conclusion:
The series of control experiments show that the TBCHII modified
by the process of double adsorption can be used qualitatively to affirm
the presence of plasminogen in saliva. A quantitative estimation is
also possible but an exact figure cannot be given. The figure cal¬





Object: To examine the MNS of an edentate and dentate population
for the presence of plasminogen.
Method:
Tanned Red Cell Haemagglutination Inhibition Immunoassay. TRCHII
modified by double adsorption.
Materials:
1. As described in Methodology, p. X.
2. Mixed Native Saliva. MNS.
Subjects^
1. Dentate: 25 Males, 25 Females. Aged 18 - 40, who had
no clinical evidence of gingivitis.
2. Edentate: 25 Males, 25 Females. Aged 20 - 82.
Each subject was carefully examined for evidence of palatal
stomatitis resulting from chronic denture irritation and any
other inflammatory reaction in the mouth. Only those subjects
with healthy mucous membranes were accepted.
Collection of Saliva:
Saliva was collected using the method described in Methodology,
p. XXV ) for the collection of saliva with minimal stimulation.
Approximately 0.5 - 1.5 ml. was collected from each subject.
Immediately after collection, the saliva sample was centrifuged
o
at 4154 g. at 4 c for 30 minutes. The supernatant was then stored
at 4°C until the adsorption process commenced. With most speci¬




The saliva samples were adsorbed and the Microtitre plate prepared
in accordance with the method described in Methodology, p. XVI,
Results:
Concentration of plasminogen in the test sample = Sensitivity of assay
x l/titre of sample.
The sensitivity of every test was determined from the titres obtained
with the two control plasminogen standard solutions set up on every
plate. The concentration of these standards was known in Caseino-
lytic Units/ml. (CU/ml. ) and therefore it was possible to express
the concentration of the test samples in the same units.
Every test was set up in duplicate.
The results are recorded in Tables 69 and 70 (Appendix 1).
Summary of Results:
Dentates:






0. 053 ± 0. 02
0. 049 "t 0. 03
0.051 * 0. 025
Edentates:






0.055 ± 0. 02
0.058 ± 0. 03
0.056 ± 0. 026
All Subjects (100) 0. 054 ± 0. 025
These results record the calculated amount of plasminogen in a sample
of MNS. It has been demonstrated in the control experiments that
approximately/
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approximately a 50% loss can be expected and this must be borne in
mind when interpreting the figures. The numerical value should be
understood to mean "not less than x CU/ml. "
Analysis and Discussion of Results:
Dentates
94% of samples contained detectable plasminogen.
There was no significant difference between the amount of plasminogen
detected in male saliva compared to that detected in female saliva
("t" = 0. 54).
Edentates
96% of samples contained detectable plasminogen.
There was no significant difference between the amount of plasminogen
detected in male saliva compared to that detected in female saliva,
("t" = 0.408).
Combined total of edentates and dentates.
95% of samples contained detectable plasminogen.
Mean value for plasminogen (100) 0. 054 "t 0. 025 CU/ml.
There was no significant difference between the amount of plasminogen
detected in dentate saliva compared to that detected in edentate saliva.
("t" - 0. 969).
As there was no significant difference between the measurable amount
of plasminogen present in dentate saliva compared with that in edentate
saliva, the contribution of plasminogen from the gingival fluid to the
MNS must, in the uninflamed mouth, be also insignificant. Higher
plasminogen levels might be detected in the MNS of patients suffering
from acute gingivitis where the gingival fluid contribution would be
greatly increased.
It has now been established that the gingival fluid contributes an insig¬
nificant amount of plasminogen to the MNS in the healthy mouth and,
therefore, /
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therefore, the most probable source is the secretions of the major
salivary glands. If their secretions contain plasminogen in the same
order of magnitude as the supernatant of MNS, then the major sources




Object: To examine the parotid and submandibular saliva




Parotid and submandibular/sublingual saliva were collected (Method¬
ology, p. XXIX ) from twelve subjects, aged between 18 - 35, who
were in good health, taking no drugs, and who had no clinical evidence
of gingivitis. Approximately 0.5 - 1.0 ml. of each saliva was collec¬
ted from each subject.
Method:
Double adsorption and TRCHII as described in Methodology, p. X.
Results:
These are recorded in Table 71 (Appendix 1).
Summary of results : -
Subjects Number Concentration of Plasminogen: CU/ml.
Parotid Submandibular/ sublingual
Male and
Female 12 0.049 * 0.02 0.051 *0.02
Discussion:
The sample was small but adequately demonstrated in the twelve
parotid and submandibular salivas plasminogen to be present in the
same order of magnitude as in the MNS. No negative results were
obtained. These results confirm the immunodiffusion findings that
plasminogen is present in both parotid and submandibular/sublingual
saliva and whilst not excluding the possibility of a contribution by
diffusion/
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diffusion through the mucous membrane, the plasminogen in MNS





Gel chromatography is a separation method based on differences in
molecular dimensions. The tool for obtaining a separation is the
chromatographic bed which consists of minute particles usually
packed into a tube. The space between the particles is occupied
by a liquid which is made to flow through the bed, and carries the
substances to be separated. The separation is in accord with mole¬
cular weight. Large molecules will emerge first from the bed while
smaller molecules are retarded because the small molecules, can
pass into the gel particles and lag behind the large molecules that
cannot penetrate into the gel.
Object:
1. To fraction the supernatant of MNS and determine the absence
or presence of plasminogen in the fractions by observing
whether or not lysis of bovine fibrin takes place after combining
the fractions with streptokinase and also by direct measure¬
ment using TRCHII.
2. To observe whether or not those fractions that appear to
contain plasminogen contain substances whose molecular weight
is in the same order of magnitude as that of plasminogen.
3. To determine whether or not any of the fractions have any
activator activity.
Materials and Methods:
Chromatograph Gel. Sephadex G200. A dextran gel, medium
grade, of particle size 40 - 120 micron
diameter. Fractionation range 5, 000 -
800, 000 (Pharmacia Fine Chemicals AB,
Box 604 S-751 Uppsala 1, Sweden).
Treatment/
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Treatment of Gel. Fines were removed by decantation lOx
with saline before packing. This achieves
better resolution and a better flow rate.
Elution Medium. AG azide saline. (Aronson-Gronwal azide
saline and comprises 25mM tris, 4mM
borate, 3mM NaN , ImM EDTA and 0. 15
O
M NaClat pH 8. 6.
Eluting conditions. Flow 20 ml. /hour. 15 minute fractions each
of 5 ml. at 20°C.
Optical density. The optical density of the fractions was measured
at 280 nm on a spectrophotometer in 1 cm. cells.
Standard human fibrin plates (Methodology, p. I).
Standard bovine fibrin plates (Methodology, p. IV).
Reagents and equipment for Tanned Red Cell Haemagglutination In¬
hibition Immunoassay (TRCHII). See Methodology, p. X.
Streptokinase: 2, 500 units/ml.
Urokinase: 5 Ploug units/ml. pH 7.8, 0. 15M.
Tris buffer, pH 7. 8, 0. 15M.
MNS supernatant. MNS was collected in accordance with the method
described in Methodology, p. XXVI for the collection of stimulated
MNS. The supernatant was prepared by centrifugation at 4154 g. for
30 minutes followed by centrifugation at 14, 000 r.p.m. , 28, 000 g. for
one hour.
Subjects. All subjects were aged 18 - 33, in good health, were taking
no drugs and had no clinical evidence of gingivitis.
Procedure:
About 110 ml. of MNS supernatant was concentrated in an ultra-filt¬
ration cell (Amicon, PM10) to between 8-10 ml. to form the test
sample. /
sample.
The density of the sample was not greater than the eluant in this
system and therefore glucose (50 mg. ) was added to it. (The glucose
is eluted later than the test substances and does not disturb the ex¬
periment).
The sample was now applied as follows. The eluant above the surface
of the bed was removed until a layer about 1 cm. thick remained. The
sample was then layered on manually under the surface of the eluant
with a long Pasteur pipette. The sample solution, now denser than
the eluant, displaced it, formed an even layer on top of the bed and
was then carried into the bed by the flow. When the sample had
passed into the bed, the space above the top of the bed was filled with
eluant and the column connected to the eluant reservoir. The eluting
conditions allowed a flow of 20 ml./hour and the 15 minute fractions
(each 5 ml. ) were collected automatically. After 20 hours, the frac¬
tions were removed and the run stopped. The optical density of each
fraction was measured at 280 nm (maximum absorption by amino acids)
and the protein profile plotted.
Calculation:
The glucose is detected on elution with a Clinistick and the point (fraction)
of elution gives V (elution volume of the solvent),
s
V Void volume. This is the volume of the liquid in the interstitial
o
space between the grains in the bed. It is determined by a substance
that is not retarded by the bed material by measurement of its elution
volume. As it is completely excluded, it gives a very sharp peak after
which the protein profile for the sample appears. Thus can be deter¬
mined by visual inspection of the protein profile of the complete run.
Now the volume of liquid, for small samples, that has passed the column
between the application of the sample and elution of the maximum con¬
centration of a particular substance is the elution volume of that sub¬




plasminogen. Every fraction from a run was stored at 4°C. From
each fraction was removed 0. 5 ml. of solution which was then mixed
1:1 with streptokinase (2, 500 units). This mixture was then plated
(3 x 0. 03 ml. ) upon SBFP and incubated at 37°C for 19 hours.
Evidence of lysis was interpreted as being suggestive of the pre¬
sence of plasminogen. Reference was now made to the protein
profile for the saliva from which the fractions were derived and
those fractions containing "plasminogen" marked. The most con¬
centrated fraction effectively gives V .
The elution behaviour from Gel columns has been found to be so
reproducible that columns do not need frequent recalibration and
that for a particular Gel, here G200, a standard reference curve
(Graph 5) can be drawn describing the relationship between elution
behaviour and molecular weight. It is obtained by applying samples
of known molecular weight such as IgG (158, 000) Ovalbumin (45, 000)
and albumin (68, 000).
Now if only the liquid imbibed in the gel is assumed to be the stationary
phase, then the partition coefficient may be defined as :-
V - V




to solvent volume respectively. A relationship exists between
and the molecular weight. Thus having obtained V , V and V
o s e
experimentally, can be calculated with reference to and as the
molecular weight is accurately known can be plotted against the
log of the molecular weight. Given three known molecular weights,
preferably more, the curve can be plotted showing the relationship
between molecular weight and K . This is diagrammatically re¬
presented in Graph 5. The curve represents the working range of
the Gel.
If now a saliva sample is run on this column and the fractions tested
for/
Plot of the K_j volume against logarithms of the molecular weight
for the different proteins on Sephadex G200. Inserted figure shows
the whole separation range: 1. Sucrose 2. Vitamin B 3. Cyto¬
chrome C 4. Alpha Chymotrypsin 5. Ovalbumin 6. Gamma globu¬
lin and 7. Blue dextran.
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for plasminogen as described then may be determined. From the
formula above, K is calculated and by reference to the standard curve
for G200, the corresponding molecular weight may be obtained.
In this experiment, the information required was whether or not those
fractions that displayed activator activity on bovine fibrin plates after
being combined with streptokinase contained protein whose molecular
weight was in the same order of magnitude as that of plasminogen.
If the fractions did coincide with such a molecular weight, then the
probability of them containing plasminogen as distinct from some
other streptokinase-activated proactivator would be extremely high.
Summary of Results: Table 7 2. (Appendix 1).
Fraction 1. Graph 6.
Fraction numbers 37 - 44 produced lysis on SBFP when combined 1:1
with streptokinase.
Molecular weight range : 95, 000 - 44, 000
Molecular weight of fraction which gave maximum lysis 58, 880.
Fraction 2. Graph 7.
Fraction numbers 50 - 58 produced lysis as above.
Molecular weight range : 138,000 - 70,790.
Molecular weight of fraction which gave maximum lysis 117, 500.
Fraction 3. Graph 8.
Fraction numbers 40 - 47 produced lysis as above.
Molecular weight range 102, 300 - 53, 700.
Molecular weight of fraction which gave maximum lysis 93, 330.
Fraction 4. Graph 9.
Fraction numbers 35 - 42 produced lysis as above.
Molecular weight range 107, 000 - 52,480.
Molecular/
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Molecular weight of fraction which gave maximum lysis 52,480.
Fraction 5. Graph 10A.
Fraction numbers 43 - 46 produced lysis as above.
Molecular weight range 89, 130 - 66, 070.
Molecular weight of fraction which gave maximum lysis 74, 130.
Fraction 6. Graph 11A.
Fraction numbers 37 - 43 produced lysis as above.
Molecular weight range 67, 610 - 38, 000.
Molecular weight of fraction which gave maximum lysis 63, 000.
Duplicate graphs of Fractions 5 and 6 are illustrated displaying the
additional information obtained by TRCHII (Graphs 10B and 11B).
After the fractions had all been tested with streptokinase, the active
fractions and a random selection of non-active fractions were subjected
to TRCHII using the double adsorption technique. The results are
described by the plots on these two graphs. Positive readings occur¬
red only in those fractions which, when combined with streptokinase,
produced lysis in SBFP. The shape of the lysis graph and the TRCHII
graph are very similar and thus confirm beyond all reasonable doubt
that the streptokinase-activated proactivator contained in those frac¬


























































































Object: To examine the streptokinase-activated proactivator
activity of the cellular components of MNS using
SBFP and fibrinolytic autography.
Materials:
1. Salivary pellet. Stimulated MNS (Methodology, p. XXVI)
was collected from 20 healthy persons with no clinical evidence
of gingivitis. Each MNS sample was centrifuged at 4°C, 4154 g.
for 20 minutes after which the supernatant was discarded and the
pellet washed in tris buffer by centrifugation 3 times and finally re-
suspended in 0. 5 ml. of tris. The washing was necessary to re¬
move plasminogen in solution, but it also removed many epithe¬
lial cell fragments, leukocytes and bacteria.
2. Oral bacteria. The same isolates, suspensions and filtrates
were used as were prepared in Part IV, Chapter 4 , Experiment 2.
3. Leukocytes. The same suspensions of washed leukocytes in
Heparin-Saline-Dextrose (I4SD), MNS supernatant and freeze-
thawed cells in MSD as in Part IV, Chapter 5 , Experiment 1.
4. Oral epithelial cells. Buccal and tongue scrapings were made
with a wooden tongue spatula. The scrapings were pooled to
form dense concentrations of buccal and tongue cells. The two
sets of cells were then washed by centrifugation in tris buffer and
finally resuspended and doubly diluted to form several concent¬
rations of cell suspensions. A cell count was carried out upon
each prepared sample using an Improved Neubauer counting
chamber.
5. SBFP. (Methodology, p. IV).
6. Tris buffer, pH 7. 8, 0. 15M. Negative control.
7./
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7. Urokinase, 5 Ploug units/ml. pH 7. 8, 0. 15M. Positive control.
8. Streptokinase. 2, 500 units/ml. (SK).
9. Molar Epsilon-amino-caproic acid (eACA).
10. Bovine fibrin autography.
Methods:
1. SBFP
Each of the cell preparations was divided into two. One half was
mixed 1:1 (v/v) with tris buffer while the other half was similarly
mixed with streptokinase. 'Each preparation was plated (3 x 0. 03
ml. ) upon SBFP and upon SBFP containing 0. 1 ml. of molar eACA.
The plates were incubated at 37°C for 19 hours and controls were
set up as described in Part II, Experiment 3, Fig. 3. In addition,
streptokinase was set up as a negative control.
2. Bovine fibrin autography.




Salivary pellet. All 20 specimens lysed SBFP when mixed with SK
(Mean 118 - 44 sq. mm. ) There was no lysis in the absence of SK
nor in the presence of eACA.
Bacteria. Of all the bacterial preparations, only the BHS suspension
caused lysis and BHS filtrate probable lysis of SBFP alone. No acti¬
vity was recorded on SBFP with eACA by any preparation. The ad¬
dition of SK to concentrated preparations brought about lysis with BHS,
bacterial/
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bacterial sweep and with the mixed bacterial suspension and probable
lysis with bacterial isolates and BHS filtrate. When eACA was pre¬
sent in the plates, however, no lysis occurred and probable lysis was
present only with the isolates and the bacterial sweep.
Leukocytes. Upon SBFP alone, the greatest activity was brought
about by freeze thawed cells followed by those resuspended in MNS
supernatant and very little activity from cells that had been washed
in saline, and then only at high concentration. The addition of SK
increased lysis considerably in all cell preparations, but the same
pattern of relative activity existed. In the absence of SK and upon
SBFP containing eACA only very concentrated suspensions of freeze-
thawed cells caused any lysis. Upon the same plates but with SK
present in the suspension, activity reappeared in the most concent¬
rated samples, in the same order of relative activity as before, but
reduced compared to the SBFP without eACA.
Oral epithelial cells. The buccal and tongue epithelial cell prepar¬
ations did not lyse SBFP. Lysis was produced on SBFP when SK
was included with the cells, and this lysis did not occur if eACA was
also present.
2. Bovine fibrin autographs.
Salivary pellet. Isolated foci of lysis were related to epithelial cells
in the presence of SK. (Fig. 59). No lysis occurred in the absence
of SK or in the presence of eACA.
Bacteria. Foci of lysis, often coalescing to lyse the whole film, were
seen in the presence of SK (Fig. 60). No lysis occurred in the absence
of SK or in the presence of eACA.
Leukocytes. Foci of lysis were related to leukocytes especially where
they were present in clumps but only in the presence of SK. (Fig. 61
and/
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and 62). No lysis was present in the absence of SK or in the presence
of eACA.
N. B. No lysis was seen in relation to erythrocytes also present in
the leukocyte suspensions either with or without SK.
Epithelial cells. Foci of lysis were related to both nucleated and
anucleated epithelial cells from the cheek (Fig. 63 and 64),and the
dorsum of the tongue (Fig. 65) in the presence of SK but once more,
no lysis occurred in the absence of SK or in the presence of eACA.
Discussion:
Using fibrinolytic autography and SBFP, the cellular components of
MNS have been shown to have a streptokinase-activated proactivator
activity which was inhibited with eACA. The study of the individual
cellular components complemented the findings of the whole salivary
pellet. On the fibrin autographs, bacterial morphology was altered
with prolonged incubation with SK and extreme lysis (Fig. 66 and 67).
The possibility arises that this might be related to the streptodornase
content of the commercially available SK (Varidase). As purified
SK was not available, this possibility was not investigated further.
The significance of this observation is that the reaction appeared to
be non-specific in relation to bacteria (i. e. all isolates were affected)
and this type of activity must be considered when any test solution
that is contaminat ed is examined for proactivator activity with SK.
Human epidermis has a SK-activated proactivator activity (Nishioka
and Ryan, 1971) and it has been shown that oral epithelial cells have
a similar property. Troll and Sherry (1955) suggest two possibili¬
ties to explain interaction with SK and proactivator: SK may remove
an inhibitor, or it may itself combine with the proactivator to form
the activator. Furthermore, it is postulated that plasminogen acti¬
vator and inhibitor exist as an easily dissociable complex in the blood
(Wolf, 1968). It is, therefore, possible that in the epidermis (Nish¬




Fibrinolytic autograph of washed salivary pellet with streptokinase
included in the bovine fibrin film and showing foci of lysis related




Fibrinolytic autograph of Alpha Haemolytic Streptococci isolated
from MNS with streptokinase included in the bovine fibrin film.
Lysis related to a clump of bacteria. N. B. The bacteria have
fallen to one side of the focus of lysis during incubation due to
gravity. Incubated overnight at room temperature and 1 hour at
37°C. Mag. x 48.
Fig. 61.
Figs. 61 & 62.
Fibrinolytic autograph of fresh leukocytes suspended in saline and
included together with streptokinase in bovine fibrin showing lysis
related to clumps of leukocytes but not to the erythrocytes which
were also present. N. B. The leukocytes have fallen to one side
of the foci of lysis during incubation due to gravity.
Incubated overnight at room temperature and 1 hour at 37°C.
Mag. Fig. 61 x 48. Fig. 62 x 120.
Fig. 63. Fig. 64.
Figs. 63 & 64. Fibrinolytic autographs of a suspension of buccal
cells in tris buffer included together with streptokinase in bovine
fibrin , showing lysis related to nucleated and anuclear cells.
Incubated overnight at room temperature. Mag. Fig. 63 x 120
Fig. 64 x 48.
Fig. 65. Fibrinolytic autograph of a suspension of dorsum tongue
cells in tris buffer together with streptokinase in bovine fibrin ,
showing lysis related to an anuclear cell fragment. Incubated for
1 hour at 37°C. Mag. x 120.
Fig. 66.
Fig. 66.
Fibrinolytic autograph of Alpha Haemolytic Streptococci isolated
from MNS showing no lysis with bovine fibrin. Incubated over¬
night at room temperature. Mag. x 300.
Fig. 67.
Fig. 67.
Fibrinolytic autograph similar to Fig. 66 except that streptokinase
was included in the bovine fibrin film. Total lysis of the fibrin
has occurred with gross alteration of bacterial morphology.
Mag. x 300.
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may exist as a complex which is dissociated by Sk-treatment. This
might apply also to oral epithelial cells. This Thesis is concerned
with the source of the SK-activated proactivator activity and the
nature of that activity will constitute further work. However, a
preliminary indirect immunofluorescence study of human buccal
epithelial cells using antiplasminogen has already suggested that the
buccal cell associated activity is due to plasminogen (Fig. 68). It
is not known whether this plasminogen is produced from within the
cell or adsorbed onto its surface from saliva. Recent permeability
studies of the oral mucosa (Hopps and Squier, 197 6) suggest that a
molecule as large as plasminogen would not diffuse through the oral
mucosa.
Conclusion:
1. All the cellular components of MNS have SK activated pro -
activator activity when studied in isolation.
2. In view of the fact that some individual cells showed activity
with fibrinolytic autography and with due regard to their size




Indirect immunofluorescence using antiplasminogen serum showing
strong fluorescence of a single cell and slight fluorescence of many




From these experiments, it can be concluded that there are two com¬
ponents in MNS reacting with streptokinase. One of these is in solu¬
tion and the other cell associated. The two components have been
separated and it has been demonstrated that a soluble streptokinase
activated proactivator is present in MNS, parotid and submandibular/
sublingual saliva. This proactivator activity remains when all acti¬
vator activity has been removed either by filtration or centrifugation.
The nature of this soluble proactivator has been investigated by ob¬
serving its activity after combination with streptokinase upon S BFP,
by studying it in an immunodiffusion system and by TRCHII, and lastly
by gel chromatography and observing at what molecular weight plas-
minogen-like activity occurred. The results were consistent quali¬
tatively and all the evidence indicated that this streptokinase-activ-
ated proactivator was plasminogen.
The major source undoubtedly appeared to be the paired salivary
glands but a little plasminogen may re-enter the MNS from the mucous
membrane to which some may be adsorbed (or produced) for the high
speed supernatant MNS plasminogen level as indicated by SK-activated
proactivator activity upon SBFP was consistently higher than that of
isolated parotid or submandibular/sublingual saliva albeit the differ¬
ence was small.
Washed salivary pellet cells capable of producing only a little lysis
upon SHFP when placed in a solution of plasminogen of 0. 05 CU/ml.
produced lysis in the same order of magnitude as achieved by placing
the washed cells back in the MNS supernatant. Two points arise from
this. Firstly, the plasminogen solution, based upon the calculated
amount of plasminogen in MNS, behaved very like MNS supernatant
and secondly, the activator activity of the washed cells, and these
must/
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must necessarily be mainly epithelial cells, can activate the plas¬
minogen in solution to bring about lysis. This then suggests that
the fibrinolytic activity in MNS is generated by plasminogen in sol¬
ution and a cell-associated activator.
The findings of Part IV indicate that although salivary leukocytes may
have a small activator activity, both their contribution and that of the
oral bacteria is negligible and the predominant activator cell is the
desquamated epithelial cell.
It is concluded then from this series of experiments that the soluble
proactivator in MNS, parotid and submandibular/sublingual saliva
is plasminogen and that in vivo, the plasminogen activator is cell-
associated and does not appear to diffuse into solution. Hence, plas¬
minogen in MNS is not immediately converted into plasmin but is so
converted if the activator cell (epithelial cell) and the MNS are incub¬
ated together, e. g. upon a SHFP.
Quantitatively, the results are less satisfying. The level of plas¬
minogen present in the average MNS from clean dentate and eden¬
tate mouths appeared to be in the region of 0. 05 CU/ml. The control
experiments indicated a considerable loss, in the region of 50% and
clearly further work needs to be done to improve this. An attempt
to produce a satisfactory euglobulin is one approach; immunoelectro-
phoresis another. The writer believes, however, that the correct









Summary of Results and Conclusions
Part I concludes with a statement of Objectives, viz.
1. Does human MNS possess specific plasminogen activator
activity?
2. If activator activity is present, what is its source?
3. What is the nature of 'proactivator' in saliva?
Question 1
It was demonstrated, consistently, that MNS had plasminogen activator
activity and that within the sensitivity of the fibrin plate technique, this
activity appeared to be specific as no lysis took place in the presence
of eACA, a specific competitive inhibitor of plasminogen activation.
Conclusion: MNS possesses specific plasminogen activator activity.
Question 2
When MNS was rendered cell free either by filtration or centrifugation-
the activator activity (even in concentrated supernatant) was lost.
Isolated parotid and submandibular/sublingual secretions occasionally
showed activity, but when contaminating cells were removed, the
secretions became inactive. The concentrated supernatant of pooled
MNS was examined by gel chromatography and each fraction was tested
for fibrinolytic activity. No fraction lysed an SHFP even after con¬
centrating 25 times. Salivary pellet separated on a density gradient
showed that although part of the activity was confined to the least dense
fraction, this was related to cellular material and no soluble activator
was present. From these results, it is deduced that there is no solu¬
ble plasminogen activator in MNS and that the activator activity is cell
associated. /
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associated. Experiments have been described and discussed which
systematically examined the cellular components of MNS and which
demonstrated that it was epithelial cells and epithelial cell fragments
which had.activator activity.
Conclusion: There is no soluble plasminogen activator in MNS.
The activator activity is associated with epithelial cells and cell
fragments.
Question 3
Streptokinase-activated 'proactivator' activity has been demonstrated
both in MNS and in the supernatant of MNS. The activity in MNS
however was much greater and was separated into two compartments,
one in solution, the other cell associated. Using the techniques of
immunodiffusion, TRCHII and gel chromatography, plasminogen has
been established as being present in MNS, parotid and submandibular/
sublingual saliva and in sufficient quantity as to account for all the
streptokinase-activated proactivator activity in solution. No experi¬
ments however were carried out to investigate the presence of any
streptokinase-activated proactivator that was not plasminogen.
Systematic examination of the individual cellular components of MNS
showed activator activity with streptokinase to be associated with all
cell types, but in view of frequent individual cell activity, their num¬
bers and size, the epithelial cells were the most important. With
both bacteria and leukocytes much higher numbers than found in
saliva were required to produce measurable lysis. The nature of
this cell associated proactivator activity has been discussed.
Conclusion: Proactivator exists in MNS in two compartments:
soluble and cell associated. The evidence shows that the soluble
proactivator is mostly, if not entirely, plasminogen.
The cell associated proactivator activity is a property of all cell
types present but is predominantly associated with desquamated
epithelial cells.
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To summarise the.major plasminogen activating system in human
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The question of "function" inevitably arises whenever an enzyme
system is studied. It has been suggested that urokinase may serve
to maintain the patency of the ureter (McNicol et al, 1961) but no
similar function can be attributed to saliva in respect of the parotid
and submandibular ducts for here the activator is not in solution.
1. Inevitable Action.
In this study as well as in the investigations on human vaginal epith¬
elium (Tympanidis et al, 19 68), rat vaginal epithelium (Henrichsen
and Astrup, 1967) and human oral epithelial cells (Birn and Fejer-
skov, 1971) it was found that a minority of the epithelial cells were
fibrinolytically active and the activity was not restricted to any
specific cell layer. It is not at all clear what the value of fibrin¬
olytic activity in these sites could be, but Wunschmann-Henderson
and Astrup (1972) suggest that fibrinolysis may be involved in the
process of cell desquamation. This is, at least, consistent with
the presence of a few, about 2%, fibrinolytically active desquamated
epithelial cells in MNS. Plasminogen in the parotid and submandi¬
bular/sublingual secretions has been established and it may be pre¬
sent as a filtrate of blood. A future experiment is intended to
establish whether or not a relationship exists between plasminogen
levels in plasma and MNS. It has been shown that the supernatant
of MNS is fibrinolytically inactive, but when incubated with washed
desquamated epithelial cells derived from salivary pellet, the sus¬
pension produced lysis upon an SHFP. The same result was ob¬
tained by incubating the cells with a concentration of plasminogen
calculated to be equivalent to that present in MNS. The cells alone
produced only/
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only a little activity. Thus it may be that it is the method which,
as it were, 'confers' fibrinolytic properties upon MNS by incubating
together a weak activator and plasminogen. In vivo with a clearance
time for MNS of twenty minutes, the fibrinolytic activity may effect¬
ively not exist. It is a well established practice in dentistry to try
and keep saliva out <■' the socket immediately following extraction
of a tooth for it has been observed that when saliva has contaminated
the wound prior to a clot forming, then the clot frequently lyses
rapidly and the wound becomes infected. This is generally attri¬
buted to infection by the oral flora and hence the pre-extraction
cleansing of the mouth when ever possible. Given the vast number
of oral bacteria, the depressingly large number of teeth extracted
daily and the relatively infrequent occurrence of 'dry sockets', it is
possible that the bacteria are not responsible. The mouth cleansing
procedures will greatly reduce the numbers of desquamated epith¬
elial cells in MNS and hence the number available to be incorporated in
a blood clot within a socket. Desquamated epithelial cells incubated
within the blood clot in vivo may greatly reduce the clot lysis time.
This suggests future experimental work and as a preliminary, the
writer and his colleagues have incorporated urokinase in rat tooth
sockets with tris buffer being incorporated in control sockets. Where
urokinase has been incorporated, dry sockets have developed.
Thus the fibrinolytic activity of MNS may be simply an inevitable con¬
sequence of incubating desquamated epithelial cells with plasminogen
and the danger of allowing saliva into a socket may not be related to
bacteria or the fibrinolytic activity of MNS, per se, but rather to des¬
quamated epithelial cells that become incorporated in the blood clot.
2. Evolutionary advantage.
Nour-Eldin and Wilkinson (1957) list the many blood clotting factors
present in MNS and observe that saliva mixed with blood brings about
a clotting time of between 2.5-4 minutes even when the saliva is
derived/
282
derived from a haemophiliac and mixed with a haemophiliac's own
blood. Mason and Chisholm (1975) list the many antibacterial sub¬
stances present in saliva. If these are considered with the mechanical
cleansing effects of saliva, then there is a sound basis for the idiom
"to lick one's wounds". It would confer little advantage if a potent
fibrinolytic substance was also in saliva at the very time when a
stable clot was required. Therefore, the absence of a soluble plas¬
minogen activator in MNS may be of some advantage.
3. Comparative Physiology.
With the exclusion of a soluble plasminogen activator in MNS, there
is no need to attribute any atavistic function to salivary fibrinolysis
but the species specific plasminogen activator in the saliva of the
common vampire bat, Desmodus rotundus (Hawkey, 1966) and the
equally specific (but for different species) plasminogen activator
in the saliva of Disemus youngi (Cartwright and Hawkey, 1968) illus¬
trate a vital role for salivary fibrinolysis in some animals.
Future studies.
The work carried out for this Thesis has raised more questions
than it has answered.
1. Plasminogen. A more accurate quantitative technique for
saliva requires to be developed. A possibility is the production of
a euglobulin fraction obtained by dialysis and ammonium sulphate
precipitation of parotid and submandibular/sublingual secretions.
2. Physiological studies concerning plasminogen levels in secreted
salivas with respect to levels in plasma. The effect of age, sex,
menstruation etc. might be studied.
3. The activator has been described as 'cell associated' but
from where in the cell does it arise? The fragments and anuc-
lear/
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lear cells suggest it may be cell bound and certainly in preliminary
investigations by the writer, no 'release' has yet been obtained using
sonication or potassium thiocyanate.
4. How stable is this cell activator at various temperatures and pH?
The early preliminary experiments which studied the stability of acti¬
vator in MNS suggest it is not very stable at 37°C, but systematic
studies upon cells has yet to be carried out.
5. Are there any fibrinolytic inhibitors in MNS?
6. What is the relationship, if any, between the presence of plasmin¬
ogen in MNS and the coagulant factors also present?
7. Is there an association between plasminogen levels in saliva and
the finding that some patients bleed for an excessively long time after
extraction of teeth and yet appear to fall within normal parameters
when examined for a bleeding disorder and do not bleed excessively
from a wound anywhere else in the body?
8. Is the plasminogen activating activity of some desquamated epi¬
thelial cells responsible for 'dry sockets'? If so, can preventive
treatment be devised?
9. Spontaneous gingival haemorrhage is poorly understood. Could
it be related to accumulated desquamated epithelial cells in the
materia alba being allowed to incubate with plasminogen in the ging¬
ival fluid?
10. Is the clinical observation that with exception of gross traumatic
wounds and clot filled sockets blood clots are not seen in the mouth
(even after quite severe denture irritation associated with atrophy,
ulceration and granulation tissue) attributable to the plasminogen
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